Table of Contents

UNITED STATES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K


FORM 10-K

(Mark One)

xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 20172019

OR

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244


VEECO INSTRUMENTS INC.INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

11-2989601

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

Terminal Drive

Plainview, New York

11803

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code:

(516) (516677-0200

Securities registered pursuant to Section 12(b) of the Act:

(Title of each class)class

Trading Symbol(s)

(Name of each exchange on which registered)registered

Common Stock, par value $0.01 per share

VECO

The NASDAQ Stock Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes oNo x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by references in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x

Accelerated filer o

Non-accelerated filer o (Do not check if a smaller reporting company)

Smaller reporting company o

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). o Yes x No

The aggregate market value of the common stock held by non-affiliates of the registrant at June 30, 201728, 2019 (the last business day of the registrant’s most recently completed second quarter) was $1,328,017,475$584,427,830 based on the closing price of $27.85$12.22 on the NASDAQ StockGlobal Select Market on that date.

The numberAs of February 14, 2020, there were 49,000,023 shares of each of the registrant’s classes of common stock outstanding on February 14, 2018 was 48,156,865 shares of common stock, par value $0.01 per share.share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the definitive Proxy Statement to be used in connection with the Registrant’s 20182020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K.10-K.



2

This Annual Report on Form 10-K (“Form 10-K”) contains certain forward-looking information relating to Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “Registrant,” “we,” “our,” or “us,” unless the context indicates otherwise) that is based on the beliefs of, and assumptions made by, our management as well as information currently available to management. When used in this Form 10-K, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions relating to the future are intended to identify forward-looking information. Discussions containing such forward-looking statements may be found in Part I, Items 1 and 3, Part II, Items 7 and 7A hereof, as well as within this Form 10-K generally. This forward-looking information reflects our current views with respect to future events and is subject to certain risks, uncertainties, and assumptions, some of which are described under the caption “Risk Factors” in Part I, Item 1A, and elsewhere in this Form 10-K. Should one or more of these risks or uncertainties occur, or should our assumptions prove incorrect, actual results may vary materially from the forward-looking information described in this Form 10-K as believed, anticipated, expected, estimated, targeted, planned, or similarly identified. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances after the date of such statements.

PART I

Item 1. Business

Recent Developments

On May 26, 2017, we completed the acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, we establish ourselves as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications, as well as greatly increasing our critical mass in the front-end semiconductor market. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Business Description and Overview

Headquartered in Plainview, New York, we were organized as a Delaware corporation in 1989. We develop, manufacture, sell, and supportare an innovative manufacturer of semiconductor process equipment to meet the demandswhich solve an array of key global trends such as enhancing mobility, increasing connectivity, and improving energy efficiency.challenging materials engineering problems for our customers. Our primary technologies include metalcomprehensive collection of ion beam, laser annealing, lithography, MOCVD (metal organic chemical vapor deposition, advanced packaging lithography,deposition), MBE (molecular beam epitaxy), ALD (atomic layer deposition) and single wafer wet etch and clean laser annealing, ion beam, molecular beam epitaxy, wafer inspection, and atomic layer deposition systems. These technologies play an integral role in producing Light Emitting Diodes (“LEDs”)the fabrication of key devices that are enabling the 4th industrial revolution of all things connected. Such devices include leading node application processors for solid-state lighting andmobile devices, thin film magnetic heads for hard disk drives in data storage, photonics devices for 3D sensing, advanced displays and in the fabricationhigh-speed communications, radio frequency (“RF”) filters and packagingpower amplifiers for fifth generation (“5G”) networks and mobile electronics. In close partnership with our customers, we combine decades of advanced semiconductor devices. Weapplications and materials know-how with leading-edge systems engineering to deliver high-volume manufacturing solutions with superior cost of ownership. Serving a global and highly interconnected customer base, we have comprehensive sales and service operations across the Asia-Pacific region, Europe, and North America to directly address our customers’ needs.needs and maximize our system uptime.

We are focused on:Our priorities are:

Focus on our products - Innovate by providing differentiated semiconductor and thin film process equipment to address our customers’ challenging materials engineering problems for current production requirements and next generation product development roadmaps; Invest in focused research and development in markets that we believe provide significant growth opportunities or are at an inflection point, including compound semiconductor, leading edge front-end semiconductor, and advanced packaging; Maintain strength in our foundational businesses, including our data storage and service offerings, and sales to universities and research institutions;

·                              Providing differentiated semiconductor process equipment to address customers’ current production requirements and next generation product development roadmaps;

·                              Investing to win through focused research and development in markets that we believe provide significant growth opportunities or are at an inflection point in semiconductor process equipment requirements, including LED, power electronics, photonics, front-end semiconductor, and advanced packaging technologies;

·                              Leveraging our sales channel and local process applications support teams to build strong strategic relationships with technology leaders;

·
Extend our core technologies - Penetrate new markets by leveraging our sales channel and local process applications support teams to build strong strategic relationships with leading customers; Expanding our services portfolio to improve the performance of our systems, reduce our customers’ cost of ownership, and improve customer satisfaction; Cross-selling our diverse product portfolio across our broad customer base and into new markets, such as front-end semiconductor, photonics, and 5G RF;

Strengthen – Improve profitability by selectively reducing operating expenses and delivering improved gross margins, resulting from optimizing manufacturing costs and improving product mix.

3

Table of our systems, including spare parts, upgrades, and consumables to drive growth, reduce our customers’ cost of ownership, and improve customer satisfaction;Contents

·                              Cross-selling our product portfolio across our broad customer base and end markets to both maximize sales opportunities and diversify our business;

·                              Utilizing a combination of outsourced and internal manufacturing strategies to flex manufacturing capacity through industry investment cycles without compromising quality or performance; and

·                              Pursuing partnerships and acquisitions to expand our product portfolio into new and adjacent markets to drive sales growth.

Our products are sold topurchased by semiconductor and advanced packaging device manufacturersthin film process equipment customers in the following four markets: 1) Front-End Semiconductor; 2) Advanced Packaging, MEMS & RF Filters; 3) LED Lighting, Display & Compound Semiconductor; Front-End Semiconductor; and 4) Scientific & Industrial.

Markets

Our array of process equipment systems are used in the creationproduction of a broad range of microelectronic components, including RF filters and amplifiers, power electronics, thin film magnetic heads, laser diodes, 3D NAND, DRAM, logic, LEDs (including mini- and micro-LEDs), micro-electro mechanical systems (“MEMS”), radio frequency (“RF”) filters, power electronics, thin film magnetic heads (“TFMHs”), laser diodes, 3D NAND logic, and other semiconductor devices. In additionMany of our systems are used to directly deposit advanced materials critical to the creationoperation of microelectronic components,the device and some of our systems are used in cleaning and surface preparation as well as the precision removal of critical materials. We are also a leader in systems used in the advanced packaging process flow of suchmicroelectronic components in applications such as flip chip, Fan outFan-Out Wafer Level Packaging (“FOWLP”), and other wafer level packaging approaches. Ourapproaches used in the modern integration of diverse semiconductor products, especially used in consumer electronics. In general, our customers who manufacture these devices invest inpurchase our systems to both produce current-generation devices in volume and to develop next generationnext-generation products andwhich deliver more efficient, cost effective,cost-effective, and advanced technological solutions. We operate in aseveral highly cyclical business environment,environments, and our customers’ buying patterns are dependent upon industry trends. Ourtrends and consumer buying patterns for consumer electronics. As our products are sold into multiple markets, and the following discussion focuses on the trends that most influence our business within each of those markets.

Advanced Packaging, MEMS & RF FiltersFront-End Semiconductor

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable the miniaturization and performance improvement of electronic products, such as smartphones, smartwatches, and other mobile applications.

Demand for higher performance, increased functionality, smaller form factors, and lower power consumption in mobile devices, consumer electronics, and high performance computing is driving the adoption of advanced packaging technologies. Semiconductor Foundries (“Foundries”), Independent Device Manufacturers (“IDMs”) and Outsourced Semiconductor Assembly and Test (“OSAT”) companies are implementing multiple advanced packaging approaches including FOWLP, recently deployed in high-volume manufacturing, and Through Silicon Via (“TSV”) to enable stacked memory, 2.5D, and 3D packaging devices. This increasing demand trend in Advanced Packaging is encouraging as our Lithography and Precision Surface Processing (“PSP”) products enable the process steps for Advanced Packaging.

MEMS devices are used for an increasing number of applications, including accelerometers for automobile airbags, pressure sensors for medical uses, and gyroscopes for a variety of consumer products, such as gaming consoles and mobile devices.

One of the fastest growing MEMS applications has been RF filters for mobile devices, driven by increasingly complex wireless standards, the exponential growth of mobile data, and carrier aggregation. In order to address these growing demands, the number of discrete RF filters in an average smartphone is expected to double from 50 to 100 by 2020. These trends are positive for us, particularly for our PSP products, where our technology is enabling some of the most challenging process steps, as well as our Ion Beam Etch (“IBE”) and Molecular Beam Epitaxy (“MBE”) products, which are used to create Bulk Acoustic Wave (“BAW”) and Surface Acoustic Wave (“SAW”) RF filters.

LED Lighting, Display & Compound Semiconductor

LED Lighting technology has existed for more than 50 years; however, commercial adoption of LEDs was limited to niche applications until the most recent decade. In the early 1990’s, researchers developed a process utilizing Gallium Nitride (“GaN”) that created a low cost blue LED to produce white light. With that breakthrough, the LED industry started, and the number of applications for LEDs began to expand.

Since that time, the LED industry has experienced multiple growth cycles brought on by the adoption of LED technology for consumer and commercial applications. The first wave of LED growth was driven by mobile phones, which implemented the use of LED technology for display backlighting. The LED industry experienced its second period of rapid growth as LEDs were adopted for TV display backlighting. The adoption of LEDs for solid state, general lighting gave rise to a third wave of demand. There is a broader fourth wave of compound semiconductor growth including LEDs, driven by ROY LED applications, optical communication and industrial applications requiring laser diodes, 3D sensing vertical-cavity surface emitting lasers (“VCSELs”), micro-LED displays, 5G RF infrastructure adoption, and power electronics.

Our metal organic chemical vapor deposition (“MOCVD”) technology is at the core of the manufacturing process for GaN-based LEDs. We have benefited with each growth cycle, as LED producers invest in MOCVD process equipment to capture share in these markets. Demand for our equipment has historically been cyclical in nature, influenced by multiple factors, including: macroeconomic conditions; prices for LED chips; supply and demand dynamics; and our customers’ manufacturing plans. However, we expect the ongoing adoption of LED lighting to be a major driver in the need for additional MOCVD capacity over the next several years.

MOCVD technology is equally important in the manufacturing of red, orange, and yellow (“ROY”) LEDs, which are used increasingly for fine-pitch digital signage and automotive lighting applications. For these applications, our MOCVD technology is used to deposit highly uniform Arsenic Phosphide (“AsP”) films which create amber and red hues. AsP MOCVD technology is also used to produce multiple other devices in the photonics market such as infrared LEDs and VCSELs used for optical data communication and 3D sensing. In addition to film deposition, photonics manufacturers also employ cleaning and etching process steps. Our PSP wet etch and clean technologies provide such cleaning and processing capabilities to photonics customers.

The Display market refers to LEDs or micro LEDs used directly for displays. Additionally, organic light emitting diode (“OLED”) displays are part of the Display market and are used in applications such as digital signage, smartphones,

wearable and tablet displays, and TVs. Our MOCVD systems and MBE source technology is ideally suited for the display market.

The Compound Semiconductor market refers to GaN-on-Silicon based power electronic devices and radio frequency devices. Our MOCVD and PSP technologies are crucial in the manufacturing of GaN-on-Silicon based power electronic devices. Global demand is increasing for advanced power electronics with greater energy efficiency, smaller footprints, higher operating temperatures, faster switching capabilities, and greater reliability. These devices support many needs, including more efficient IT servers, electrical motors, electric vehicles, wind turbines, and photovoltaic power inverters. While silicon-based transistors are widely used in power electronic devices today, GaN-on-Silicon based power electronics developed on MOCVD tools can potentially deliver higher performance (e.g., smaller power supply form factors, higher efficiency, and faster switching speeds). In addition to depositing the critical GaN layer with our MOCVD products, our PSP products address multiple etch and clean steps required to manufacture these advanced power electronics devices. In recent years, global industry leaders in power electronics have focused on research and development programs to commercialize this new technology. Device manufacturers will likely begin to transition from development to production of these devices over the next couple of years; we can benefit from this transition as our customers invest in process equipment to support this production ramp-up.

The Radio Frequency device portion of the Compound Semiconductor market is driven by demand for RF power amplifiers in mobile devices. Our PSP products are used for process steps such as metal lift off and photo resist strip for RF devices such as heterojunction bipolar transistors (“HBTs”) used in smartphones.

Front-End Semiconductor

Front-End Semiconductor refers to early process steps where transistors are formed directly on silicon. There are many different process steps in forming integrated circuits, such as Deposition, Etching, Masking, and Doping, where the microchips are created but still remain on the silicon wafer. As device architecture continue to shrink with advanced nodes, more precise process control is paramount to achieving high yields and competitive cost. Our Laser Spike Anneal products are well suited to assist our customersAnnealing (“LSA”) systems enable precision doping of materials at a controlled temperature in the doping process.semiconductor manufacturing process and is qualified and deployed in several advanced node applications. Our IBEIon Beam Etch (“IBE”) for front-end semiconductor applications has been demonstrated in Spin Torque Transfer Magnetic Random Access Memory (“STT-MRAM”) applications. MRAMSTT-MRAM has many benefits over traditional random access memory such as its non-volatility, speed, endurance, and power consumption. Our Ion Beam Deposition (“IBD”) products are well suitedhave been adopted for the manufacturemanufacturing of Extreme Ultraviolet (“EUV”) mask blanks. Our ability to precisely deposit high quality films with extremely low particulate levels make our IBD technology ideal for manufacturing defect-free EUV photomask blanks. The front-end semiconductor industry is expected to adoptin the process of adopting EUV lithography to meet futureleading edge device requirements. Future growth will depend on overall adoption of EUV technology. And lastly,lithography by Independent Device Manufacturers (“IDMs”) and Semiconductor Foundries (“Foundries”).

Advanced Packaging, MEMS & RF Filters

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Demand for higher performance, increased functionality, smaller form factors, and lower power consumption in applications such as Artificial Intelligence in mobile devices, consumer electronics, and high-performance computing is driving the adoption of advanced packaging technologies. Foundries, IDMs, and Outsourced Semiconductor Assembly and Test (“OSATs”) companies are implementing multiple advanced packaging approaches including FOWLP, which has been deployed in high-volume manufacturing, and copper-pillar to enable stacked memory devices. These demand drivers in Advanced Packaging are encouraging as our 3D inspection productsLithography and wet etch and clean systems enable several process steps for Advanced Packaging.

MEMS devices are used for shape inspectionan increasing number of 3D topographiesapplications, including accelerometers for automobile airbags, pressure sensors for medical uses, and gyroscopes for a variety of consumer products, such as gaming consoles and mobile devices.

4

One of the fastest growing MEMS applications has been RF filters for mobile devices, driven by increasingly complex wireless standards, the proliferation of an increasing number of communication bands, the exponential growth of mobile data, and carrier aggregation. These trends are positive for us, particularly for our wet etch and clean products, where our technology is enabling some of the most challenging process steps, as well as our IBE and MBE systems, which are used to create Bulk Acoustic Wave (“BAW”) and Surface Acoustic Wave (“SAW”) RF filters.

LED Lighting, Display & Compound Semiconductor

MOCVD technology is important in memorythe manufacturing of GaN based LEDs for general lighting and logicfor red, orange, and yellow (“ROY”) LEDs, which are used increasingly for fine-pitch digital signage and automotive applications. For these applications, our MOCVD technology is used to deposit highly uniform Arsenides and Phosphides (“As/P”) films which helpscreate amber and red output colors.

The Display market refers to LEDs, mini-LEDs, or micro-LEDs used for displays. Mini-LEDs are larger than micro-LEDs and a recent trend for manufacturers has been to use mini-LEDs to backlight LCD displays in a similar but more effective manner than traditionally LED-backlit LCD displays, requiring many more mini-LEDs per display. A micro-LED display is a new approach which uses an array of red, blue, and green micro-LEDs to directly display an image without motion blur or image retention, and with improved brightness, darker blacks, and wider viewing angles. Manufacturing requirements for micro-LEDs are more stringent than normal LEDs. There are many manufacturing challenges for our customers improve their lithographyto produce micro-LED displays, however, we believe our MOCVD systems are well suited to serve this market.

The Compound Semiconductor market broadly refers to the deposition of GaN or As/P based thin film compounds on a variety of substrates including Silicon, Gallium Arsenide (“GaAs”), Indium Phosphide (“InP”), and deposition processes.Silicon Carbide (“SiC”) to enable a variety of power electronics, RF, and photonics devices. Future growth is anticipated in this market driven by optical communication and industrial applications requiring laser diodes, 3D sensing and world facing vertical cavity surface emitting lasers (“VCSELs”), 5G RF infrastructure adoption, and power electronics.

Demand for RF power amplifiers in mobile devices drives the RF device portion of the Compound Semiconductor market. Our GaN and As/P technologies are used to deposit critical thin film layers for the production of RF amplifiers. Our wet etch and clean systems are used for process steps such as metal lift off and photo resist strip for devices such as heterojunction bipolar transistors (“HBTs”) used in smartphones. We believe GaN and As/P based devices will enable the evolution of wireless technology to 5G. It is expected that the transition to 5G will take several years to become fully adopted.

Scientific & Industrial

The Scientific and Industrial markets includemarket includes advanced materials research and a broad range of manufacturing applications including high-power fiber lasers, infrared detectors, thin film magnetic heads on HDDs,hard disk drives (“HDDs”), and optical coatings.

Our MBE systems are used by scientific research organizations and universities to drive new discoveries in the areas of materials science. MBE enables precise epitaxial crystal growth for a very wide variety of materials, which supports the development of new performance materials used for emerging technologies. MBE technology is also used in the

manufacturing of specialized, lower volume products such as high-power lasers and infrared sensors. Our toolsfully automated process equipment systems create highly uniform, Gallium-Arsenide (“GaAs”)and high purity GaAs or Indium-Phosphide (“InP”)InP film layers, which are critical to the performance of these devices. Our PSP productswet etch and clean systems are also used in the manufacture of infrared sensors.

Our Ion Beam Deposition, Ion Beam Etch,IBD, IBE, Physical Vapor Deposition (“PVD”), and lapping and dicing tools are used in data storage applications, including HDDs that will continue to provide significant value for mass storage and will remain an important part of large capacity storage applications. This is especially true for data center applications where large volumes of data storage are required to serve an increasingly mobile population. In addition, our IBD tools are used to produce high quality optical films for multiple applications including laser mirrors, optical filters, and anti-reflective coatings. Our tools deposit thin layers of advanced materials on various substrates to alter how light is reflected and transmitted.

5

Our ALD toolsatomic layer deposition (“ALD”) systems are sold into a variety of Scientific & Industrial market applications such asincluding optical, semi/nano-electronics, MEMS, nanostructures, and biomedical.

System productsProducts

Metal Organic Chemical VaporIon Beam Deposition and Etch Systems

We are the world’s leading supplierOur NEXUS® IBD systems use ion beam technology to deposit precise layers of MOCVD systems. MOCVD productionthin films. IBD systems deposit high purity thin film layers and provide excellent uniformity and repeatability. Our NEXUS IBE systems utilize a charged particle beam consisting of ions to etch precise, complex features. The NEXUS systems may be included on our cluster system platform to allow either parallel or sequential deposition/etch processes. These systems are used primarily by data storage, semiconductor, and telecommunications device manufacturers in the fabrication of discrete and integrated microelectronic devices.

Our IBD technology has also been adapted to make GaN-based devices (such as blue and green LEDs) and AsP-based devices (such as ROY LEDs), which are useddeposit precise layers in television and computer display backlighting, general illumination, large area signage, specialty illumination, power electronics, andthe manufacture of EUV lithography mask blanks. The semiconductor industry has been collectively working toward using extreme ultraviolet light in the lithography process to enable shrinking feature sizes in advanced node semiconductor manufacturing. We have been involved for many other applications. Our TurboDisc® EPIK® line of MOCVD systems enables cost per wafer savings foryears in applying our technology, so our customers can produce mask blanks with a combined advantagelow defect density.

Our SPECTOR® Ion Beam Sputtering system was developed for high precision optical coatings and offers manufacturers state of best operating uptime, low maintenance costs, and best-in-class wafer uniformity and yield. In 2016, we introduced the TurboDisc K475i™ AsP MOCVD system, which offers best-in-classart optical thickness monitoring, improved productivity, and yieldstarget material utilization, for ROY LEDs, infra-red LEDs, and high-efficiency triple junction photovoltaic solar cellcutting-edge optical interference coating applications. Our Propel™ PowerGaN™ MOCVD System (“Propel”) enables the developmentWe also provide a broad array of highly-efficient GaN-based power electronic devices that have the potential to accelerate the industry’s transition from research and development to high volume production. The Propel system offers 200mm technology and incorporates single-wafer reactor technology for outstanding film uniformity, yield, and device performance.

Advanced Packaging Lithography

We have a leading positionion beam sources. These technologies are applicable in the Advanced Packaging lithography equipment market. The Advanced Packaging market is driven by the needHDD industry as well as for improved performance, reduced power consumption,optical coatings and smaller geometries for mobile and automotive applications. In turn, these applications continue to demand increasingly complex packaging techniques from IDMs, Foundries, and OSATs. Our Advanced Packaging tools are designed to optimize productivity for leading-edge 200mm and 300mm Advanced Packaging applications by enabling extremely reliable, cost-effective, high-volume manufacturing solutions. Our best-in-class yield coupled with outstanding resolution and depth of focus addresses all leading edge requirements for Advanced Packaging applications such as redistribution layers (“RDLs”), Copper Pillar, Micro-Bump, FOWLP, interposers, and TSVs to provide the lowest cost of ownership in the industry.other end markets.

Precision Surface Processing Systems (Wet Etch and Clean)

Our PSP systems offer single wafer wet etch, clean, and surface preparation solutions which target high growth segments in advanced packaging, MEMS, LEDs, and compound semiconductor markets. The WaferStorm platform is based on PSP’s unique ImmJET™ technology, which provides improved performance at a lower cost of ownership than conventional wet bench-only or spray-only approaches. This highly flexible platform targets solvent based cleaning applications that require a significant level of process control and flexibility. The WaferEtch® platform provides highly uniform, selective etching with onboard end point detection for improved process control and yield in bumping applications. In addition, PSP has developed a state-of-the-art solution with the WaferEtch platform to address the

requirements of TSV reveal, in which the backside of a wafer is thinned to reveal the copper interconnects. PSP’s TSV technology offers a significant cost of ownership reduction compared with dry etch processing by replacing up to four separate process steps.

Laser Annealing Systems

The progression of Moore’s law has led semiconductor manufacturers to implement a variety of material and process changes to overcome the technical hurdles related to shrinking of feature sizes in integrated circuits. Along with new materials and smaller dimensions have come new process challenges. One such challenge has been new constraints on thermal annealing processes. One example is the thermal annealing of dopants for activation, in order to form the transistor junction, critical to the function and performance of a complementary metal-oxide semiconductor (“CMOS”) logic integrated circuit. In this and other thermal process steps, traditional lamp-based annealing techniques have challenges meeting the thermal budget (time/temperature regime) required by new materials and designs. Our Laser Spike Anneal (“LSA”)LSA systems meet the industry demand for millisecond time-scale annealing, heating the wafer up to temperatures just below the Siliconsilicon melting point over a range of ultra-short timeframes (microseconds to milliseconds), enabling thermal annealing solutions at the 65nm technology node and below.most advanced processing nodes. This advancedunique annealing technology provides solutionsthe solution to the difficult challenge of fabricating ultra-shallow junctions and highly activated source/drain contacts at these advanced logic nodes. In addition, our proprietary hardware design enables outstanding temperature uniformity across the wafer and die, by minimizing the pattern-density effect, thus reducing absorption variations.

We have also developed a next generation melt anneal technology (“MELT”) targeted for annealing advanced logic devices at 7nm and below.advanced nodes. As FinFET devices scale, below the 10nm node, achieving the performance targets has become a challenge. To continue the roadmap, the industry is looking at new materials and the use of thermal processes that require nanosecond time-scale thermal annealing with temperatures exceeding the melting point. To help address this concern we have developed a unique (and patented) approach to nanosecond-scale thermal annealing. Our design utilizes two lasers; a millisecond laser as a low thermal budget localized preheat and a nanosecond laser “on top” of the millisecond laser to

raise the peak temperature to the melt temperature of the material being processed beyond silicon melt. Similar to LSA, the melt system architecture is targeted to reduce pattern effects and increase the process window. It is believed that nanosecond annealing will be required to meet the device targets at 7nm and below;future nodes; the initial application being explored by customers is contact annealing aimed to improve reduce source/drain contact resistance, which has become a performance bottleneck at the most advanced FinFET nodes, and as devices continue to scale, we see the application space for our melt product expanding.

Ion Beam Etch andMetal Organic Chemical Vapor Deposition Systems

Our NEXUS® IBD systems utilize ion beam technology to deposit precise layers of thin films. IBD systems deposit high purity thin film layers and provide excellent uniformity and repeatability. Our NEXUS IBE systems utilize a charged particle beam consisting of ions to etch precise, complex features. The NEXUS systems may be included on our cluster system platform to allow either parallel or sequential deposition/etch processes. TheseMOCVD production systems are used primarily by data storage, semiconductor,to make GaN-based devices (such as blue and telecommunicationsgreen LEDs) and As/P-based devices (such as ROY LEDs), which are used in television and computer display backlighting, general illumination, large area signage, specialty illumination, power electronics, and many other applications. Our proven TurboDisc®

6

technology is at the heart of our MOCVD systems and it the key to enabling best-in-class deposition uniformity and yield performance and cost per wafer savings for our customers with a combined advantage of best operating uptime and low maintenance costs. In February of 2020, we introduced the Lumina platform for As/P deposition, based on Veeco’s industry leading MOCVD TurboDisc® technology. It features long campaigns and low defectivity for exceptional yield and flexibility. Our Propel™ series of MOCVD Systems (“Propel”) enables the development of highly-efficient GaN-based power electronic and RF devices. The Propel system offers 200mm and fully-automated 300mm technology and incorporates single-wafer reactor technology for outstanding film uniformity, yield, and device manufacturersperformance.

Advanced Packaging Lithography

We have a leading position in the fabricationAdvanced Packaging lithography equipment market. The Advanced Packaging market is driven by the need for improved performance, reduced power consumption, and the ability to image smaller geometries for mobile and automotive applications. These applications continue to demand increasingly complex packaging techniques and heterogeneous device integration from IDMs, Foundries, and OSATs. Our Advanced Packaging tools are designed to optimize productivity for leading-edge 200mm and 300mm Advanced Packaging applications by delivering proven reliability and low cost of discreteownership in high-volume manufacturing environments. Our best-in-class yield coupled with outstanding resolution and integrated microelectronic devices.depth of focus addresses all leading-edge requirements for Advanced Packaging applications such as redistribution layers (“RDLs”), Copper Pillar, Micro-Bump, FOWLP, interposers, and TSVs.

Our SPECTOR® Ion Beam Sputtering system was developed for high precision coatings and offers manufacturers state of the art optical thickness monitoring, improved productivity, and target material utilization, for cutting-edge optical interference coating applications. We also provide a broad array of ion beam sources. These technologies are applicable in the HDD industry as well as for optical coatings and other end markets.

Single Wafer Wet Etch and Clean Systems

We offer single wafer wet etch and clean, and surface preparation systems which target high-growth segments in advanced packaging, MEMS, LEDs, and compound semiconductor markets. The WaferStorm® platform is based on our unique ImmJET™ technology, which provides improved performance at a lower cost of ownership than conventional wet bench-only or spray-only approaches. This highly flexible platform targets solvent-based cleaning applications that require a significant level of process control and flexibility. The WaferEtch® platform provides highly uniform, selective etching with onboard end-point detection for improved process control and yield in bumping applications. In addition, we have developed a state-of-the-art solution with the WaferEtch® platform to address the requirements of wafer thinning.

Molecular Beam Epitaxy Systems

Molecular beam epitaxy is the process of precisely depositing epitaxially-aligned atomically-thin crystalline layers, or epilayers, of elemental materials onto a substrate in an ultra-high vacuum environment. We are thea leading supplier of MBE systems worldwide.

Our MBE systems, sources, and components are used to develop and manufacture compound semiconductor devices in a wide variety of applications such as high-power fiber lasers, infrared detectors, mobile phones, radar systems, high efficiency solar cells, and basic materials science research. For many compound semiconductors, MBE is the critical step of the fabrication process, ultimately determining device functionality and overall performance. We offer a full complement of MBE systems customized for the specific end application depositing on single 3” substrates up to fully automated production systems that can deposit on seven 6” substrates simultaneously. The GENxplor® MBE system creates high quality epitaxial layers and is ideal for cutting-edge research on a wide variety of materials including gallium arsenide,GaAs, antimonides, nitrides, and oxides.oxides on 3” diameter substrates. The GENxcel® MBE system extends the same performance of the GENxplor to 4” diameter substrates.

3D Wafer Inspection Systems

As the semiconductor industry continues its pursuit of increased productivity and performance by shrinking device dimensions along Moore’s law, manufacturers are running into bottlenecks limited by fundamental materials properties and lithographic resolution. The industry has opted for 3D integration schemes to circumvent these limitations (e.g. Vertical NAND, HAR DRAM, Logic FinFET). The high volume manufacturing ramp of these 3D schemes requires low cost, high performance 3D wafer inspection systems. The Superfast 3D Wafer Inspection System is a Coherent Gradient Sensing (“CGS”) based 3D wafer inspection system that enables the wafer fab to inspect the patterned wafer at key processing steps, enabling statistical process control as well as advanced process control (“APC”) for topography, displacement, and stress.

Atomic Layer Deposition and Other Deposition Systems

ALD is a thin-film deposition method in which a film is deposited on a substrate uniformly with precise control down to the atomic scale. Veeco offers a full suite of ALD systems for non-semiconductor front-end production applications across a wide range of markets and applications such as energy, optical, electronics, MEMS, nanostructures, and biomedical. We have recently developed a fully automated tool capable of managing fragile wafers in a continuous

7

operational sequence. Other deposition systems includinginclude Physical Vapor Deposition, Diamond-Like Carbon Deposition, and Chemical Vapor Deposition Systems. In addition, our Optium® products generally are used in “back-end” applications in data storage fabrication facilities where TFMHs or “sliders” are fabricated. This equipment includes lapping tools, which enable precise material removal within three nanometers, which is necessary for advanced TFMHs. We also manufacture dicing tools that cut wafers into row bars and TFMHs.

Sales and Service

We sell our products and services worldwide primarily through various strategically located facilities in the United States, Europe, and the Asia-Pacific region. We believe that our customer service organization is a significant factor in our success. We provide service and support on a warranty, service contract, and an individual service-call basis. We believe that offering timely support creates stronger relationships with customers and provides us with a significant competitive advantage.customers. Revenue from the sales of parts, upgrades, service, and support represented approximately 27%26%, 28%, and 22%27% of our net sales for the years ended December 31, 2017, 2016,2019, 2018, and 2015,2017, respectively. Parts and upgrade sales represented approximately 22%19%, 22%23%, and 18%22% of our net sales for those years, respectively, and service and support sales were 5%7%, 6%5%, and 4%5% respectively.

Customers

We sell our products to many of the world’s semiconductor, HDD, OSAT, LED, MEMS, OSAT, HDD, and semiconductorMEMS manufacturers, as well as research centers and universities. We rely on certain principal customers for a significant portion of our sales. Sales to Seagate Technology accounted for more than 10% of our total net sales in 2019; sales to Focus Lighting Tech Co. accounted for more than 10% of our total net sales in 2018; and sales to OSRAM Opto Semiconductors accounted for more than 10% of our total net sales for both 2017 and 2016; sales to San’an Optoelectronics Co. and KAISTAR Lighting (Xiamen) Co. each accounted for more than 10% of our total net sales in 2015.2017. If any principal customer discontinues its relationship with us or suffers economic difficulties, our business prospects, financial condition, and operating results could be materially and adversely affected.

Research and Development

Our research and development functions are focused on the timely creation of new products and enhancements to existing products, both of which are necessary to maintain our competitive position. We collaborate with our customers to align our technology and product roadmaps to customer requirements. Our research and development activities take place at our facilities in San Jose, California; Waltham, Massachusetts; St. Paul, Minnesota; Somerset, New Jersey; Plainview, New York; and Horsham, Pennsylvania; and Singapore.Pennsylvania.

Our research and development expenses were approximately $82.0 million, $81.0 million, and $78.5 million, or approximately 17%, 24%, and 16% of net sales for the years ended December 31, 2017, 2016, and 2015, respectively. These expenses consisted primarily of salaries, project materials, and other product development and enhancement costs.

Suppliers

We outsource certain functions to third parties, including the manufacturingmanufacture of someseveral of our MOCVD and Ultratech systems. While we primarily rely on one supplier for the manufacturing of these systems,our outsourcing partners to perform their contracted functions, we maintain a minimumsome level of internal manufacturing capability for these systems. Refer to Item 1A, “Risk Factors,” for a description of risks associated with our reliance on suppliers and outsourcing partners.

Backlog

Our backlog consists of orders for which we received a firm purchase order, a customer-confirmed shipment date within twelve months, and a deposit when required. Our backlog increaseddecreased to $334.3$267.6 million at December 31, 20172019 from $209.2$288.3 million at December 31, 2016.2018. During the year ended December 31, 2017,2019, we increaseddecreased backlog by approximately $41.6 million relating to backlog acquired from Ultratech, while adjusting for a decrease in backlog of approximately $2.0$5.7 million relating to orders that no longer met our booking criteria.bookings criteria, as well as decreased backlog by approximately $6.7 million relating to a product line that was classified as held for sale at December 31, 2019.

Competition

In each of the markets that we serve, we face substantial competition from established competitors, some of which have greater financial, engineering, and marketing resources than we do, as well as from smaller competitors. In addition, many of our products face competition from alternative technologies, some of which are more established than those used in our products. Significant factors for customer selection of our tools include system performance, accuracy, repeatability, ease of use, reliability, cost of ownership, and technical service and support. None of our competitors compete with us across all of our product lines.

8

Our principal competitors include: Advanced Micro-Fabrication Equipment (AMEC); Aixtron; Canon Anelva;Applied Materials; Canon; Grand Plastics Technology Corporation; Leybold Optics; Mattson Technology; Onto Innovation; Riber; Rudolph Technologies; Scientech; Screen Semiconductor Solutions; and Shanghai Micro Electronics Equipment.

Intellectual Property

Our success depends in part on our proprietary technology, and we have over 8001,000 patents and pending applications in the United States and other countries and have additional applications pending for new inventions.countries.

We have patents and exclusive and non-exclusive licenses to patents owned by others covering certain of our products, which we believe provide us with a competitive advantage. We have a policy of seeking patents on inventions concerning new products and improvements as part of our ongoing research, development, and manufacturing activities. We believe that there is no single patent or exclusive or non-exclusive license to patents owned by others that is critical to our operations, as the success of our business depends primarily on the technical expertise, innovation, customer satisfaction, and experience of our employees.

Refer to Item 1A, “Risk Factors,” for a description of risks associated with intellectual property.

Employees

At December 31, 20172019 we had 1,014954 employees, of which there were 280279 in manufacturing and testing, 9986 in sales and marketing, 214218 in service and product support, 260240 in engineering and research and development, and 161131 in information technology, general administration, and finance. The success of our future operations depends on our ability to recruit and retain engineers, technicians, and other highly skilled professionals who are in considerable demand. We feel that we have adequate programs in place to attract, motivate, and retain our employees. We monitor industry practices to make sure that our compensation and employee benefits remain competitive. We believe that our employee relations are good. Refer to Item 1A, “Risk Factors,” for a description of risks associated with employee retention and recruitment.

FinancialAvailable Information about Segments and Geographic Areas

We operate as a single reportable segment and report our financial results in four geographic regions: the United States; China; Europe, Middle East, and Africa (“EMEA”); and Rest of World (“ROW”). Refer to Note 18, “Segment Reporting and Geographic Information,” in the Notes to the Consolidated Financial Statements for financial data pertaining to our geographic operations. Refer to Item 1A, “Risk Factors,” for a description of risks relating to our geographic operations.

Available Information

Our corporate website address is www.veeco.com. All filings we make with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K, our proxy statements and any amendments thereto filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, are available for free in the Investor Relations section of our website as soon as reasonably practicable after they are filed with or furnished to the SEC. Our SEC filings are available to be read or copied at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information about the operation of the Public Reference Room can be obtained by calling the SEC at 1-800-SEC-0330. Our filings can also be obtained for free on the SEC’s website at www.sec.gov. The reference to our website address does not constitute inclusion or incorporation by reference of the information contained on our website in this Form 10-K or other filings with the SEC, and the information contained on our website is not part of this document.

Item 1A. Risk Factors

Key Risk Factors That May Impact Future Results

Stockholders should carefully consider the risk factors described below. Any of these factors, many of which are beyond our control, could materially and adversely affect our business, financial condition, operating results, cash flow, and stock price.

Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results.

Conditions of the markets in which we operate are volatile and have in the past,experienced, and may in the future deteriorate significantly. We have experienced and may continue to experience, customer rescheduling and, to a lesser extent, cancellations of orderssignificant deterioration. Demand for our products.equipment and services can change depending on several factors, including the nature and timing of technology inflections, the emergence of new technologies and competitors, production capacity and end-user demand, international trade barriers, access to affordable capital, and general economic conditions (including, for example, a prolonged U.S. government shutdown). Changing market conditions require that we continuously monitor and reassess our strategic resource allocation decisions. If we fail to properly adapt to changing business

9

environments, we may lack the infrastructure and resources necessary to scale up our businesses to successfully compete during periods of growth, or we may incur excess fixed costs during periods of decreasing demand. Adverse market conditions relative to our products couldhave resulted in, and may continue to result in:

reduced demand for our products;
rescheduling and cancellations of orders for our products, resulting in negative backlog adjustments;
asset impairments, including the impairment of goodwill and other intangible assets;
unfavorable changes in customer mix and product mix;
increased price competition leading to lower margin for our products;
increased competition from sellers of used equipment or lower-priced alternatives to our products;
increased inventory obsolescence;
disruptions in our supply chain as we reduce our purchasing volumes and limit our contract manufacturing operations;
higher operating costs as a percentage of revenues; and
an increase in uncollectable amounts due from our customers resulting in increased reserves for doubtful accounts and write-offs of accounts receivable.

·                  reduced demand for our products;

·                  rescheduling and cancellations of orders for our products, resulting in negative backlog adjustments;

·                  increased price competition leading to lower margin for our products;

·                  increased competition from sellers of used equipment or lower-priced alternatives to our products;

·                  increased inventory obsolescence;

·                  an increase in uncollectable amounts due from our customers resulting in increased reserves for doubtful accounts and write-offs of accounts receivable;

·                  disruptions in our supply chain as we reduce our purchasing volumes and limit our contract manufacturing operations; and

·                  higher operating costs as a percentage of revenues.

If the markets in which we participate continue to experience deteriorations or downturns, this could negatively impact our sales and revenue generation, margins, operating expenses, and profitability.

We are exposed to the risks of operating a global business.

Most of our sales are to customers located outside of the United States, and we expect sales from non-U.S. markets to continue to represent a significant portion of our sales in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting business outside the United States, many of which are outsidebeyond our control including:

political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote the development and growth of local competitors;
global trade issues and uncertainties with respect to trade policies, including tariffs, trade sanctions, and international trade disputes, and the ability to obtain required import and export licenses;
differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;
pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country, which may necessitate the sharing of sensitive information and intellectual property rights;
multiple conflicting and changing governmental laws and regulations, including varying labor laws and tax regulations;
reliance on various information systems and information technology to conduct our business, making us vulnerable to additional cyberattacks by third parties or breaches due to employee error, misuse, or other causes, that could result in further business disruptions, loss of or damage to our intellectual property and confidential information (and that of our customers and other business partners), reputational harm, transaction errors, processing inefficiencies, or other adverse consequences;
regional economic downturns, varying foreign government support, unstable political environments, and other changes in foreign economic conditions (such as the United Kingdom’s planned departure from the European Union, commonly referred to as Brexit);

10

the impact of public health epidemics on employees, suppliers, customers and the global economy, such as the recent outbreak of a novel strain of coronavirus first identified in Wuhan, Hubei Province, China;
difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;
longer sales cycles and difficulties in collecting accounts receivable; and
different customs and ways of doing business.

·                  political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote the development and growth of local competitors;

·                  differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;

·                  pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country;

·                  multiple conflicting and changing governmental laws and regulations, including varying labor laws, tax regulations, import/export controls, changes to trade treaties, possible trade wars, and other trade barriers and uncertainties;

·                  reliance on various information systems and information technology to conduct our business, which may be vulnerable to cyberattacks by third parties or breached due to employee error, misuse, or other causes that could result in business disruptions, loss of or damage to intellectual property, transaction errors, processing inefficiencies, or other adverse consequences should our security practices and procedures prove ineffective;

·                  regional economic downturns, varying foreign government support, and unstable political environments;

·                  difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;

·                  longer sales cycles and difficulties in collecting accounts receivable; and

·                  different customs and ways of doing business.

These challenges, many of which are associated with sales into the Asia-Pacific region, have had and may continue to have a material adverse effect on our business.

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition.

The U.S. government has recently enacted changes in trade policy, including the imposition of tariffs on certain items, proposed tariffs on additional items, and new export controls. On May 15, 2019, the President of the United States issued an Executive Order that authorized the creation and implementation of controls over transactions involving Chinese and possibly other entities involving threats to U.S. national security. On the same day, the U.S. Commerce Department added Huawei (a multinational technology company with its headquarters in China) and many of its affiliates to the Entity List, which essentially requires U.S. companies and others to obtain licenses before providing commodities, software, and technology subject to the regulations. Further, the Trump Administration has expressed an intent to implement new regulations designed to address concerns about the export of emerging and foundational technologies to China, and additional controls on the export of items to China and other countries may be forthcoming. While the United States and China signed a preliminary “Phase One” trade agreement in January 2020, many uncertainties remain.

These new tariffs, and other changes in U.S. trade policy and export controls, as well as sanctions imposed by the U.S. against certain Chinese companies, have triggered retaliatory action by China and could trigger further retaliation. For example, China has instituted trade sanctions on certain U.S. goods, as well as other sanctions designed to deny U.S. companies access to critical raw materials. Also, China has provided, and is expected to continue to provide, significant assistance, financial and otherwise, to their domestic industries, including some of our competitors, and to intervene in support of national industries and/or competitors. We face increasing competition as a result of significant investment in the semiconductor industry by the Chinese government and various state-owned or affiliated entities that is intended to advance China's stated national policy objectives. In addition, the Chinese government may restrict us from participating in the China market or may prevent us from competing effectively with Chinese companies.

A “trade war” of this nature or other governmental action related to tariffs or international trade agreements or policies has the potential to adversely affect demand for our products, our costs, customers, suppliers, and/or the U.S. economy or certain sectors thereof and, in turn, may have a material adverse effect on our business, results of operations and financial condition.

Further, we hold inventory of products affected by the recent U.S. government actions and there is uncertainty relating to the disposition of this inventory. While we continue to take steps to mitigate our exposure to this developing situation, if the sale of these products is delayed or we are unable to return or dispose of our inventory on favorable economic terms, we may experience order cancellations, incur additional carrying costs for the inventory or otherwise record losses associated with the inventory.

In addition, we have experienced increasing difficulty and uncertainty in obtaining export licenses required to sell products to certain foreign customers. Further, the U.S. Bureau of Industry and Security (BIS) has indicated its intention to eliminate license exception CIV, which we utilize to facilitate the shipment of many of our products to customers in China. Without this license exception, we will be required to obtain export licenses from BIS prior to shipment. This would likely create delay and uncertainty, which would make our products less attractive to customers in China than competing products from suppliers in Europe and elsewhere which do not require an export license for shipment to China. This difficulty and uncertainty has adversely affected our ability to compete for and win business from customers in these foreign jurisdictions.

11

Foreign customers affected by these and future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by utilizing our foreign competitors’ products.

Tariff and trade policy discussions between the U.S., China and its other trading partners are ongoing and fluid. These tariffs and other policy changes are subject to a number of uncertainties as they are implemented. The ultimate reaction of other countries and the individuals in each of these countries may have an adverse impact on the U.S. and global economies, and our business, results of operations and financial condition.

Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us.

We are increasingly dependent on information technology systems and infrastructure, including mobile technologies, to operate our business. In the ordinary course of our business, we collect, store, process and transmit significant amounts of sensitive information, including intellectual property, proprietary business information, personally-identifiable information of individuals, and other confidential information, including that of our customers and other business partners. It is critical that we do so in a secure manner to maintain the confidentiality, integrity, and availability of this sensitive information. We have also outsourced elements of our operations (including elements of our information technology infrastructure) to third parties, and as a result, we manage a number of third-party vendors who have access to our computer networks and our confidential information.

All information systems are subject to disruption, breach, or failure. Potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors, business partners, or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence, sophistication, and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of expertise and motives (including industrial espionage), including organized criminal groups, nation states, and others. In addition to the extraction of sensitive information, attacks could include the deployment of harmful malware, ransomware, or other means which could affect service reliability and threaten the confidentiality, integrity, and availability of information. Significant disruptions in our, or our third-party vendors’, information technology systems or other data security incidents could adversely affect our business operations and result in the loss or misappropriation of, and unauthorized access to, sensitive information, which could result in financial, legal, regulatory, business, and reputational harm to us.

On November 1, 2018, we announced the discovery of an attack on our computer system by a highly-sophisticated actor. We notified law enforcement of the attack and retained forensic experts to assist with the investigation. It currently remains unclear whether we will be able to determine the extent of the breach or the potential impact on our operations. Also unclear is whether we will be able to identify who is responsible for the attack, or whether we will be able to pursue legal action or other remedies. The attack, including the expenses incurred to address it, may have an adverse effect on our results of operations and financial condition, may result in litigation, and may cause reputational harm.

While we are engaged in remediation and have implemented, and are continuing to implement, security measures intended to protect our information technology systems and infrastructure, there can be no assurance that such remediation and security measures will successfully prevent further security incidents. Additional information technology system disruptions, whether from attacks on our technology environment or from computer viruses, natural disasters, terrorism, war or other causes, could result in a material disruption in our business operations, force us to incur significant costs and engage in litigation, harm our reputation, and subject us to liability under laws, regulations, and contractual obligations.

We may be unable to effectively enforce and protect our intellectual property rights.

Our success as a company depends in part upon the protection of our intellectual property rights. We rely primarily on patent, copyright, trademark, and trade secret laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary information, technologies, processes, and brand identity. We own various U.S. and international patents and have additional pending patent applications relating to certain of our products and technologies. The process of seeking patent protection is lengthy and expensive, and we cannot be certain that pending or future applications will actually result in issued patents or that issued patents will be of sufficient scope or strength to provide meaningful protection or commercial advantage. In addition, our intellectual property rights may be circumvented,

12

invalidated, or rendered obsolete by the rapid pace of technological change, or through efforts by others to reverse engineer our products or design around patents that we own. Policing unauthorized use of our products and technologies is difficult and time consuming and the laws of other countries may not protect our proprietary rights as fully or as readily as U.S. laws. Given these limitations, our success will depend in part upon our ability to innovate ahead of our competitors.

In addition, our outsourcing strategy requiresefforts require that we share certain portions of our technology with our outsourcing partners, which poses additional risks of infringement and trade secret misappropriation. Infringement of our rights by a third party, possibly for purposes of developing and selling competing products, could result in uncompensated lost market and revenue opportunities. Similar exposure could result in the event that former employees seek to compete with us through their unauthorized use of our intellectual property and proprietary information. We cannot be certain that the protective steps and measures we have taken will prevent the misappropriation or unauthorized use of our proprietary information and technologies, nor can we be certain that applicable intellectual property laws, regulations, and policies will not be changed in a manner detrimental to the sale or use of our products.

Litigation has been required in the past, is currently ongoing, and may be required in the future, to enforce our intellectual property rights, protect our trade secrets, and to determine the validity and scope of proprietary rights of others. As a result of any such litigation, we could lose our ability to enforce one or more patents, incur substantial costs, and jeopardize relationships with current or prospective customers or suppliers. Any action we take to enforce or defend our intellectual property rights could absorb significant management time and attention, and could otherwise negatively impact our operating results.

We may be subject to claims of intellectual property infringement by others.

We receive communications from time to time from other parties asserting the existence of patent or other rights which they believe cover certain of our products. We also periodically receive noticenotices from customers who believe that we are required to indemnify them for damages they may incur related to infringement claims made against these customers by third parties. Our customary practice is to evaluate such assertions and to consider the available alternatives, including whether to seek a license, if appropriate. However, we cannot ensure that licenses can be obtained or, if obtained, will be on acceptable terms or that costly litigation or other administrative proceedings will not occur. If we are not able to resolve a claim, negotiate a settlement of the matter, obtain necessary licenses on commercially reasonable terms, or successfully prosecute and defend our position, our business, financial condition, and results of operations could be materially and adversely affected.

We may be unable to successfully integrate the Ultratech business and may not realize the anticipated benefits of the acquisition.

On May 26, 2017, we completed the acquisition of Ultratech, Inc., merging two companies that formerly operated as independent public companies. Significant management attention and resources have been devoted, and will need to be devoted, to integrating our respective business operations and practices. The success of our acquisition of Ultratech will depend in part on our ability to realize the anticipated benefits and revenue and cost synergies associated with this business combination, which is subject to the following risks, among others:

·                  whether the combined businesses will perform as expected;

·                  the possibility that we paid more for the acquisition of Ultratech than the value we will derive from the acquisition;

·                  complexities associated with managing the combined businesses, including difficulties addressing possible differences in corporate cultures and management philosophies and the challenge of integrating complex systems, technology, networks, and other assets of each of the companies in a seamless manner that minimizes any adverse impact on customers, suppliers, employees, and other business partners;

·                  the potential loss of customers and strategic partners who may not wish to continue their relationships with the combined company; and

·                  potential unknown liabilities and unforeseen or unanticipated costs.

In connection with the accounting for the Ultratech acquisition, we recorded goodwill and other intangible assets of approximately $539 million. Under U.S. generally accepted accounting principles, we must assess, at least annually and potentially more frequently, whether the value of the goodwill and other indefinite-lived intangible assets have been impaired. Finite-lived intangible assets will be assessed for impairment in the event of an impairment indicator. Any reduction or impairment in the value of goodwill and other intangible assets will result in a charge against earnings, which could materially and adversely affect our results of operations and financial performance.

The price of our common shares is volatile and could further decline.

The stock market in general and the market for technology stocks in particular has experienced significant volatility. The trading price of our common shares has declined, and could continue to decline, independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could fluctuate significantly in response to several factors, including among others:

·                  difficult macroeconomic conditions, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;

·                  the emergence of competitors and competing technologies;

·                  receipt of large orders or cancellations of orders for our products;

·                  issues associated with the performance and reliability of our products;

·                  actual or anticipated variations in our results of operations;

·                  announcements of financial developments or technological innovations;

·                  our failure to meet the performance estimates of investment research analysts;

·                  changes in recommendations and financial estimates by investment research analysts;

·                  strategic transactions, such as acquisitions, divestitures, and spin-offs;

·                  the commencement of, and rulings on, litigation and legal proceedings;

·                  the dilutive impact of our Convertible Senior Notes; and

·                  the occurrence of major catastrophic events.

As with many technology companies, the price of our common shares has fluctuated significantly in the past and is likely to be volatile in the future. Securities class action litigation is often brought against a company following periods of volatility in the market price of its securities. If similar litigation were to be pursued against us, it could result in substantial costs and a diversion of management’s attention and resources, which could materially and adversely affect our financial condition, results of operations, and liquidity.

We face significant competition.

We face significant competition throughout the world, which may increase as certain markets in which we operate continue to evolve. Some of our competitors have greater financial, engineering, manufacturing, and marketing resources than us. Other competitors are located in regions with lower labor costs and other reduced costs of operation. In addition, our ability to compete in foreign countries against local manufacturers may be hampered by nationalism, social attitudes, laws, regulations, and policies within such countries that favor local companies over U.S. companies or that are otherwise designed to promote the development and growth of local competitors. Furthermore, we face competition from smaller emerging equipment companies whose strategy is to provide a portion of the products and services we offer, with a focused approach on innovative technology for specialized markets. New product introductions or enhancements by us or our competitors could cause a decline in sales or loss of market acceptance of our existing or prior generation products. Increased competitive pressure could also lead to intensified price competition resulting in lower margins.

To remain competitive, we may enter into strategic alliances with customers, suppliers, and other third parties to explore new market opportunities and possible technological advancements. These alliances may require significant investments of capital and other resources and often involve the exchange of sensitive confidential information. The success of these alliances may depend on factors over which we have limited control and will likely require ongoing cooperation and good faith efforts from our strategic partners. Strategic alliances are inherently subject to significant risks, and the inability to effectively manage these risks could materially and adversely affect our business and operating results.

13

We operate in industries characterized by rapid technological change.

Each of the industries in which we operate is subject to rapid technological change. Our ability to remain competitive depends on our ability to enhance existing products and develop and manufacture new products in a timely and cost effective manner and to accurately predict technology transitions. New product development commitments must be made well in advance of sales, and we must anticipate the future demand for products when selecting which development programs to fund and pursue. Our financial results depend on the successful introduction of new products, many of which require the achievement of increasingly stringent technical specifications. We may not be successful in selecting, developing, manufacturing, and marketing new products and new technologies or in enhancing our existing products. Our performance may be adversely affected if we are unable to accurately predict evolving market trends and related customer needs and to effectively allocate our resources among new and existing products and technologies.

We are also exposed to potential risks associated with unexpected product performance issues. Our product designs and manufacturing processes are complex and could contain unexpected product defects, especially when products are first introduced. Unexpected product performance issues could result in significant costs and damages, including increased service and warranty expenses, the need to provide product replacements or modifications, reimbursement for damages caused by our products, product recalls, related litigation, product write-offs, and disposal costs. Product defects could also result in personal injury or property damage, claims for which may exceed our existing insurance coverages. These and other costs could be substantial and our reputation could be harmed, resulting in a reduced demand for our products and a negative effect on our business, financial condition, and results of operations.

OurCertain of our sales to manufacturers are highly dependent on sales ofthe demand for consumer electronics, applications, which can experience significant volatility due to seasonal and other factors.

The demand for semiconductors, LEDs, HDDs semiconductors, and other devices is highly dependent on sales of consumer electronics, such as televisions, computers, tablets, digital video recorders, smartphones, cell phones, and other mobile devices. Manufacturers of LEDs are among our largest customers and account for a substantial portion of our revenue. Factors that could influence the levels of spending on consumer electronic products include consumer confidence, access to credit, volatility in fuel and other energy costs, conditions in the residential real estate and mortgage markets, labor and healthcare costs, and other macroeconomic factors affecting consumer spending behavior. These and other economic factors have had and could continue to have a material adverse effect on the demand for our customers’ products and, in turn, on our customers’ demand for our products and services. Furthermore, manufacturers of LEDs have in the past, some of our customers have overestimated their potential for market share growth. If this growth is overestimated, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, obsolete inventory, and liabilities to our suppliers for products no longer needed.

In addition, the demand for our customers’ products can be even more volatile and unpredictable due to the possibility of competing technologies, such as flash memory as an alternative to HDDs. Unpredictable fluctuations in demand for our customers’ products or rapid shifts in demand from our customers’ products to alternative technologies could materially and adversely impact our future results of operations.

We have a concentrated customer base, located primarily in a limited number of regions, which operateoperates in highly concentrated industries.

Our customer base continues to be highly concentrated. Orders from a relatively limited number of customers have accounted for, and likely will continue to account for, a substantial portion of our net sales, which may leadallow customers to demand pricing and other terms less favorable to us.us (including extended warranties, indemnification commitments, and the obligation to continue production of older products). Customer consolidation activity involving some of our largest customers could result in an even greater concentration of our sales in the future. Management changes at key customer accounts could result in a loss of future sales due to vendor preferences or other reasons and may introduce new challenges in managing customer relationships.

If a principal customer discontinues its relationship with us or suffers economic setbacks, our business, financial condition, and operating results could be materially and adversely affected. Our ability to increase sales in the future will depend in part upon our ability to obtain orders from new customers and we cannot be certain that we will be successful in these

14

efforts. In addition, because a relatively small number of large manufacturers, many of whom are our customers, dominate the industries in which they operate, it may be especially difficult for us to replace these customers if we lose their business. A significant portion of orders in our backlog are orders from our principal customers.

In addition, a substantial investment is required by customers to install and integrate capital equipment into a production line. As a result, once a manufacturer has selected a particular vendor to supply capital equipment, the manufacturer will often attempt to consolidate its other capital equipment requirements with the same vendor. Accordingly, if a customer selects a competitor’s product over ours, we could experience difficulty selling to that customer for a significant period of time.

Furthermore, we do not have long-term contracts with our customers. As a result, our agreements with our customers do not provide assurance of future sales, and we are exposed to competitive price pressures on new orders we attempt to obtain.

Our customer base is also highly concentrated in terms of geography, and the majority of our sales are to customers located in a limited number of countries. Dependence upon sales emanating from a limited number of regions increases our risk of exposure to local difficulties and challenges, such as those associated with regional economic downturns, political instability, trade wars and other trade disruptions, fluctuating currency exchange rates, natural disasters, social unrest, pandemics, terrorism, and acts of war. Our reliance upon customer demand arising primarily from a limited number of countries could materially and adversely impact our future results of operations.

A further reduction or elimination of foreign government subsidies and economic incentives may adversely affect the future order rate for our MOCVD equipment.

We generate a significant portion of our revenue in China. In recent years, the Chinese government has provided various incentives to encourage the development of the LED industry, including subsidizing a portion of the purchase cost of MOCVD equipment. These subsidies have enabled and encouraged certain customers in this region to purchase more of our MOCVD equipment than these customers might have purchased without these subsidies. The availability and amount of these subsidies has been reduced over time and may end at some point in the future. A further reduction or elimination of these incentives may result in a reduction in future orders for our MOCVD equipment in this region, which could materially and adversely affect our business, financial condition, and results of operations. In addition, in an effort to promote Chinese competition, the Chinese government could impose restrictions on the receipt of these subsidies, including requirements that the purchased equipment be sourced locally.

A related risk pertains to the fact that many customers use or had planned to use Chinese government subsidies, in addition to other incentives from the Chinese government, to build new manufacturing facilities or to expand existing manufacturing facilities. Delays in the start-up of these facilities or the cancellation of construction plans altogether, together with other related issues pertaining to customer readiness, could adversely impact the timing of our revenue recognition, could result in order cancellations, a reduction in our order backlog, and could have other negative effects on our business, financial condition, and results of operations.

The cyclicality of the industries we serve directly affects our business.

Our business depends in large part upon the capital expenditures of manufacturers in theour four key markets: Front-End Semiconductor; Advanced Packaging, MEMS & RF Filters; LED mobile communication, data storage,Lighting, Display & Compound Semiconductor; and other device markets.Scientific & Industrial. We are subject to the business cycles of these industries, the timing, length, and volatility of which are difficult to predict. These industries have historically been highly cyclical and have experienced significant economic downturns in the last decade. As a capital equipment provider, our revenue depends in large part on the spending patterns of these customers, who often delay expenditures or cancel or reschedule orders in reaction to variations in their businesses or general economic conditions. In downturns, we must be able to quickly and effectively align our costs with prevailing market conditions, as well as motivate and retain key employees. However, because a portion of our costs are fixed, our ability to reduce expenses quickly in response to revenue shortfalls may be limited. Downturns in one or more of these industries have had, and will likely have, a material adverse effect on our business, financial condition, and operating results. Alternatively, during periods of rapid growth, we must be able to acquire and develop sufficient manufacturing capacity to meet customer demand and attract, hire, assimilate, and retain a sufficient number of qualified people. Our net sales and operating results may be negatively affected if our customers experience economic downturns or slowdowns in their businesses.

The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly.

We derive a substantial portion of our net sales in any fiscal period from the sale of a relatively small number of high-priced systems. As a result, the timing of recognition of revenue for a single transaction could have a material effect on our sales and operating results for a particular fiscal period. As is typical in our industry, orders shipments, and customer acceptancesshipments often occur during the last few weeks of a quarter. As a result, a delay of only a week or two can impact which period revenue is reported and can cause volatility in our revenue for a given reporting period. Our quarterly results have fluctuated significantly in the past and we expect this trend to continue. If our orders, shipments, net sales, or operating results in a particular quarter do not meet expectations, our stock price may be adversely affected as well.

Our sales cycle is long and unpredictable.

Historically, we have experienced long and unpredictable sales cycles (the period between our initial contact with a potential customer and the time that we recognize revenue for resulting sales to that customer). OurIt is not uncommon for our sales cycle canto exceed twelve months. The timing of an order often depends on our customer’s capital expenditure budget, over which we have no control. In addition, the time it takes us to build a product to customer specifications typically

15

ranges from three to six months. When coupled with the fluctuating amount of time required for shipment, installation, and final acceptance, our sales cycles often vary widely, and these variations can cause fluctuations in our operating results. As a result of our lengthy sales cycles, we may incur significant research, development, selling, general, and administrative expenses before we generate revenue for these products. We may never generate the anticipated revenue if a customer cancels or otherwise changes its purchase plans, which could have an adverse effect on our business.

We are now confronting many of these risks as we gain traction in the front-end semiconductor market, which is often characterized by long customer qualification times, typically twelve to eighteen months. Once qualified, the ramp to volume production can take an additional extended period of time, often twelve to twenty-four months. During these periods, little to no revenue will be recognized by us, while we will continue to incur research and development costs. Despite our efforts, our products may never be qualified and may never achieve design-tool-of-record (“DTOR”) or production-tool-of-record (“PTOR”) status, and our business, financial condition, and results of operations may be materially and adversely affected.

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed.

Customer purchase orders may be cancelled or rescheduled by the customer, sometimes with limited or no penalties, which may result in increased or unrecoverable costs for the Company. We adjust our backlog for such cancellations, contract modifications, and delivery delays that result in a delivery period in excess of one year, among other items. A downturn in one or more of our businesses could result in an increase in order cancellations and postponements.

We write-off excess and obsolete inventory based on historical trends, future usage forecasts, and other factors including the amount of backlog we have on hand. If our backlog is canceled or modified, our estimates of future product demand may prove to be inaccurate, in which case we may have understated the write-off required for excess and obsolete inventory. In the future, if we determine that our inventory is overvalued, we will be required to recognize associated costs in our financial statements at the time of such determination. In addition, we place orders with our suppliers based on our customers’ orders. If our customers cancel their orders with us, we may not be able to cancel our orders with our suppliers. Any such charges could be materially adverse to our results of operations and financial condition.

We may be unable to obtain required export licenses for the sale of our products.

Products which are either manufactured in the United States or based on U.S. technology are subject to the U.S. Export Administration Regulations (“EAR”) when exported to and re-exported from international jurisdictions, in addition to the local jurisdiction’s export regulations applicable to individual shipments. Currently, our MOCVD, MBE, and certain other systems and products are controlled for export under the EAR. Licenses or proper license exceptions may be required for the shipment of our products to certain customers or countries (and, as noted above, the U.S. Bureau of Industry and Security has indicated its intention to eliminate license exception CIV, which we currently utilize to facilitate the shipment of many of our products to customers in China). Obtaining an export license or determining whether an export license exception exists often requires considerable effort by us and cooperation from the customer, which can add time to the order fulfillment process. We may be unable to obtain required export licenses or unable to qualify for export license exceptions and, as a result, we may be unable to export products to our customers and/or meet their servicing needs. The administrative processing, potential delay and risk of ultimately not obtaining required export approvals pose a particular disadvantage to us relative to our non-U.S. competitors who are not required to comply with U.S. export controls. Non-compliance with the EAR or other applicable export regulations could result in a wide range of penalties including the denial of export privileges, fines, criminal penalties, and the seizure of commodities. In the event that an export regulatory body determines that any of our shipments violate applicable export regulations, we could be fined significant sums and our export capabilities could be restricted, which could have a material adverse impact on our business.

Our operating results may be adversely affected by tightening credit markets.

As a global company with worldwide operations, we are subject to volatility and adverse consequences associated with economic downturns in different parts of the world. In the event of a downturn, many of our customers may delay or reduce their purchases of our products and services. If negative conditions in the credit markets prevent our customers from obtaining credit or necessary financing, product orders in these channels may decrease, which could result in lower revenue.

16

In addition, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, and attendant pricing pressures. If our suppliers face challenges in obtaining credit, in selling their products, or otherwise in operating their businesses, their ability to continue to supply materials to us may be negatively affected.

In addition, we finance some of our sales through trade credit. In addition to ongoing credit evaluations of our customers’ financial condition, we seek to mitigate our credit risk by obtaining deposits and letters of credit on certain of our sales arrangements. We could suffer significant losses if a customer whose accounts receivable we have not secured fails or is otherwise unable to pay us, or if financial institutions providing letters of credit become insolvent. A loss in collections on our accounts receivable would have a negative impact on our financial condition and results of operations.

Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand.

The success of our business depends in part on our ability to accurately forecast and supply equipment and services that meet the rapidly changing technical and volume requirements of our customers. To meet these demands, we depend on the timely delivery of parts, components, and subassemblies from our suppliers. Uncertain worldwide economic conditions and market instabilities make it difficult for us (and our customers) to accurately forecast future product demand. If actual demand for our products is different than expected, we may purchase more or fewer parts than necessary or incur costs for canceling, postponing, or expediting delivery of parts. If we overestimate the demand for our products, excess inventory could result which could be subject to heavy price discounting, which could become obsolete, and which could subject us to liabilities to our suppliers for products no longer needed. Similarly, we may be harmed in the event that our competitors overestimate the demand for their products and engage in heavy price discounting practices as a result. In addition, the volatility of demand for capital equipment increases capital and otherposes risks for companies in our supply chain.chain, including challenges associated with inventory management and fluctuating working capital requirements.

Furthermore, certain key parts may be subject to long lead-times or may be obtainable only from a single supplier or limited group of suppliers, and some sourcing and assembly is provided by suppliers located in countries other than the United States. We may experience significant interruptions in our manufacturing operations, delays in our ability to timely deliver products or services, increased costs, or customer order cancellations as a result of:

the failure or inability of our suppliers to timely deliver quality parts;
volatility in the availability and cost of materials;
difficulties or delays in obtaining required import or export approvals;
information technology or infrastructure failures;
natural disasters such as earthquakes, tsunamis, floods, or storms; or
other causes such as regional economic downturns, international trade disruptions, pandemics, political instability, terrorism, or acts of war, which could result in delayed deliveries, manufacturing inefficiencies, increased costs, or order cancellations.

·                  the failure or inability of our suppliers to timely deliver quality parts;

·                  volatility in the availability and cost of materials;

·                  difficulties or delays in obtaining required import or export approvals;

·                  information technology or infrastructure failures;

·                  natural disasters such as earthquakes, tsunamis, floods, or storms; or

·                  other causes such as regional economic downturns, pandemics, political instability, terrorism, or acts of war, that could result in delayed deliveries, manufacturing inefficiencies, increased costs, or order cancellations.

In addition, in the event of an unanticipated increase in demand for our products, our need to rapidly increase our business and manufacturing capacity may be limited by our working capital constraints and those of our suppliers, which may cause or exacerbate interruptions in our manufacturing and supply chain operations. Any or all of these factors could materially and adversely affect our business, financial condition, and results of operations.

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations.

To better align our costs with market conditions, increase the percentage of variable costs relative to total costs, and to increase productivity and operational efficiency, we have outsourced certain functions to third parties, including the manufacture of several of our systems. While we maintain some level of internal manufacturing capability for these systems, we rely heavily on our outsourcing partners to perform their contracted functions to allow us flexibility to adapt to

17

changing market conditions, including periods of significantly diminished order volumes. If our outsourcing partners do not perform as required, or if our outsourcing model doesefforts do not allow us to realize the intended cost savings and flexibility, our results of operations (and those of our third partythird-party providers) may be adversely affected. Disputes and possibly litigation involving third party providers could result and we could suffer damage to our reputation. Dependence on contract manufacturing and outsourcing may also adversely affect our ability to bring new products to market. Although we attempt to select reputable providers, it is possible that one or more of these providers could fail to perform as we expect. If we do not effectively manage our outsourcing strategyefforts or if third party providers do not perform as anticipated, we may not realize the benefits of productivity improvements and we may experience operational difficulties, increased costs, manufacturing and installation interruptions or delays, inefficiencies in the structure and operation of our supply chain, loss of intellectual property rights, quality issues, increased product time-to-market, and an inefficient allocation of our human resources, any or all of which could materially and adversely affect our business, financial condition, and results of operations.

We rely on a limited number of suppliers, some of whom are our sole source for particular components.

Certain of the parts, components, and sub-assemblies included in our products are obtained from a single source or a limited group of suppliers. Our inability to develop alternative sources, as necessary, could result in a prolonged interruption in our ability to supply related products, a failure on our part to meet the demands our customers, and a significant increase in the price of related products, which could adversely affect our business, financial condition, and results of operations.

The price of our common shares is volatile and could decrease.

The stock market in general and the market for technology stocks in particular has experienced significant volatility. The trading price of our common shares has fluctuated significantly and could decline independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could continue to fluctuate in response to several factors, including among others:

difficult macroeconomic conditions, international trade disputes, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;
���the emergence of competitors and competing technologies;
receipt of large orders or cancellations of orders for our products;
issues associated with the performance of our products, or the performance of our internal systems such as our customer relationship management (“CRM”) system or our enterprise resource planning (“ERP”) system;
actual or anticipated variations in our results of operations;
announcements of financial developments or technological innovations;
our failure to meet the performance estimates of investment research analysts;
changes in recommendations and financial estimates by investment research analysts, and decisions by investment research analysts to cease coverage of our company;
strategic transactions, such as acquisitions, divestitures, and spin-offs, and the results of our investment decisions;
our failure to successfully and timely implement cost reduction initiatives and restructuring activities, if and when required;
the commencement of, and rulings on, litigation and legal proceedings;
the dilutive impact of our Convertible Senior Notes; and
the occurrence of major catastrophic events.

Securities class action litigation is often brought against a company following periods of volatility in the market price of its securities. We have defended security class actions lawsuits in the past, and are currently defending such a lawsuit now.

18

These lawsuits, if and when brought, can result in substantial costs and a diversion of management’s attention and resources, which can adversely affect our financial condition, results of operations, and liquidity.

We may be required to take impairment charges on assets.

We are required to assess goodwill and indefinite-lived intangible assets annually for impairment, or on an interim basis whenever certain events occur or circumstances change, such as an adverse change in business climate or a decline in the overall industry, that would more likely than not reduce the fair value below its carrying amount. We maintain a single reporting unit, and as such, if our stock price decreases to the point where our fair value, as determined by our adjusted market capitalization, is less than the carrying value of our single reporting unit, this would also indicate a potential impairment, and we may be required to record an impairment charge in that period, which could adversely affect our results of operations. Such an impairment charge was taken by the Company during the fourth quarter of 2018, in the amount of $122.8 million.

As part of our long term strategy, we may pursue future acquisitions of, or investments in, other companies or assets which could potentially increase our assets. We are required to test certain of our assets, including acquired intangible assets, property, plant, and equipment, and equity investments without readily observable market prices, for recoverability and impairment whenever there are indicators of impairment such as an adverse change in business climate. Adverse changes in business conditions or worse-than-expected performance by these acquired companies could negatively impact our estimates of future operations and result in impairment charges to these assets. For example, during the second quarter of 2018, we recorded an asset impairment charge of $252.3 million related to the intangible assets acquired as part of our acquisition of Ultratech, Inc. In addition, in the fourth quarter of 2019 we recorded asset impairment charges of $25.0 million, primarily related to our equity investments without readily observable market prices. If our assets are further impaired, our financial condition and results of operations could be materially and adversely affected.

Our inability to attract, retain, and motivate employees could have a material adverse effect on our business.

Our success depends in part upon our ability to attract, retain, and motivate employees, including those in executive, managerial, finance, engineering and marketing positions, as well as highly skilled and qualified technical personnel. Attracting, retaining, and motivating such qualified personnel may be difficult due to challenging industry conditions, competition for such personnel by other technology companies, consolidations and relocations of operations, and workforce reductions, and there can be no assurance that we will be successful in recruiting or retaining key personnel. We have entered

into employment agreements with certain key personnel but our inability to attract, retain, and motivate key personnel could have a material adverse effect on our business, financial condition, and results of operations.

We are exposed to risks associated with business combinations, acquisitions, strategic investments and strategic investments.divestitures.

We have completed several significant acquisitions and investments in the past and we will consider new opportunities in the future. Acquisitions and investments involve numerous risks, many of which are unpredictable and beyond our control, including the following:

difficulties and increased costs in integrating the personnel, operations, technologies, and products of acquired companies;
diversion of management’s attention and disruption of ongoing businesses;
the inability to complete proposed transactions as anticipated, resulting in obligations to pay professional and other expenses, including any applicable termination fees;
potential loss of key employees of acquired companies, especially if a relocation or change in responsibilities is involved;
difficulties in managing geographically dispersed operations in a cost effective manner;
the failure to realize expected synergies;
unknown, underestimated, and undisclosed commitments or liabilities;

19

increased amortization expenses relating to intangible assets; and
other adverse effects on our business, including the potential impairment and write-down of amounts capitalized as intangible assets and goodwill as part of the acquisition, as a result of such matters as technological advancements or worse-than-expected performance by the acquired company.

·                  difficulties and increased costs in integrating the personnel, operations, technologies, and products of acquired companies;

·                  diversion of management’s attention and disruption of ongoing businesses;

·                  the inability to complete proposed transactions as anticipated, resulting in obligations to pay professional and other expenses, including any applicable termination fees;

·                  potential loss of key employees of acquired companies, especially if a relocation or change in responsibilities is involved;

·                  difficulties in managing geographically dispersed operations in a cost effective manner;

·                  the failure to realize expected synergies;

·                  unknown, underestimated, and undisclosed commitments or liabilities;

·                  increased amortization expenses relating to intangible assets; and

·                  other adverse effects on our business, including the potential impairment and write-down of amounts capitalized as intangible assets and goodwill as part of the acquisition, as a result of such matters as technological advancements or worse-than-expected performance by the acquired company.

As discussed above with respect to our recent acquisition of Ultratech, our inability to effectively manage these risks could materially and adversely affect our business, financial condition, and results of operations. In addition, ifIf we issue equity securities to pay for an acquisition or investment, the ownership percentage of our then-current shareholders would be reduced and the value of the shares held by these shareholders could be diluted, which could adversely affect the price of our stock. If we use cash to pay for an acquisition or investment, the payment could significantly reduce the cash that would be available to fund our operations, pay our indebtedness, or be used for other purposes, which could have a negative effect on our business.

WeIn addition, we continually assess the strategic fit of our businesses and may be unablefrom time to obtain required export licenses fortime seek to divest portions of our business that no longer fit our strategic plan, such as the potential sale of our products.

Products which are either manufactureda non-core product line that was classified as held for sale as of December 31, 2019. Divestitures involve significant risks and uncertainties, including the ability to sell such businesses at satisfactory prices, on acceptable terms, and in the United States or based on U.S. technology are subject to the U.S. Export Administration Regulations (“EAR”) when exported to and re-exported from international jurisdictions, in addition to the local jurisdiction’s export regulations applicable to individual shipments. Currently, our MOCVD, MBE, and certaina timely manner. Divestitures may also disrupt other systems and products are controlled for export under the EAR. Licenses or proper license exceptions may be required for the shipmentparts of our products to certain customers or countries. Obtaining an export license or determining whether an export license exception exists often requires considerable effort by us and cooperation frombusinesses, distract the customer, which can add time to the order fulfillment process. We may be unable to obtain required export licenses or unable to qualify for export license exceptions and, as a result, we may be unable to export products toattention of our customers. The administrative processing, potential delay and risk of ultimately not obtaining required export approvals pose a particular disadvantage to us relative to our non-U.S. competitors who are not required to comply with U.S. export controls. Non-compliance with the EAR or other applicable export regulations couldmanagement, result in a wide rangeloss of penalties includingkey employees or customers, and require that we allocate internal resources that would otherwise be devoted to operating our existing businesses. Divestitures may expose us to unanticipated liabilities (including those arising from representations and warranties made to a buyer regarding the denialbusinesses) and to ongoing obligations to support the businesses following such divestitures, any and all of export privileges, fines, criminal penalties, and the seizure of commodities. In the event that an export regulatory body determines that any of our shipments violate applicable export regulations, we could be fined significant sums and our export capabilities could be restricted, which could have a material adverse impact on our business.

Our operating results may be adversely affected by tightening credit markets.

As a global company with worldwide operations, we are subject to volatility and adverse consequences associated with economic downturns in different parts of the world. In the event of a downturn, many of our customers may delay or further reduce their purchases of our products and services. If negative conditions in the credit markets prevent our customers from obtaining credit or necessary financing, product orders in these channels may decrease, which could result in lower revenue. In addition, we may experience cancellations of orders in backlog, rescheduling of customer deliveries, and attendant pricing pressures. If our suppliers face challenges in obtaining credit, in selling their products, or otherwise in operating their businesses, their ability to continue to supply materials to us may be negatively affected.

In addition, we finance some of our sales through trade credit. In addition to ongoing credit evaluations of our customers’ financial condition, we seek to mitigate our credit risk by obtaining deposits and letters of credit on certain of our sales arrangements. We could suffer significant losses if a customer whose accounts receivable we have not secured fails or is otherwise unable to pay us, or if financial institutions providing letters of credit become insolvent. A loss in collections on our accounts receivable would have a negative impact on our financial condition and results of operations.

We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws.

We are subject to the Foreign Corrupt Practices Act of 1977 (“FCPA”) and other laws that prohibit improper payments or offers of payments to foreign government officials, as defined by the statute, for the purpose of obtaining or retaining business. In addition, many of our customers have policies limiting or prohibiting us from providing certain types or amounts of entertainment, meals, or gifts to their employees. It is our policy to implement safeguards to discourage these practices by our employees and representatives. However, our safeguards may prove to be ineffective and our employees, consultants, sales agents, or distributors may engage in conduct for which we may be held responsible. In addition, we may acquire a company that has engaged in unlawful conduct in the past, and be held responsible for this conduct through successor liability principles. Violations of the FCPA or similar laws or similar customer policies may result in severe criminal or civil sanctions or the loss of supplier privileges to a customer and we may be subject to other liabilities, which could negatively affect our business, financial condition, and results of operations.

We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulties in satisfying these requirements or negative reports concerning our internal controls could adversely affect our future results of operations and our stock price.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we must include in our Annual Report on Form 10-K a report by management on the effectiveness of our internal control over financial reporting. Ongoing compliance with this requirement is complex, costly, time-consuming, and is subject to significant judgment. If our internal controls are ineffective or if our management does not timely assess the adequacy of such internal controls, our ability to file timely and accurate periodic reports may be impeded. Any delays in filing may cause us to face the following risks and concerns, among others:

concern on the part of our customers, partners, investors, and employees about our financial condition and filing delay status, including the potential loss of business opportunities;
significant time and expense required to complete delayed filings and the distraction of our senior management team and board of directors as we work to complete delayed filings;
investigations by the SEC and other regulatory authorities of the Company and our management;
limitations on our ability to raise capital or possible violations of existing debt covenants;
suspension or termination of our stock listing on The NASDAQ Global Select Market and the removal of our stock as a component of certain stock market indices; and
general reputational harm.

·                  concern on the part of our customers, partners, investors, and employees about our financial condition and filing delay status, including the potential loss of business opportunities;

·                  significant time and expense required to complete delayed filings and the distraction of our senior management team and board of directors as we work to complete delayed filings;

·                  investigations by the SEC and other regulatory authorities of the Company and our management;

·                  limitations on our ability to raise capital;

·                  suspension or termination of our stock listing on The NASDAQ Stock Market and the removal of our stock as a component of certain stock market indices; and

·                  general reputational harm.

Any or all of the foregoing could result in the commencement of stockholder lawsuits against the Company. Any such litigation, as well as any proceedings that could arise as a result of a filing delay and the circumstances which gave rise to it, may be time consuming and expensive, may divert management attention from the conduct of our business, could have a

material adverse effect on our business, financial condition, and results of operations, and may expose us to costly indemnification obligations to current or former officers, directors, or other personnel, regardless of the outcome of such matters, which may not be adequately covered by insurance.

20

Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results.

Changes in accounting pronouncements or taxation rules or practices can have a significant effect on our reported results. New accounting pronouncements and taxation rules can have a material impact on revenue recognition practices, effective tax rates, results of operations, and our financial condition. On December 22, 2017, President Trump signed into law the statute commonly referred to as the Tax Cuts and Jobs Act (“2017 Tax Act”), which makes broad and complex changes to the U.S. tax code. As we collect and prepare necessary data, and interpret the 2017 Tax Act and any additional guidance issued by the IRS or other standard-setting bodies, we may make adjustments to the provisional amounts in accordance with Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. This change could materially affect our financial position and tax attributes carryforward. In addition, varying interpretations of accounting pronouncements or taxation practices, and the questioning of our current or past practices (such as those associated with our transfer pricing), may adversely affect our reported financial results.

Our income taxes may change.

We are subject to income tax on a jurisdictional or legal entity basis and significant judgment is required in certain instances to allocate our taxable income to a jurisdiction and to determine the related income tax expense and benefits. Losses in one jurisdiction generally may not be used to offset profits in other jurisdictions. As a result, changes in the mix of our earnings (or losses) between jurisdictions, among other factors, could alter our overall effective income tax rate, possibly resulting in significant tax rate increases.

We are regularly audited by various tax authorities. Income tax audit assessments or changes in tax laws, regulations, or other interpretations may result in increased tax provisions which could materially affect our operating results in the period or periods in which such determinations are made or changes occur.

In addition, our effective tax rate could increase if we determine that it is no longer more likely than not that we are able to realize our remaining net deferred tax assets, if we are unable to generate sufficient future taxable income in certain jurisdictions, or if we are otherwise required to increase our valuation allowances against our deferred tax assets.

We may be required to take additional impairment charges on assets.

We are required to assess goodwill and indefinite-lived intangible assets annually for impairment, or on an interim basis whenever certain events occur or circumstances change, such as an adverse change in business climate or a decline in the overall industry, that would more likely than not reduce the fair value below its carrying amount. We are also required to test our long-lived assets, including acquired intangible assets and property, plant, and equipment, for recoverability and impairment whenever there are indicators of impairment such as an adverse change in business climate.

As part of our long term strategy, we may pursue future acquisitions of other companies or assets which could potentially increase our assets. Adverse changes in business conditions could materially impact our estimates of future operations and result in impairment charges to these assets. A significant decline in the market price of our common stock could indicate a decline in the fair value of our reporting unit such that goodwill becomes impaired. If our assets are impaired, our financial condition and results of operations could be materially and adversely affected.

We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders.

In January of 2017, we issued $345 million of 2.70% Convertible Senior Notes due 2023 (“Convertible Senior Notes”). The Convertible Senior Notes are convertible into Company common stock at an initial conversion rate of 24.98 shares of Company common stock per $1,000 principal amount of the Convertible Senior Notes. The Company is obligated to repurchase the Convertible Senior Notes upon the occurrence of certain events described in the indenture relating to the Convertible Senior Notes. The degree to which we are leveraged could have negative consequences, including but not limited to the following:

·
we may be more vulnerable to economic downturns, less able to withstand competitive pressures, and less flexible in responding to changing business and economic conditions;
our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate, and other purposes may be limited;
a substantial portion of our cash flows from operations in the future may be required for the payment of the principal amount of our existing indebtedness when it becomes due; and
we may elect to make cash payments upon any conversion of the Convertible Senior Notes, which would reduce our cash on hand.

·                  our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate, and other purposes may be limited;

·                  a substantial portion of our cash flows from operations in the future may be required for the payment of the principal amount of our existing indebtedness when it becomes due; and

·                  we may elect to make cash payments upon any conversion of the Convertible Senior Notes, which would reduce our cash on hand.

Our ability to meet our payment obligations under the Convertible Senior Notes depends on our ability to generate significant cash flow in the future. This, to some extent, is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond our control. There can be no assurance that our business will generate cash flow from operations, or that additional capital will be available to us, in an amount sufficient for us to meet our debt payment obligations and to fund other liquidity needs. If we are unable to generate sufficient cash flow to service our debt obligations, we may need to refinance or restructure our debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. If we wereare unable to implement one or more of these alternatives, we may be unable to meet our debt payment obligations, which could have a material adverse effect on our business, results of operations, and financial condition.

21

Furthermore, if the Convertible Senior Notes are converted into shares of Company common stock, the issuance of additional shares of Company common stock would dilute the ownership interest of our existing shareholders and could have a dilutive effect on our net income per share to the extent that the price of our common stock exceeds the conversion price of the Convertible Senior Notes. In addition, any sales in the public market of our common stock issuable upon conversion of the Convertible Senior Notes could adversely affect prevailing market prices of our common stock.

The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Senior Notes, could have a material effect on our reported financial results.

Under Accounting Standards Codification 470-20, Debt with Conversion and Other Options (“ASC 470-20”), an entity must separately account for the liability and equity components of certain convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the Convertible Senior Notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the Convertible Senior Notes. As a result, we will be required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the Convertible Senior Notes to their face amount over the term of the Convertible Senior Notes. We will report lower net income in our financial results because ASC 470-20 will require interest to include both the current period’s amortization of the debt discount and the instrument’s coupon interest, which could adversely affect our financial results, the trading price of our common stock, and the trading price of the Convertible Senior Notes.

In addition, under certain circumstances, including our ability and intent to settle the convertible debt instruments in cash, convertible debt instruments (such as the Convertible Senior Notes) that may be settled entirely or partly in cash can be accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the Convertible Senior Notes are not included in the calculation of diluted earningsincome per share except to the extent that the conversion value of the Convertible Senior Notes exceeds their principal amount. Under the treasury stock method, for diluted earningsincome per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot be sure that we will meet the accounting standards in the future will continuecriteria to permit the use ofutilize the treasury stock method or that we will continue to expect to settlein the principal balance in cash.future. If we are unable to utilize the treasury stock method, we would be required to apply the if-converted method. Under that method, diluted income per share would generally be calculated assuming that all the Convertible Senior Notes were converted solely into shares of our common stock at the beginning of the reporting period, unless the result would be anti-dilutive. If we are unable or otherwise elect not to use the treasury stock method in accounting for the shares issuable upon conversion of the Convertible Senior Notes, then our diluted income per share would be adversely affected.

In July 2019, the FASB issued an exposure draft that proposes to change the accounting for convertible debt instruments, such as the Convertible Senior Notes. Under the exposure draft, an entity may no longer be required to separately account for the liability and equity components of convertible debt instruments. This could have the impact of reducing non-cash interest expense, and thereby increasing net income. Additionally, as currently proposed, the treasury stock method for calculating earnings per share will no longer be allowed for convertible debt instruments whose principal amount may be settled using shares. Rather, the if-converted method may be required, which would adversely affect our diluted net income per share. We cannot be sure that the proposed changes in this exposure draft will be adopted, or will be adopted in their current format. We also cannot be sure whether other changes may be made to the current accounting standards related to the Convertible Senior Notes, or otherwise, that could be adversely affected.have an adverse impact on our financial statements.

We are subject to foreign currency exchange risks.

We are exposed to foreign currency exchange rate risks that are inherent in our anticipated sales, sales and purchase commitments, and assets and liabilities that are denominated in currencies other than the U.S. dollar. Although we attempt to mitigate our exposure to fluctuations in currency exchange rates, hedging activities may not always be available or adequate to mitigate the impact of our exchange rate exposure. Failure to sufficiently hedge or otherwise manage foreign currency risks properly could materially and adversely affect our financial condition, results of operations, and liquidity.

Our previously announced share repurchase program could affect the price22

Repurchases pursuant to our share repurchase program could affect our stock price and increase its volatility. The existence of a share repurchase program could also cause our stock price to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our stock. There can be no assurance that any share repurchases will enhance stockholder value because the market price of our common stock may decline below the levels at which we repurchased shares of common stock. Although our share repurchase program is intended to enhance long term stockholder value, short term stock price fluctuations could reduce the program’s effectiveness. Furthermore, the program does not obligate the Company to repurchase any dollar amount or number of shares of common stock, and may be suspended or discontinued at any time and any suspension or discontinuation could cause the market price of our stock to decline.

If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations.

We manage, store, and transmit proprietary information and sensitive data relating to our operations. We may be subject to breaches of the information technology systems we use for these purposes. Experienced computer programmers and hackers may be able to penetrate our network security and misappropriate and compromise our confidential information (and third party confidential information), create system disruptions, or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our systems or our products, or that otherwise exploit security vulnerabilities.

The costs to address the foregoing security problems and security vulnerabilities before or after a cyber-incident could be significant. Our remediation efforts may not be successful and could result in interruptions, delays, a cessation of service, and a loss of existing or potential customers, impeding our sales, manufacturing, distribution, and other critical functions. In addition, breaches of our security measures and the unapproved dissemination of proprietary information or sensitive data about us, our customers or other third parties, could expose us, our customers and others to a risk of loss or misuse of this information, result in litigation and potential liability for us, damage our reputation, and otherwise harm our business.

We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult.

We have adopted, and may in the future adopt, certain measures that may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company, which a holder of our common stock might not consider to be in the holder’s best interest. These measures include:

“blank check” preferred stock;
a classified board of directors; and
certain other provisions appearing in our certificate of incorporation and bylaws.

·                  “blank check” preferred stock;

·                  a classified board of directors; and

·                  certain other certificate of incorporation and bylaws provisions.

Our board of directors has the authority to issue up to 500,000 shares of preferred stock and to fix the rights (including voting rights), preferences and privileges of these shares (“blank check” preferred). Such preferred stock may have rights, including economic rights, senior to our common stock. As a result, the issuance of the preferred stock could have a material adverse

effect on the price of our common stock and could make it more difficult for a third party to acquire a majority of our outstanding common stock.

Our board of directors is divided into three classes with each class serving a staggered three-year term. The existence of a classified board makes it more difficult for our shareholders to change the composition of our board of directors, and therefore the Company’s policies, in a relatively short period of time.

We have adopted certain certificate of incorporation and bylaws provisions which have anti-takeover effects. These include: (a) requiring certain actions to be taken at a meeting of shareholders rather than by written consent, (b) requiring a super-majority of shareholders to approve certain amendments to our bylaws, (c) limiting the maximum number of directors, and (d) providing that directors may be removed only for “cause.”cause. These measures and those described above may have the effect of delaying, deferring, or preventing a takeover or other change in control of our Company that a holder of our common stock mightmay not consider to be in the holder’s best interest.

In addition, we are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination, including mergers and asset sales, with an interested stockholder (generally, a 15% or greater stockholder) for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. The operation of Section 203 may have anti-takeover effects, which could delay, defer, or prevent a takeover attempt that a holder of our common stock mightmay not consider to be in the holder’s best interest.

Despite the above measures, an activist shareholder could undertake action to implement governance, strategic, or other changes to the Company which a holder of our common stock mightmay not consider to be in the holder’s best interest. Such activities could interfere with our ability to execute our strategic plans, be costly and time consuming, disrupt our operations, and divert the attention of management and our employees.

We are exposed to various risks associated with global regulatory requirements.

As a public company with global operations, we are subject to the laws of the United States and multiple foreign jurisdictions, and the rules and regulations of various governing bodies, which may differ among jurisdictions. We are required to comply with legal and regulatory requirements pertaining to such matters as data privacy (including, for example, the European Union General Data Protection Regulation and similar laws), labor laws, immigration, customs, trade, taxes, corporate governance, conflict minerals and other social responsibility legislation, and antitrust regulations, among others. These laws and regulations, which are ever-evolving and at times complex and inconsistent, impose costs on our business and divert management time and attention from revenue-generating activities. Changes to or ambiguities in these laws and regulations may create uncertainty regarding our compliance requirements. While we intend to invest the required resources to comply with these regulatory requirements, if we are found by a court or regulatory agency to have failed in these efforts, our business, financial condition, and results of operations could be adversely affected.

23

We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws.

We are subject to the Foreign Corrupt Practices Act of 1977 (“FCPA”) and other laws that prohibit improper payments or offers of payments to foreign government officials, as defined by the statute, for the purpose of obtaining or retaining business. In addition, many of our customers have policies limiting or prohibiting us from providing certain types or amounts of entertainment, meals, or gifts to their employees. It is our policy to implement safeguards to discourage these practices by our employees and representatives. However, our safeguards may prove to be ineffective and our employees, consultants, sales agents, or distributors may engage in conduct for which we may be held responsible. In addition, we may acquire a company that has engaged in unlawful conduct in the past, and be held responsible for this conduct through successor liability principles. Violations of the FCPA or similar laws or similar customer policies may result in severe criminal or civil sanctions or the loss of supplier privileges to a customer and we may be subject to other liabilities, which could negatively affect our business, financial condition, and results of operations.

We are subject to risks of non-compliance with environmental, health, and safety regulations.

WeFrom a corporate governance perspective, there is an increasing focus on reducing energy usage and improving the environmental impact and sustainability associated with manufacturing operations. In addition, we are subject to environmental, health, and safety regulations in connection with our business operations, including but not limited to regulations related to the development, manufacture and use of our products, recycling and disposal of related materials, and the operation and use of our facilities and real property. Failure or inability to comply with existing or future environmental, safety and safetysustainability standards and regulations which vary from jurisdiction to jurisdiction, could result in significant remediation liabilities, the imposition of fines, and the suspension or termination of research, development, or use of certain of our products, each ofand other harm to the Company, which could have a material adverse effect on our business, financial condition, and results of operations. In addition,Furthermore, some of our operations involve the storage, handling, and use of hazardous materials that may pose a risk of fire, explosion, or environmental release. Such events could result from acts of terrorism, natural disasters, or operational failures and may result in injury or loss of life to our employees and others, local environmental contamination, and property damage. These events mightmay cause a temporary shutdown of an affected facility, or portion thereof, and we could be subject to penalties or claims as a result. Each of these events could have a material adverse effect on our business, financial condition, and results of operations.

Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chain more complex, and may harm our relationships with customers.

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), the SEC adopted requirements for companies that manufacture products that contain certain minerals and metals, known as conflict minerals. These rules require public companies to perform diligence and to report annually to the SEC whether such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability, and pricing of minerals we use in the manufacture of our products. In addition, we have incurred and will continue to incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals used in our products. Given the complexity of our supply chain, we may not be able to ascertain the origins of these minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. We may also face difficulties in satisfying customers who require that our products be certified as conflict mineral free, which could harm our relationships with these customers and lead to a loss of revenue. These requirements could limit the pool of suppliers that can provide conflict-free minerals, and we may be unable

to obtain conflict-free minerals at competitive prices, which could increase our costs and adversely affect our manufacturing operations and our profitability.

We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism, or other significant disruption.

Our operations in the United States, in the Asia-Pacific region, and in other areas could be subject to natural disasters or other significant disruptions, including earthquakes, tsunamis, fires, hurricanes, floods, water shortages, other extreme weather conditions, medical epidemics and severe outbreaks (such as coronavirus), power shortages and blackouts, telecommunications failures, and other natural and manmade disasters or disruptions. In the event of such a natural disaster or other disruption, we could experience disruptions or interruptions to our operations and to the operations of our suppliers, distributors, resellers and customers, destruction of facilities and loss of life, all of which could materially increase our costs and expenses and materially and adversely affect our business, financial condition, and results of operations. In addition, various regions of the world in which we do business are subject to the threat of terrorism and acts of war. Any act of terrorism or war that affects the economy or the industries in which we operate could result in significant harm to us, including the loss of life and property, manufacturing and transportation delays, disruptions in our supply chain, the need to comply with enhanced security measures, and other increased costs.

Item 1B. Unresolved Staff Comments

None.

24

Item 2. Properties

Our corporate headquarters and principal research and development, manufacturing, and sales and service facilities are:

    

Approximate

    

    

Owned Facilities Location

Size (sq. ft.)

Use

Plainview, NY

 

80,000

 

Corporate Headquarters; R&D; Sales & Service; Administration

Somerset, NJ

 

80,000

 

R&D; Manufacturing; Sales & Service; Administration

St. Paul, MN

 

43,000

 

R&D; Manufacturing; Sales & Service; Administration

Somerset, NJ

 

38,000

 

R&D; Sales & Service; Administration

 

 

Approximate

 

 

 

Lease

 

Leased Facilities Location

 

Size (sq. ft.)

 

Use

 

Expires

 

San Jose, CA

 

100,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2021

 

Somerset, NJ

 

57,000

 

Warehouse

 

2020

 

Kingston, NY (1)

 

52,000

 

Manufacturing

 

2018

 

Horsham, PA

 

49,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2024

 

Singapore

 

23,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2023

 

Waltham, MA

 

19,000

 

R&D; Sales & Service; Administration

 

2023

 

Hsinchu City, Taiwan

 

13,000

 

Sales & Service; Administration

 

2020

 

Shanghai, China

 

10,000

 

Sales & Service; Administration

 

2020

 

    

Approximate

    

    

    

Lease

Leased Facilities Location

Size (sq. ft.)

Use

Expires

San Jose, CA

 

100,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2023

Somerset, NJ

 

57,000

 

Warehouse

 

2022

Horsham, PA

 

49,000

 

R&D; Manufacturing; Sales & Service; Administration

 

2024

Singapore

 

23,000

 

Sales & Service; Administration

 

2023

Waltham, MA

 

19,000

 

R&D; Sales & Service; Administration

 

2023


(1) Manufacturing site has been consolidated into Somerset, we expect to vacate this location during 2018.

In addition to the above, we lease a small office in Edina, Minnesota and Malta, New York for sales and service and our foreign sales and service subsidiaries lease office space in China, Germany, Japan, Malaysia, Philippines, South Korea, Thailand, Taiwan and the United Kingdom. We believe our facilities are adequate to meet our current needs.

Item 3. Legal Proceedings

On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262. We believe that the merger price, which was the product of

arms-length negotiations, was fair and reasonable, and intend to contest the appraisal claim. Discovery1933 for, among other things, alleged false/misleading statements in the matter has commencedregistration statement and a trial on the action is scheduled to begin in December 2018.

On April 12, 2017, we filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLC and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted our motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using our patented technology without our express authorization.

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that our MOCVD products infringed a Chinese utility model patentprospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in a chemical vapor deposition reactor and seeking injunctive relief and monetary damages against Veeco Shanghai. On December 7, 2017, without providing notice to us and without hearing our position on alleged infringement, the Fujian High Court issued a preliminary injunction, applicable in China, that requires Veeco Shanghai to stop importing, making, selling, and offering to sell Veeco EPIK 700 modeladvanced packaging business, increased MOCVD systems and to stop importing, selling, and offering to sell wafer carriers used as supplies for the EPIK 700 MOCVD system.

On February 8, 2018, Veeco, AMEC, and SGL announced that they had mutually agreed to settle the pending litigation among the parties and to amicably resolve all pending disputes, including AMEC’s lawsuit against Veeco before the Fujian High Courtcompetition in China, and Veeco’s lawsuit against SGL beforean intellectual property dispute. Veeco is defending this matter vigorously.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the U.S. DistrictSuperior Court for the Eastern District of New York. As part of the settlement, all legal actions worldwide (in court, patent offices,State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and otherwise), betweenunjust enrichment against current and former Veeco AMEC,directors premised on purported misstatements and SGL, and their affiliates, will be dismissed and/or otherwise withdrawn. As a result, all business processes, including sales, service, and importation, will be continued.omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously.

 

We areThe Company is involved in various other legal proceedings arising in the normal course of business. We doThe Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 4. Mine Safety Disclosures

Not Applicable.

25

PART II

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is quoted on The NASDAQ StockGlobal Select Market under the symbol “VECO.” The 2017 and 2016 high and low closing bid prices by quarter are as follows:

 

 

2017

 

2016

 

 

 

High

 

Low

 

High

 

Low

 

First Quarter

 

$

30.05

 

$

24.85

 

$

20.64

 

$

16.89

 

Second Quarter

 

34.20

 

27.40

 

19.72

 

15.79

 

Third Quarter

 

32.95

 

18.60

 

20.98

 

15.91

 

Fourth Quarter

 

22.25

 

11.90

 

29.95

 

19.75

 

OnAs of February 14, 2018, the closing price for2020, there were approximately 131 stockholders of record of our common stock.Because many of our shares of common stock are held by brokers and other institutions on The NASDAQ Stock Market was $18.70, andbehalf of stockholders, we had 124 shareholdersare unable to estimate the total number of record.

stockholders represented by these record holders. We have not paid dividends on our common stock. The Board of Directors will determine future dividend policy based on our consolidated results of operations, financial condition, capital requirements, and other circumstances.

Issuer Purchases of Equity Securities

Share repurchase activity during the three months ended December 31, 2017 is as follows:

Period

 

Total Number of
Shares Purchased

 

Average Price
Paid Per Share

 

Total Number of
Shares Purchased
as Part of
Publicly Announced
Plans or Programs

 

Approximate Dollar
Value of Shares
That May Yet Be
Purchased Under the
Plans or Programs

 

 

 

(in thousands, except average price paid per share)

 

October 2, 2017

October 29, 2017

 

 

$

 —

 

 

$

  —

 

October 30, 2017

December 3, 2017

 

 

 

 

 —

 

December 4, 2017

December 31, 2017

 

203

 

14.83

 

203

 

96,982

 

During fiscal year 2017, 2016, and 2015, we repurchased 0.2 million shares, 0.7 million shares, and 0.5 million shares of our common stock for $3.0 million, $13.1 million, and $9.2 million, respectively, through our share repurchase programs. On December 11, 2017, our Board of Directors authorized a program to repurchase up to $100 million of the Company’s outstanding common stock to be completed through December 11, 2019, after completion of the previous program on October 28, 2017. Repurchases may be made from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The timing During fiscal years 2018 and amount2017, we repurchased 1.0 million shares and 0.2 million shares of future repurchases, if any, will depend upon market conditions, SEC regulations, and other factors. The repurchases would be funded using available cash balances and cash generated from operations. The program does not obligate us to acquire any particular amount ofour common stock for $11.3 million and may be modified or suspended at$3.0 million, respectively, through our share repurchase programs. We did not purchase any time at our discretion.shares during the fiscal year 2019. At the end of the program, $14.3 million of the $100 million had been utilized.

26

Stock Performance Graph

Graphic

ASSUMES $100 INVESTED ON DEC. 31, 20122014

ASSUMES DIVIDENDS REINVESTED

FISCAL YEAR ENDING DEC. 31

 

2012

 

2013

 

2014

 

2015

 

2016

 

2017

 

    

2014

    

2015

    

2016

    

2017

    

2018

    

2019

Veeco Instruments Inc.

 

100.00

 

111.60

 

118.28

 

69.72

 

98.85

 

50.36

 

 

100.00

 

58.94

 

83.57

 

42.57

 

21.24

 

42.10

S&P Smallcap 600

 

100.00

 

141.31

 

149.45

 

146.50

 

185.40

 

209.94

 

 

100.00

 

98.03

 

124.06

 

140.48

 

128.56

 

157.85

RDG MidCap Technology

 

100.00

 

161.83

 

159.04

 

138.67

 

123.87

 

132.83

 

 

100.00

 

90.54

 

91.63

 

95.17

 

80.39

 

96.51

27

Item 6. Selected Financial Data

The information set forth below should be read in conjunction with the “Results of Operations” section included in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

 

Year ended December 31,

 

 

 

2017 (1) 

 

2016

 

2015

 

2014 (2)

 

2013

 

 

 

(in thousands, except per share data)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

  484,756

 

$

  332,451

 

$

  477,038

 

$

  392,873

 

$

  331,749

 

Operating income (loss)

 

(63,778

)

(120,402

)

(23,232

)

(79,209

)

(71,812

)

Income (loss) from continuing operations, net of tax

 

(44,793

)

(122,210

)

(31,978

)

(66,940

)

(42,263

)

Basic income (loss) per common share from continuing operations

 

(1.01

)

(3.11

)

(0.80

)

(1.70

)

(1.09

)

Diluted income (loss) per common share from continuing operations

 

(1.01

)

(3.11

)

(0.80

)

(1.70

)

(1.09

)

Year ended December 31,

    

2019

    

2018

    

2017 (1)(2)

    

2016 (1)

    

2015 (1)

(in thousands, except per share data)

Statement of Operations Data:

 

 

  

  

 

  

 

  

 

  

Net sales

 

$

419,349

$

542,082

$

475,686

$

331,702

$

477,038

Operating income (loss)

 

(39,578)

 

(415,502)

 

(71,868)

 

(120,162)

 

(23,232)

Net income (loss)

 

(78,733)

 

(407,088)

 

(51,396)

 

(122,027)

 

(31,978)

Basic income (loss) per common share

 

(1.66)

 

(8.63)

 

(1.16)

 

(3.10)

 

(0.80)

Diluted income (loss) per common share

 

(1.66)

 

(8.63)

 

(1.16)

 

(3.10)

 

(0.80)


(1) 

(1)Effective January 1, 2018, the Company adopted the new revenue accounting standard (“ASC 606”). The results of operations for 2017 and 2016 have been recast for the new standard, while prior years have not. Refer to Note 1, “Significant Accounting Policies” for additional information.
(2)During the second quarter of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since that date.

December 31,

    

2019 (1)

    

2018

    

2017 (2)

    

2016 (2)

    

2015

(in thousands)

Balance Sheet Data:

 

 

  

  

 

  

 

  

 

  

Cash and cash equivalents

 

$

129,294

$

212,273

$

279,736

$

277,444

$

269,232

Short-term investments

 

115,252

 

48,189

 

47,780

 

66,787

 

116,050

Working capital

 

357,654

 

360,027

 

372,822

 

365,374

 

379,904

Total assets

 

818,088

 

900,816

 

1,387,475

 

763,988

 

890,789

Long-term debt (less current installments)

 

300,068

 

287,392

 

275,630

 

826

 

1,193

Total equity

 

374,512

 

437,775

 

840,093

 

601,704

 

714,615

(1)Effective January 1, 2019, the Company adopted the new lease accounting standard (“ASC 842”). The balance sheet and results of operations for prior periods have not been recast for the new standard. Refer to Note 1, “Significant Accounting Policies” for additional information.
(2)Effective January 1, 2018, the Company adopted the new revenue accounting standard (“ASC 606”). The results of operations for 2017 and 2016 have been recast for the new standard, while prior years have not. Refer to Note 1, “Significant Accounting Policies” for additional information.

28

Table of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since that date.Contents

(2) During the fourth quarter of 2014, the Company acquired PSP. The results of operations of PSP have been included in the consolidated financial statements since that date.

 

 

December 31,

 

 

 

2017

 

2016

 

2015

 

2014

 

2013

 

 

 

(in thousands)

 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

$

269,232

 

$

270,811

 

$

210,799

 

Short-term investments

 

47,780

 

66,787

 

116,050

 

120,572

 

281,538

 

Working capital

 

373,536

 

357,999

 

379,904

 

387,254

 

485,452

 

Total assets

 

1,387,287

 

758,532

 

890,789

 

929,455

 

947,969

 

Long-term debt (less current installments)

 

275,630

 

826

 

1,193

 

1,533

 

1,847

 

Total equity

 

840,713

 

594,595

 

714,615

 

738,932

 

780,230

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

On May 26, 2017, we completed the acquisitionWe are an innovative manufacturer of Ultratech. Ultratech develops, manufactures, sells, and supports lithography,semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, we establish ourselves as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications, as well as greatly increasing our critical mass in the front-end semiconductor market. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

We categorize our revenue by the key market segments into which we sell. Our four key markets are: Advanced Packaging, MEMSsingle wafer etch & RF Filters; LED Lighting, Display & Compound Semiconductor; Front-End Semiconductor; and Scientific & Industrial.

We are a technology company that develops, manufactures, sells, and supports semiconductor process equipment aligned to meet the demands of key global trends such as enhanced mobility, increased connectivity, and energy efficiency. Our primary technologies include metal organic chemical vapor deposition, advanced packaging lithography, wet etch and clean laser annealing, ion beam, molecular beam epitaxy, wafer inspection, and atomic layer deposition systems. These technologies play an integral role in producing LEDs for solid-state lighting and displays, and in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, we holdVeeco holds leading technology leadership positions in allmany of these served markets.the markets we serve.

We categorize our revenue by the key market segments into which we sell. Our four key markets are: Front-End Semiconductor; Advanced Packaging, MEMS & RF Filters; LED Lighting, Display & Compound Semiconductor; and Scientific & Industrial.

Sales in the Front-End Semiconductor market were driven by Laser Annealing systems and Low Defect Density Ion Beam Deposition (“LDD-IBD”) systems for Extreme Ultraviolet (“EUV”) Mask Blank Production. We continue to build momentum in the Front-End Semiconductor market with shipments and additional orders for our EUV mask blank systems as well as advanced node penetration with our Laser Annealing systems. The ongoing adoption of EUV Lithography for advanced node, front-end semiconductor manufacturing is a good trend for us, as is our Laser Annealing progress and opportunity with current advanced nodes and future nodes.

Sales in the Advanced Packaging, MEMS & RF Filter marketsmarket were driven by Lithography and PSP systems, as the market continues to be influenced by the mobility trendwet etch and increasing functionality in mobile devices.clean systems. Advanced Packaging opportunities slowedremained soft in 20172019 as customers temporarily delayed adoption of fan-out wafer level packaging (“FOWLP”) in favor of cheaper flip chip solutions. Our versatile PSP product architecture has allowed usmobile supply chains were dealing with excess capacity due to continue to generate solid business in the MEMS and RF Filter portion of this category.weak mobile device forecasts. We remain well positioned for future growth in these markets, supported by trends such as artificial intelligence, mobile connectivity, automotive electronics, big data processing, and 5G infrastructure deployment, as well as the longer term growth of FOWLP and other Advanced Packaging applications.

Sales in the LED Lighting, Display & Compound Semiconductor market were driven by the continued shipmentvery weak in 2019 with limited system shipments of MOCVD and PSP systems to customers in China, Malaysia, and Europe. The largest applications for LEDs are solid state lighting, followed by TV displays. Over the past several quarters, demand has increased for larger LCD TV displays, which require relatively more LEDs to backlight than smaller display sizes.systems. More recently, we have seen an increase in demand in non general-lightingbeen focused on compound semiconductor applications such as 3D sensors, VCSELs, laser diodes, and RF devices. Our broad portfolio of MOCVD and PSPwet etch and clean technologies have been developed to support these significant industry trends, driving an increaseapplications. During 2019, we shipped our first Lumina evaluation system. This As/P-based system was developed to meet our customers’ requirements for the photonics market which includes specialty LEDs, edge emitting lasers and VCSELs. Additionally, in demand2019 we shipped and received acceptance on our fully automated, 300mm single wafer MOCVD cluster system to a major front-end fab. This GaN based system is ideal for our MOCVDpower and PSP equipment. Our product mix in the LED market is expected to shift, and we expect to see a decline in gross margins in the first half of 2018. We expect margins in the second half of 2018 to be higher than the first half.5G RF applications.

Sales in the Front-End Semiconductor market were primarily driven by Laser Annealing systems, an IBD Photomask system for EUV applications, and IBE systems sold into STT-MRAM applications. We see strong interest from customers for our laser melt anneal systems which are being qualified in 7nm and 5nm applications, as well as our 3D inspection systems which are being evaluated at several high volume manufacturing fabs.

Sales in the Scientific & Industrial marketsmarket were supported by shipments of Ion Beam systems for optical coatings and data storage applications and optical coatings as well as shipments of MBE systems to universities and laboratories. Demand for our Ion Beam products for Data Storage is being driven by big data and cloud-based storage growth. In order to be successful, hard disk drive manufacturers are required to improve areal density of magnetic heads for hard disk drives and are manufacturing drives with an increasing number of thin film magnetic heads. These two factors taken together along with new innovations by HDD manufacturers such as heat assisted magnetic recording (“HAMR”) and microwave assisted magnetic recording (“MAMR”) are driving additional capacity and equipment upgrades. While equipment demand from each individual market may fluctuate quarter to quarter, the diverse customer base has historically provided a relatively stable revenue stream for the Company.

29

Results of Operations

Years Ended December 31, 20172019 and 20162018

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 20172019 and 20162018 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment, includingsegment. See Part II, Item 7 of our Annual Report on Form 10-K for the Ultratech business acquired.fiscal year ended December 31, 2018, filed with the SEC on February 25, 2019, as amended by Amendment No. 1 to such Annual Report on Form 10-K, filed with the SEC on May 1, 2019, for Management’s Discussions and Analysis of Financial Condition and Results of Operations for the fiscal year ended December 31, 2017.

 

 

For the year ended December 31,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Cost of sales

 

300,438

 

62%

 

199,593

 

60%

 

100,845

 

51%

 

Gross profit

 

184,318

 

38%

 

132,858

 

40%

 

51,460

 

39%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

81,987

 

17%

 

81,016

 

24%

 

971

 

1%

 

Selling, general, and administrative

 

100,250

 

21%

 

77,642

 

23%

 

22,608

 

29%

 

Amortization of intangible assets

 

35,475

 

7%

 

19,219

 

6%

 

16,256

 

85%

 

Restructuring

 

11,851

 

2%

 

5,640

 

2%

 

6,211

 

110%

 

Acquisition costs

 

17,786

 

4%

 

 

0%

 

17,786

 

*

 

Asset impairment

 

1,139

 

0%

 

69,520

 

21%

 

(68,381

)

(98)%

 

Other, net

 

(392

)

(0)%

 

223

 

0%

 

(615

)

*

 

Total operating expenses, net

 

248,096

 

51%

 

253,260

 

76%

 

(5,164

)

(2)%

 

Operating income (loss)

 

(63,778

)

(13)%

 

(120,402

)

(36)%

 

56,624

 

*

 

Interest income (expense), net

 

(17,122

)

(4)%

 

958

 

0%

 

(18,080

)

*

 

Income (loss) before income taxes

 

(80,900

)

(17)%

 

(119,444

)

(36)%

 

38,544

 

*

 

Income tax expense (benefit)

 

(36,107

)

(7)%

 

2,766

 

1%

 

(38,873

)

*

 

Net income (loss)

 

$

(44,793

)

(9)%

 

$

(122,210

)

(37)%

 

$

77,417

 

*

 

For the year ended December 31,

Change

 

2019

2018

Period to Period

 

(dollars in thousands)

 

Net sales

    

$

419,349

100

%  

$

542,082

100

%  

$

(122,733)

(23)

%

Cost of sales

 

261,155

62

%  

 

348,363

64

%  

 

(87,208)

(25)

%

Gross profit

 

158,194

38

%  

 

193,719

36

%  

 

(35,525)

(18)

%

Operating expenses, net:

 

  

  

 

  

 

  

Research and development

 

90,557

22

%  

 

97,755

18

%  

 

(7,198)

(7)

%

Selling, general, and administrative

 

79,749

19

%  

 

92,060

17

%  

 

(12,311)

(13)

%

Amortization of intangible assets

 

17,085

4

%  

 

32,351

6

%  

 

(15,266)

(47)

%

Restructuring

 

6,403

2

%  

 

8,556

2

%  

 

(2,153)

(25)

%

Acquisition costs

 

 

2,959

1

%  

 

(2,959)

(100)

%

Asset impairment

 

4,020

1

%  

 

375,172

69

%  

 

(371,152)

*

Other operating expense (income), net

 

(42)

 

368

 

(410)

*

Total operating expenses, net

 

197,772

47

%  

 

609,221

112

%  

 

(411,449)

(68)

%

Operating income (loss)

 

(39,578)

(9)

%  

 

(415,502)

(77)

%  

 

375,924

*

Interest income (expense), net

 

(17,405)

(4)

%  

 

(18,332)

(3)

%  

 

927

(5)

%

Other income (expense), net

(20,973)

(5)

%  

(20,973)

*

Income (loss) before income taxes

 

(77,956)

(19)

%  

 

(433,834)

(80)

%  

 

355,878

*

Income tax expense (benefit)

 

777

 

(26,746)

(5)

%  

 

27,523

*

Net income (loss)

$

(78,733)

(19)

%  

$

(407,088)

(75)

%  

$

328,355

*


*

Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

Year ended December 31,

Change

 

2019

2018

Period to Period

 

(dollars in thousands)

 

Sales by market

    

  

  

    

  

  

    

  

  

Front-End Semiconductor

$

120,128

29

%  

$

62,582

12

%  

$

57,546

92

%

Advanced Packaging, MEMS & RF Filters

 

66,909

16

%  

 

90,775

17

%  

 

(23,866)

(26)

%

LED Lighting, Display & Compound Semiconductor

 

72,791

17

%  

 

249,974

46

%  

 

(177,183)

(71)

%

Scientific & Industrial

 

159,521

38

%  

 

138,751

25

%  

 

20,770

15

%

Total

$

419,349

100

%  

$

542,082

100

%  

$

(122,733)

(23)

%

Sales by geographic region

 

  

  

 

  

  

 

  

  

United States

$

126,160

30

%  

$

125,659

23

%  

$

501

China

 

71,078

17

%  

 

194,032

36

%  

 

(122,954)

(63)

%

EMEA

 

57,351

14

%  

 

89,102

16

%  

 

(31,751)

(36)

%

Rest of World

 

164,760

39

%  

 

133,289

25

%  

 

31,471

24

%

Total

$

419,349

100

%  

$

542,082

100

%  

$

(122,733)

(23)

%

30

 

 

Year ended December 31,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

253,785

 

52%

 

$

144,675

 

44%

 

$

109,110

 

75%

 

Advanced Packaging, MEMS & RF Filters

 

69,353

 

14%

 

68,304

 

21%

 

1,049

 

2%

 

Scientific & Industrial

 

120,788

 

25%

 

111,198

 

33%

 

9,590

 

9%

 

Front-End Semiconductor

 

40,830

 

9%

 

8,274

 

2%

 

32,556

 

393%

 

Total

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

94,936

 

20%

 

$

85,637

 

26%

 

$

9,299

 

11%

 

China

 

107,844

 

22%

 

85,834

 

26%

 

22,010

 

26%

 

EMEA

 

76,636

 

16%

 

83,410

 

25%

 

(6,774

)

(8)%

 

Rest of World

 

205,340

 

42%

 

77,570

 

23%

 

127,770

 

165%

 

Total

 

$

484,756

 

100%

 

$

332,451

 

100%

 

$

152,305

 

46%

 

Total sales increased across all market categoriesdecreased for the year ended December 31, 20172019 against the comparable prior year period drivenin the LED Lighting, Display & Compound Semiconductor and Advanced Packaging, MEMS & RF Filters markets, partially offset by ongoing improvements in LED industry conditions, as well as additional sales of approximately $65.5 million from the Ultratech business acquired in May 2017, primarilyincreases in the Front-End Semiconductor and Advanced Packaging, MEMS, and RF FiltersScientific & Industrial markets. Pricing wasdid not have a significant driver ofimpact on the change in total sales. By geography, sales increaseddecreased in the United States, China and Rest of WorldEMEA regions, partially offset by a slight decrease in the EMEA region. The most significantan increase occurred in the Rest of World region. The most significant decrease occurred in the China region, which was largely attributable to the increaseddecreased sales in the LED Lighting, Display & Compound Semiconductor market. We do not expect significant new orders in China for the LED Lighting, Display & Compound Semiconductor market in Malaysia, as well as additionalthe near future. Sales increased in Rest of World due to an increase of sales fromin the Ultratech business acquired.Front-End Semiconductor market in Japan for our EUV mask blank systems. Sales into Malaysiain Japan and Taiwan were $48.1 million and $48.8 million, respectively, for the year ended December 31, 2017 was approximately $78.2 million, compared to $6.6 million for the year ended December 31, 2016. Sales in China increased principally due to increased sales in the LED Lighting, Display, and Compound Semiconductor market.2019. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

Orders increased to $570.7 million in 2017, an increase of $196.5 million, or 53% compared with 2016. The LED Lighting, Display, and Compound Semiconductor and Scientific & Industrial markets increased 51% and 56%, respectively, driven by overall improvements in industry conditions. The Advanced Packaging, MEMS, and RF Filters and Front-End Semiconductor markets increased 52% and 49%, respectively, driven by the additional bookings from the Ultratech acquisition.Gross Profit

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. In 2017, the ratio was 1.2, a rise2019, gross profit decreased compared to the 2016 ratio of 1.1. Our backlog at December 31, 2017 was $334.3 million, which was higher than the ending backlog at December 31, 2016 of $209.2 million. During the year ended December 31, 2017, we increased backlog by approximately $41.6 million relating2018 primarily due to backlog acquired from Ultratech, while adjusting for a decrease in backlog of approximately $2.0 million relating to orders that no longer met our bookings criteria. For certain sales arrangements, we require a deposit for a portion of the sales price prior to manufacturing a system for a customer. At December 31, 2017 and 2016, we had customer deposits of $41.5 million and $22.2 million, respectively.

Gross Profit

In 2017, gross profit increased compared to 2016 due to an increase in sales volume, including the acquisition of Ultratech, partially offset by decreasedincreased gross margins. Gross margins decreasedincreased principally due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition. Our product and region mix of sales in the periods, which included an exit out of the low margin commoditized LED market is expected to shift, and we expect to see a decline in gross marginsChina, partially offset by an increase in the first half of 2018. We expect margins in the second half of 2018 to be higher than the first half.inventory reserves.

Research and developmentDevelopment

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses remained relatively flatdecreased in 20172019 compared to 2016, as the addition of the acquired Ultratech2018 primarily related research and development projects was offset by our decision to reduce investments in certain technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs.

Selling, general,General, and administrativeAdministrative

Selling, general, and administrative expenses increaseddecreased in 2019 compared to 2018 primarily duerelated to the addition of the acquired Ultratech related selling, general,personnel-related expenses and administrative costs,professional fees as well as increased professional and legal fees.

Amortization expense

The increase in amortization expense is a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of the certain technology assets in the prior year

as well as certain other intangible assets becoming fully amortized during 2016.

Restructuring expense

During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiency, and reduce costs.

Amortization Expense

Amortization expense decreased in 2019 compared to 2018 primarily as a result of the impairment of intangible assets during the second quarter of 2018.

Restructuring Expense

During the second quarter of 2018, we initiated plans to reduce excess capacity associated with the manufacture and support of our advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into our San Jose, California facility. As a result of this and other cost saving initiatives, we announced headcount reductions of approximately 40 employees.

We continued to record restructuring charges in 2019 as a result of our efforts to further streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technologycosts. In the second half of 2019, we executed an initiative to reorganize various functions along product lines and created a central research and development which togetherorganization to better allocate our resources to our highest priority projects. In addition, we delayered the organization while preserving our ability to execute. Collectively, these actions impacted approximately 7560 employees. These activities were substantially completed in 2017. In addition, during 2017, we began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Restructuring expense for the year ended December 31, 2017 included non-cash charges of $1.9 million related to accelerated share-based compensation for employee terminations.

Acquisition costsCosts

Acquisition costs incurred during 2018 are non-recurring charges incurred in connection with the acquisition of the Ultratech business, as well as legal and professional fees incurred in connection with certain integration activities.

31

Asset Impairment

During the fourth quarter of 2019, we determined that one of our product lines met the criteria for held for sale accounting treatment and recorded a non-cash impairment charge of $4.0 million to reduce these assets to their expected fair value upon sale.

During the second quarter of 2018, we lowered our projected results for the Ultratech asset group, which included $4.2were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as FOWLP, and a delay in the adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and reduced revenue projections for our advanced packaging lithography systems. In addition, there was a delay in the build out of 28nm facilities by companies in China who were expected to purchase our LSA systems. Taken together, the reduced projections identified during the second quarter of 2018 required us to assess the Ultratech asset group for impairment. As a result of the analysis, during the second quarter of 2018 we recorded a $252.3 million non-cash intangible asset impairment charge.

Additionally, as a result of non-cash charges relateda significant decline in our stock price during the fourth quarter of 2018, we concluded it was appropriate to accelerated share-based compensation for employee terminationsperform an interim goodwill impairment test as of the end of fiscal 2018. The fair value of our reporting unit was determined using an adjusted market capitalization approach, which is calculated by multiplying our stock price by the number of outstanding shares and adding a control premium. The fair value of our reporting unit was determined to be below the carrying value, and we recorded an impairment charge equal to the excess of carrying value over fair value, or $122.8 million, for the year ended December 31, 2017.2018. The valuation of goodwill will continue to be subject to changes in our market capitalization and observable market control premiums. 

Asset impairment

During 2016, we recorded non-cash impairment charges of $57.6 million relating to our decision to reduce investments in certain technologies, $5.7 million relating to our assessments of the fair market value of assets held for sale, and $6.2 million relating to the disposal of certain lab equipment. Impairment charges for the year ended December 31, 2017, primarily relate to further reductions to the fair market value of assets held for sale upon disposal.

Interest Income (Expense)

For the year ended December 31, 2017,2019, we recorded net interest expense of $17.1$17.4 million, including non-cashcompared to $18.3 million for the comparable prior period. Included in interest expense for the year ended December 31, 2019 and 2018 were non-cash charges of $10.4$12.7 million compared with net interest incomeand $11.8 million, respectively, related to the amortization of $1.0 million in the prior year period. The change primarily relates todebt discount and transaction costs of the Convertible Senior Notes issuedNotes. Interest income increased to $4.7 million for 2019, compared to $3.2 million for the comparable prior period, primarily related to higher average interest yields.

Other Income (Expense)

During the fourth quarter of 2019, we determined that our equity investment in January 2017.Kateeva had indicators of impairment, and as such, we reviewed this investment for impairment. Based on this review, we recorded a non-cash impairment charge of $21.0 million.

Income Taxes

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (“2017 Tax Act’), which makes broad and complex changes to the U.S. tax code. CertainThe 2019 income tax effectsexpense of the 2017 Tax Act are reflected in our financial results in accordance with SAB 118. SAB 118 provides SEC staff guidance regarding the application of Accounting Standards Codification Topic 740 (“ASC 740”) Income Taxes, and the required disclosures due to the enactment of the 2017 Tax Act. The income tax effects of the 2017 Tax Act include a provisional $11.3 million income tax benefit related to the re-measurement of our deferred tax assets and liabilities at the reduced rate of 21 percent and a reduction in our U.S. valuation allowance attributable to indefinite lived intangibles becoming a source of future taxable income for certain deferred tax assets that are expected to have an indefinite life due to the 2017 Tax Act. Refer to Note 17, “Income Taxes,” in the Notes to the Consolidated Financial Statements for further information on the financial statement impact of the 2017 Tax Act.

The 2017 income tax benefit of $36.1$0.8 million is comprised of: (i) a $24.2$1.0 million income tax benefit related to domestic losses incurred during the year ended December 31, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes and recorded as a component of APIC is treated as a source of income in fiscal 2017, (ii) a $11.3 million income tax benefit recorded in connection with the 2017 Tax Act, primarily due to the re-measurement of our deferred tax assets and liabilities at the new federal statutory rate of 21 percent, as well as a reduction in our valuation allowance attributable to deferred tax liabilities associated with indefinite-lived intangible assets that became available as a source of income to offset existing deferred tax assets, and (iii) $0.6 million income tax benefit from non-U.S. operations primarily attributable to a reduction in uncertain tax positions and the recognition of a deferred tax asset for certain non-U.S. net operating losses generated in prior years that have become realizable on a more-likely-than-not basis, offset by tax expense attributed to the profitable non-U.S. operations, as well as withholding taxes recordedtax as we now expect to repatriate certain foreign earnings as a result of changes in tax laws under the 2017 Tax Act.

The 2016Act, (ii) a $0.3 million income tax expense of $2.8 million is comprised of three components: (i) a $1.9 million tax expense related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets, and related valuation allowance, as well as state and local income taxes, (ii) a $0.4 million tax benefit associated with the termination of a pension plan, and (iii) $1.3 million in net tax expense related primarily to our profitable foreign operations. The current period non-U.S. tax expense is attributable to the profitable non-U.S. operations.

Years Ended December 31, 2016 and 2015

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2016 and 2015 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

 

 

For the year ended December 31,

 

Change

 

 

 

2016

 

2015

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Cost of sales

 

199,593

 

60%

 

299,797

 

63%

 

(100,204

)

(33)%

 

Gross profit

 

132,858

 

40%

 

177,241

 

37%

 

(44,383

)

(25)%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

81,016

 

24%

 

78,543

 

16%

 

2,473

 

3%

 

Selling, general, and administrative

 

77,642

 

23%

 

90,188

 

19%

 

(12,546

)

(14)%

 

Amortization of intangible assets

 

19,219

 

6%

 

27,634

 

6%

 

(8,415

)

(30)%

 

Restructuring

 

5,640

 

2%

 

4,679

 

1%

 

961

 

21%

 

Asset impairment

 

69,520

 

21%

 

126

 

0%

 

69,394

 

*

 

Other, net

 

223

 

0%

 

(697

)

(0)%

 

920

 

*

 

Total operating expenses, net

 

253,260

 

76%

 

200,473

 

42%

 

52,787

 

26%

 

Operating income (loss)

 

(120,402

)

(36)%

 

(23,232

)

(5)%

 

(97,170

)

*

 

Interest income (expense), net

 

958

 

0%

 

586

 

0%

 

372

 

63%

 

Income (loss) before income taxes

 

(119,444

)

(36)%

 

(22,646

)

(5)%

 

(96,798

)

*

 

Income tax expense (benefit)

 

2,766

 

1%

 

9,332

 

2%

 

(6,566

)

(70)%

 

Net income (loss)

 

$

(122,210

)

(37)%

 

$

(31,978

)

(7)%

 

$

(90,232

)

*

 


* Not Meaningful

Net Sales

The following is an analysis of sales by market and by region:

 

 

Year ended December 31,

 

Change

 

 

 

2016

 

2015

 

Period to Period

 

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

144,675

 

44%

 

$

291,133

 

61%

 

$

(146,458

)

(50)%

 

Advanced Packaging, MEMS & RF Filters

 

68,304

 

21%

 

61,935

 

13%

 

6,369

 

10%

 

Scientific & Industrial

 

111,198

 

33%

 

118,132

 

25%

 

(6,934

)

(6)%

 

Front-End Semiconductor

 

8,274

 

2%

 

5,838

 

1%

 

2,436

 

42%

 

Total

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

85,637

 

26%

 

$

86,627

 

18%

 

$

(990

)

(1)%

 

China

 

85,834

 

26%

 

242,442

 

51%

 

(156,608

)

(65)%

 

EMEA

 

83,410

 

25%

 

64,019

 

13%

 

19,391

 

30%

 

Rest of World

 

77,570

 

23%

 

83,950

 

18%

 

(6,380

)

(8)%

 

Total

 

$

332,451

 

100%

 

$

477,038

 

100%

 

$

(144,587

)

(30)%

 

Total sales decreased in 2016 from 2015 primarily due to reduced sales in LED Lighting, Display & Compound Semiconductor driven by an oversupply of LED units in the market. Pricing was not a significant driver of the change in total sales. By geography, sales decreased in all regions, except EMEA. The largest sales decline was in China, which was attributable to the decline in LED Lighting, Display & Compound Semiconductor.

Between 2016 and 2015, orders decreased $10.2 million, or 3%, to $374.2 million. The decrease in orders was primarily attributable to a 43% decrease in orders in Advanced Packaging, MEMS & RF Filters as well as a 16% decrease in Scientific & Industrial. These decreases were offset by increases in LED Lighting, Display & Compound Semiconductor and Front-End Semiconductor. In the second half of 2016, we saw some improvements in LED industry conditions.

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. In 2016, the ratio was 1.1, a rise compared to 2015, when it was 0.8. Our backlog at December 31, 2016 was $209.2 million, which was higher than the ending backlog at December 31, 2015 of $186.0 million. During the year ended December 31, 2016, we recorded backlog adjustments of approximately $17.9 million primarily relating to a partial cancellation of a prior period customer order. For certain sales arrangements, we require a deposit for a portion of the sales price prior to manufacturing a system for a customer. At December 31, 2016 and 2015, we had customer deposits of $22.2 million and $28.2 million, respectively.

Gross Profit

Gross profit decreased compared to 2015 due to sharp decline in sales volume, partially offset by improved gross margins. Gross margins increased despite the decline in overall sales volume principally due to favorable product and region mix of sales in the period and from the benefits associated with ongoing cost reduction activities.

Research and development

R&D expenses increased in 2016 compared to 2015 as a result of a reduction in external funding used to offset the cost of R&D activities, as well as the additional use of third party contractors to accelerate the development of products for the LED Lighting, Display & Compound Semiconductor market. We also incurred increased depreciation of research and development-related property, plant, and equipment. These increases were partially offset by decreased personnel-related incentive compensation.

Selling, general,(iii) a $0.5 million income tax benefit related to the amortization and administrativesubsequent impairment of certain non-U.S. intangible assets during the year.

Selling, general, and administrative expenses decreased primarily dueThe 2018 income tax benefit of $26.7 million is comprised of: (i) a $25.2 million income tax benefit related to reductions in sales commissions and incentive compensation as a result of the decline in our financial performance, as well as a decrease in personnel-related expenses as a result of our initiative to streamline operations, enhance efficiency, and reduce costs in response to market conditions.

Amortization expense

The decrease in amortization expense is a result of the impairment of certain technology assets as well as certain other intangible assets becoming fully amortized during 2016.

Restructuring expense

During 2016, additional accruals were recognized and payments made related to previous years’ restructuring initiatives. In addition, during 2016, we undertook additional restructuring activities as part of our initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investmentsthe year, (ii) a $1.7 million income tax benefit recorded in certain technology development, which together impacted approximately 75 employees.

Asset impairment

During 2016, we recorded non-cash impairment charges of $57.6connection with the 2017 Tax Act, (iii) a $0.4 million relating to our decision to reduce investments in certain technologies, $5.7 million relating to our assessments of the fair market value of assets held for sale, and $6.2 million relating to the disposal of certain lab equipment.

Income Taxes

The 2016 income tax expense is comprised of three components: (i) $1.9 million related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets, and related valuation allowance as well as state and local income taxes, (ii)and (iv) a $0.4$0.2 million income tax benefit associated with the terminationfrom non-U.S. operations and non-U.S. withholding taxes recorded as we expected to repatriate certain foreign earnings as a result of the pension plan, and (iii) $1.3 million in net tax expense related primarily to our profitable foreign operations. The 2015 income tax expense is comprised of two components: (i) $1.8 million related primarily to U.S. tax amortization of our indefinite-lived intangible assets that is not available to offset existing deferred tax assets and related valuation allowance and state and local income taxes and (ii) $7.5 millionchanges in tax expense relating to our profitable foreign operations. Our 2016 and 2015 effective tax rate is different thanlaws under the statutory rate primarily due to our inability to recognize our U.S. deferred tax assets on a more-likely-than-not basis with respect to the pre-tax U.S. operating losses in those years.2017 Tax Act.

32

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

December 31,

December 31,

    

2019

    

2018

(in thousands)

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

$

129,294

$

212,273

Restricted cash

 

847

 

 

 

657

 

809

Short-term investments

 

47,780

 

66,787

 

 

115,252

 

48,189

Total

 

$

328,363

 

$

344,231

 

$

245,203

$

261,271

A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At December 31, 20172019 and 2016,2018, cash and cash equivalents of $214.3$73.0 million and $149.2$66.9 million, respectively, were held outside the United States. As of December 31, 2017,2019, we had $155.8$9.4 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided and did not require the use of which approximately $140.2 million was subject to the one-time transition tax on foreign earnings required by the 2017 Tax Act. We do not expect to incur a current U.S. tax liability for the one-time transition taxcash due to the utilizationuse of foreign tax

credits and research and development credits. We expect to repatriate accumulatednet operating loss carryforwards. Approximately $5.0 million of undistributed earnings from certain non-U.S. subsidiaries and have recognized applicablewould be subject to foreign withholding taxes of $6.2 million.if distributed back to the United States. We believe that our projected cash flow from operations, combined with our cash and short term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our Convertible Senior Notes issued in January 2017.due 2023.

A summary of the cash flow activity for the year ended December 31, 20172019 and 20162018 is as follows:

Cash Flows from Operating Activities

 

For the year ended December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

    

For the year ended December 31,

    

2019

    

2018

(in thousands)

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(78,733)

$

(407,088)

Non-cash items:

 

 

 

 

 

Depreciation and amortization

 

50,095

 

32,650

 

 

34,399

 

49,998

Non-cash interest expense

 

10,446

 

 

 

12,676

 

11,762

Deferred income taxes

 

(33,875

)

940

 

 

360

 

(27,620)

Share-based compensation expense

 

24,396

 

15,741

 

 

15,270

 

16,074

Asset impairment

 

1,139

 

69,520

 

 

4,020

 

375,172

Other

 

99

 

(259

)

Impairment of equity investments

20,973

Provision for bad debts

392

Changes in operating assets and liabilities

 

26,639

 

(20,226

)

 

(16,773)

 

(56,036)

Net cash provided by (used in) operating activities

 

$

34,146

 

$

(23,844

)

$

(7,416)

$

(37,738)

Net cash provided byused in operating activities was $34.1$7.4 million for the year ended December 31, 20172019 and was due to the net loss of $44.8 million offset by adjustments for non-cash items of $52.3 million and an increase in cash flow from operating activities due to changes in operating assets and liabilities of $26.6 million. The changes in operating assets and liabilities were largely attributable to increases in accounts payable and accrued expenses and customer deposits and deferred revenue, decreases in accounts receivable and inventory and deferred cost of sales, partially offset by increases in prepaid expenses and other current and non-current assets, and decreases in income tax payables.

Net cash used in operating activities was $23.8 million in 2016 and was due to the net loss of $122.2$78.7 million plus a decline in cash flow from operating activities due to changes in operating assets and liabilities of $20.2$16.8 million, partially offset by adjustments for non-cash items of $118.6$88.1 million. The changes in operating assets and liabilities was largely attributable to a decreasedecreases in accounts payable and accrued expenses an increaseand customer deposits and deferred revenue, partially offset by decreases in inventories and deferred cost of sales, accounts receivable and contract assets, and prepaid expenses and other current assets.

Net cash used in operating activities was $37.7 million for the year ended December 31, 2018 and was due to the net loss of $407.1 million plus a decline in cash flow from operating activities due to changes in operating assets and liabilities of $56.0 million, partially offset by adjustments for non-cash items of $425.4 million. The changes in operating assets and liabilities was largely attributable to decreases in accounts receivable,payable and accrued expenses, customer deposits and deferred

33

revenue, and an increase in inventories and deferred cost of sales, partially offset by a decreasedecreases in accounts receivable and contract assets, and prepaid expenses and other current assets and an increase in customer deposits and deferred revenue.assets.

Cash Flows from Investing Activities

 

For the year ended December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

For the year ended December 31,

    

2019

    

2018

(in thousands)

Acquisitions of businesses, net of cash acquired

 

$

(401,828

)

$

 

$

$

(2,662)

Capital expenditures

 

(24,272

)

(11,479

)

 

(10,873)

 

(12,654)

Changes in investments, net

 

65,980

 

48,907

 

 

(65,639)

 

(2,981)

Other

 

2,284

 

9,282

 

Proceeds from held for sale assets

645

Net cash provided by (used in) investing activities

 

$

(357,836

)

$

46,710

 

$

(75,867)

$

(18,297)

The net cash used in investing activities during the year ended December 31, 20172019 was primarily attributable to net change in investments as well as capital expenditures. The net cash used in investing activities during the year ended December 31, 2018 was attributable to capital expenditures, net change in investments, and net cash used in the final payout related to the acquisition of Ultratech as well as capital expenditures, offset by the net changes in investments. In 2017, as part of our efforts to streamline operations, enhance efficiency, and reduce costs, we made certain investments in our facilities to support the consolidation activities. These activities were substantially completed in 2017. The cash provided by investing activities in 2016 was primarily attributable to net changes in investments and sales of property, plant, and equipment, partially offset by capital expenditures.Ultratech.

Cash Flows from Financing Activities

 

 

 

For the year ended December 31,

 

 

 

 

2017

 

2016

 

 

 

 

(in thousands)

 

For the year ended December 31,

    

2019

    

2018

(in thousands)

Settlement of equity awards, net of withholding taxes

 

 

 

 

$

(5,749

)

$

(945

)

$

126

$

(5)

Purchases of common stock

 

 

 

(2,869

)

(13,349

)

 

 

(11,457)

Proceeds from long-term debt borrowings

 

 

 

335,752

 

 

Repayments of long-term debt

 

 

 

(1,194

)

(340

)

Net cash provided by (used in) financing activities

 

 

 

 

$

325,940

 

$

(14,634

)

$

126

$

(11,462)

The net cash provided by financing activities for the year ended December 31, 20172019 was primarily related to theimmaterial. The net cash proceeds received from the issuance of the Convertible Senior Notes in January 2017. The cash used in financing activities for 2016the year ended December 31, 2018 was primarily related to the share repurchase program which commencedthat expired in November 2015.December 2019.

Convertible Senior Notes

On January 10, 2017, we issued $345.0 million of 2.70% Convertible Senior Notes. We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.

Business Combination

As discussed above, on May 26, 2017, the Company acquired 100% of Ultratech, Inc., a leading supplier of lithography, laser-processing, and inspection systems used to manufacture semiconductor devices and LEDs. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.business, as well as existing cash and cash equivalents and short-term investments. In addition, we have bank guarantees and letters of credit issued by a financial institution on our behalf as needed. At December 31, 2019, outstanding bank guarantees and letters of credit totaled $10.2 million and unused bank guarantees and letters of credit of $21.6 million were available to be drawn upon.

34

The following table summarizes our contractual arrangements at December 31, 2017,2019 and the timing and effect that those commitments are expected to have on our liquidity and cash flow in future periods. The effect of unrecognized tax benefits, which total $0.6 million at December 31, 2017, have been excluded from the table since we are unable to reasonably estimate the period of potential cash settlement, if any, with the respective tax authorities.

 

 

Payments due by period

 

 

 

 

 

Less than

 

1 – 3

 

3 – 5

 

More than

 

 

 

Total

 

1 year

 

years

 

years

 

5 years

 

 

 

(in thousands)

 

Principal payments on long-term debt

 

$

345,000

 

$

 

$

 

$

 

$

345,000

 

Cash interest on debt

 

46,963

 

9,315

 

18,630

 

18,630

 

388

 

Operating leases

 

24,251

 

5,655

 

11,061

 

4,616

 

2,919

 

Bank guarantees

 

6,498

 

6,498

 

 

 

 

Purchase commitments(1)

 

181,032

 

181,032

 

 

 

 

Total

 

$

603,744

 

$

202,500

 

$

29,691

 

$

23,246

 

$

348,307

 

Payments due by period

Less than

1 – 3

3 – 5

More than

    

Total

    

1 year

    

years

    

years

    

5 years

  (in thousands)

Principal payments on long-term debt

$

345,000

$

$

$

345,000

$

Cash interest on debt

 

28,333

 

9,315

 

18,630

 

388

 

Operating leases

 

16,064

 

4,932

 

10,581

 

551

 

Purchase commitments(1)

 

63,258

 

63,258

 

 

 

Total

$

452,655

$

77,505

$

29,211

$

345,939

$


(1)Purchase commitments are primarilygenerally for inventory used in the manufacturing of our products. We generally do not enter into purchase commitments extending beyond one year. WeAt December 31, 2019, we have $7.6$5.9 million of offsetting supplier deposits that will be applied against these purchase commitments as of December 31, 2017.

commitments.

In December 2017, we entered into a Receivable Purchase Agreement with a financial institution to sell certain of our trade receivables from customers without recourse, up to $23.0 million at any point in time for a term of one year. Under the terms of the agreement, we may offer to sell certain eligible accounts receivable (the “Receivables”) to the financial institution (“the Purchaser”), which may accept such offer, and purchase the offered Receivables. The Purchaser will assume credit risk of the Receivables purchased; provided, however, that we will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of the Purchaser. Pursuant to this agreement, we sold $15.0 million of Receivables during the year ended December 31, 2017 and maintained $8.0 million available under the agreement for additional sales of Receivables as of December 31, 2017. The net sale of accounts receivable, under the agreement is reflected as a reduction of accounts receivable in our Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, results of operations, liquidity, capital expenditures, or capital resources other than operating leases, bank guarantees and purchase commitments disclosedreflected in the preceding “Contractual Obligations and Commitments” table.

Application of Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requirerequires a high degree of judgment, either in the application and interpretation of existing accounting literature or in the development of estimates that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate our estimates and judgments based on historical experience as well as other factors that we believe to be reasonable under the circumstances. The results of our evaluation form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. These estimates may change in the future if underlying assumptions or factors change, and actual results may differ from these estimates.

We consider the following significant accounting policies to be critical because of their complexity and the high degree of judgment involved in implementing them.

Revenue Recognition

We recognize revenue when persuasive evidenceadopted ASC 606 as of an arrangement exists, delivery has occurred or services have been rendered,January 1, 2018, using the selling pricefull retrospective method. Refer to Note 1, “Significant Accounting Policies,” for additional information.

Revenue is fixed or determinable, collectability is reasonably assured, and, for system sales, we have received customer acceptance or we have otherwise objectively demonstrated thatrecognized upon the delivered system meets alltransfer of control of the agreed-topromised product or service to the customer specifications. Each sales arrangement mayin an amount that reflects the consideration we expect to receive in exchange for such product or service. Our contracts with customers generally do not contain commercial termsvariable consideration. In the rare instances where variable consideration is included, we estimate the amount of variable consideration and determine what portion of that, differif any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from other arrangements. In addition, wethe transaction price. Our contracts with customers frequently enter into contracts that contain multiple deliverables.deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the accounting units of the multiple deliverable transactionsperformance obligations within a contract and to determine how the manner in which

revenue should be allocated among the accounting units. Moreover, judgment is usedperformance obligations. We also evaluate whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period. The maximum revenue we recognize on a delivered element is limited to the amount that is not contingent upon the deliverycontemplation of additional items. While changes in the allocationone another.

35

When there are separate units of accounting, willwe allocate revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which we separately sell the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not affectsold separately, we estimate stand-alone selling prices generally using an expected cost plus margin approach.

Most of our revenue is recognized at a point in time when the amountperformance obligation is satisfied. We consider many facts when evaluating each of total revenue recognized for a particularour sales arrangement, any material changes in these allocations could impactarrangements to determine the timing of revenue recognition, which couldincluding our contractual obligations and the nature of the customer’s post-delivery acceptance provisions. Our system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in our facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When we objectively demonstrate that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or our historical experience of our tools meeting specifications, transfer of control of the product to the customer is considered to have a material effect on our financial conditionoccurred and results of operations. We generally recognize revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where we cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. We recognize such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases, our contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by us and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of components and spare parts upon shipment. the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

We generally recognize revenue related to maintenance and service contracts ratably over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. We recognize revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable contract term. See Note 1, “Significant Accounting Policies,” insales arrangement.

We may receive customer deposits on system transactions. The timing of the Notestransfer of goods or services related to the Consolidated Financial Statementsdeposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, we do not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a description of our revenue recognition policy.customer contract, such as sales commissions, are expensed as incurred since the expected performance period is one year or less.

 

We have elected to treat shipping and handling costs as a fulfillment activity, and we include such costs in cost of services when we recognize revenue for the related goods. Taxes assessed by governmental authorities that are collected by us from a customer are excluded from revenue.

Inventory Valuation

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter we assess the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of our estimated usage requirements is written down to its estimated net realizable value if less than cost. We evaluate usage requirements by analyzing historical andusage, anticipated demand and anticipated demand is estimated based upon current economic conditions, utilization requirements related to current backlog, current sales trends,alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for our products may require a write down of inventory that could materially affect our operating results.

36

Goodwill and Intangible Assets

Goodwill is tested for impairment at least annually in the beginning of the fourth quarter of our fiscal year. We may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, we then quantitatively compare the fair value of our reporting unit to its carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. If the carrying amount of the reporting unit exceeds its fair value, we then record an impairment loss equal to the difference, up to the carrying value of goodwill.

We determine the fair value of our reporting unit based on a reconciliation of the aggregate fair value of our reporting unit to our adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of our common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

The carrying values of long-lived assets, including identifiable intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability on a quarterly basis. The facts and circumstances considered include the recoverability of the cost of other intangible assets from futuretest is performed utilizing undiscounted cash flows expected to be derived from the use of thegenerated by that asset or asset group.group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals. It is not possible for us to predict the likelihood of any possible future impairments or, if such an impairment were to occur, the magnitude of any impairment.

Intangible assets with finite useful lives, including purchased technology, customer-related intangible assets, patents, trademarks, covenants not-to-compete, backlog, and software licenses, are subject to amortization over the expected period of economic benefit to us. We evaluate whether events or circumstances have occurred that warrant a revision to the remaining useful lives of intangible assets. In cases where a revision is deemed appropriate, the remaining carrying amounts of the intangible assets are amortized over the revised remaining useful life.

Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time.

Accounting Indefinite-lived intangible assets are tested for Business Combinations

The allocationimpairment at least annually in the beginning of the purchase price for acquisitions requires extensive usefourth quarter of accounting estimates and judgments to allocate the purchase price to the identifiable tangible andour fiscal year. In testing indefinite-lived intangible assets acquired, including in-process research and development and liabilities assumed based on their respectivefor impairment, we may first perform a qualitative assessment of whether it is more likely than not that the fair values. The estimates we make include expected cash flows, expected cost savings, and the appropriate weighted average cost of capital. We complete these assessments as

soon as practical after the acquisition closing dates. Any excessvalue of the purchase price overindefinite-lived intangible asset is less than its carrying amount, and, if so, we then quantitatively compare the estimated fair valuesvalue of the identifiable netindefinite-lived intangible asset to its carrying amount. We determine the fair value of our indefinite-lived intangible assets acquired is recorded as goodwill.using a discounted cash flow method.

Income Taxes

We estimate our income taxes in each of the jurisdictions in which we operate. Deferred income taxes reflect the net tax effect of temporary differences between the asset and liability balances recognized for financial reporting purposes and the balances used for income tax purposes, as well as the tax effect of carry forwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income.

We recognize the effect of income tax positions for only those positions which are estimated to more likely than not be sustained if challenged. We reflect changes in recognition or measurement in the period in which our change in judgment occurs. We record interest and penalties related to uncertain tax positions in income tax expense.

Because of Income taxes related to the complexity of the new global intangible low-taxed income (“GILTI”) rules we are continuing to evaluate this provisionexpensed as incurred.

37

Recent Accounting Pronouncements

The FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers, which has been codified as Accounting Standards Codification 606 (“ASC 606”).We adopted ASC 606 requires our revenue recognitionand ASU 2016-01 as of January 1, 2018. We also adopted ASC 842 as of January 1, 2019. Refer to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchangeNote 1, “Significant Accounting Policies,” for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017. The most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance as well as the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, will generally be recognized at the time we transfer control of the system to the customer, which is earlier than under our current revenue recognition model. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under our current revenue recognition model. Taken together, we do not believe these changes will have a material impact on the consolidated financial statements. We plan to adopt using the full retrospective method.additional information.

In January 2016, the FASB issued ASU 2016-01: Financial Instruments — Overall, which requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. For equity investments without readily observable market prices, entities have the option to either measure these investments at fair value every quarter, or measure at cost adjusted for changes in observable prices minus impairment. Changes in measurement under either alternative must be recognized in net income. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017; early adoption is permitted. We do not expect this ASU will have a material impact on the consolidated financial statements upon adoption, and will monitor our cost method investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

In February 2016, the FASB issued ASU 2016-02: Leases, which generally requires our operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be

recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the Statement of Cash Flows. When the standard is adopted, we will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early application permitted. We are evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. We do not expect this ASU will have a material impact on the consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. We do not expect this ASU will have a material impact on the consolidated financial statements.

We are also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $47.8$115.3 million at December 31, 2017.2019. These securities are subject to interest rate risk and, based on our investment portfolio at December 31, 2017,2019, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.1$0.3 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

From time to time, we manage our risks and exposures toChanges in currency exchange rates throughcould affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts with the useintent of derivative financial instruments (e.g., forward contracts).mitigating a portion of this risk. We mainlyonly use derivative financial instruments in the context of hedging and generally do not use them for speculative purposes. During fiscal 2017, we had an immaterial amount of foreign exchange derivativespurposes and have not designated as hedges. During fiscal 2016, we did not designateour foreign exchange derivatives as hedges. Accordingly, most foreign exchange derivatives are recorded in our Consolidated Balance Sheets at fair value and changes in fair value from these contracts are recordedincluded in “Other operating expense (income), net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 80%70%, 74%77%, and 82%80% of our total net sales in 2017, 2016,2019, 2018, and 2015,2017, respectively. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our net sales denominated in currencies other than the U.S. dollar represented approximately 1%4%, 4%1%, and 2%1% of total net sales in 2017, 2016,2019, 2018, and 2015,2017, respectively.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 8. Financial Statements and Supplementary Data

Our Consolidated Financial Statements are listed in the Index to Consolidated Financial Statements and Financial Statement Schedule filed as part of this Form 10-K.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

38

Item 9A. Controls and Procedures

Management’s Report on Internal Control over Financial Reporting

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of December 31, 2017.2019. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is

accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Our principal executive and financial officers are responsible for establishing and maintaining adequate internal control over financial reporting, which is a process designed and put into effect to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Using the criteria established in the Internal Control — Integrated Framework (2013) published by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), Management has evaluated, assessed, and concluded that internal control over financial reporting is effective as of December 31, 2017.2019.

We acquired Ultratech, Inc. (“Ultratech”) on May 26, 2017, and the results of Ultratech from the acquisition date through December 31, 2017 are included in our 2017 consolidated financial statements. The results of Ultratech constituted 50 percent of total assets and 14 percent of net sales as of and for the year ended December 31, 2017. We have excluded Ultratech from our annual assessment of the effectiveness of our internal control over financial reporting.

KPMG LLP, an independent registered public accounting firm, has audited the consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued their report, included herein, on the effectiveness of our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

During the quarter ended December 31, 2017,2019, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

39

Report of Independent Registered Public Accounting Firm

TheTo the Stockholders and Board of Directors and Stockholders of

Veeco Instruments Inc.:

Opinion on Internal Control Over Financial Reporting

We have audited Veeco InstrumentInstruments Inc.’s and subsidiariessubsidiaries’ (the “Company”)Company) internal control over financial reporting as of December 31, 2017,2019, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017,2019, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the consolidated balance sheets of the Company as of December 31, 20172019 and 2016,2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017,2019, and the related notes and financial statement Scheduleschedule II — Valuation– valuation and Qualifying Accountsqualifying accounts (collectively, the consolidated financial statements), and our report dated February 21, 20182020 expressed an unqualified opinion on those consolidated financial statements.

The Company acquired Ultratech, Inc. (“Ultratech”) on May 26, 2017, and the results of Ultratech from the acquisition date through December 31, 2017 are included in the 2017 consolidated financial statements. The results of Ultratech constituted 50% of total assets and 14% of net sales as of and for the year ended December 31, 2017. Management has excluded Ultratech from its annual assessment of the effectiveness of the Company’s internal control over financial reporting. Our audit of internal control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of Ultratech.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Overover Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of

unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become

40

inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Melville, New York

February 21, 20182020

41

Item 9B. Other Information

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information required by this Item that will appear under the headings Governance,“Governance,” “Executive Officers,” and “Section“Delinquent Section 16(a) Beneficial Ownership Reporting Compliance”Reports” in the definitive proxy statement to be filed with the SEC relating to our 20182020 Annual Meeting of Stockholders is incorporated herein by reference.

We have adopted a Code of Ethics for Senior Officers (the “Code”) which applies to our chief executive officer, principal financial officer, principal accounting officer, and persons performing similar functions. A copy of the Code can be found on our website (www.veeco.com). We intend to disclose on our website the nature of any future amendments to and waivers of the Code that apply to the chief executive officer, principal financial officer, principal accounting officer, or persons performing similar functions. We have also adopted a Code of Business Conduct which applies to all of our employees, including those listed above, as well as to our directors. A copy of the Code of Business Conduct can be found on our website (www.veeco.com). The website address above is intended to be an inactive, textual reference only. None of the material on this website is part of this report.

Item 11. Executive Compensation

Information required by this Item that will appear under the heading “Compensation” in the definitive proxy statement to be filed with the SEC relating to our 20182020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information required by this Item that will appear under the headings “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” in the definitive proxy statement to be filed with the SEC relating to our 20182020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information required by this Item that will appear under the headings Certain“Certain Relationships and Related Transactions” and “Independence of Board” in the definitive proxy statement to be filed with the SEC relating to our 20182020 Annual Meeting of Stockholders is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services

Information required by this Item that will appear under the heading “Proposal 4 — Ratification of Appointment of KPMG”“Independent Auditor Fees and Other Matters” in the definitive proxy statement to be filed with the SEC relating to our 20182020 Annual Meeting of Stockholders is incorporated herein by reference.

42

PART IV

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)   (1)  The Registrant’s financial statements together with a separate table of contents are annexed hereto

(2)  Financial Statement Schedules are listed in the separate table of contents annexed hereto.

(3)  Exhibits

Unless otherwise indicated, each of the following exhibits has been previously filed with the Securities and Exchange Commission by the Company under File No. 0-16244.

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

3.1

Amended and Restated Certificate of Incorporation of Veeco dated December 1, 1994, as amended June 2, 1997 and July 25, 1997.

10-Q

3.1

8/14/1997

3.2

Amendment to Certificate of Incorporation of Veeco dated May 29, 1998.

10-K

3.2

3/14/2001

3.3

Amendment to Certificate of Incorporation of Veeco dated May 5, 2000.

10-Q

3.1

8/14/2000

3.4

Amendment to Certificate of Incorporation of Veeco dated May 16, 2002.

10-Q

3.1

10/26/2009

3.5

Amendment to Certificate of Incorporation of Veeco dated May 18, 2010.

10-K

3.8

2/24/2011

3.6

Fifth Amended and Restated Bylaws of Veeco effective February 5, 2016.

8-K

3.1

2/10/2016

3.7

Certificate of Designation, Preferences, and Rights of Series A Junior Participating Preferred Stock of Veeco dated March 14, 2001.

10-Q

3.1

5/9/2001

4.1

Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

8-K

4.1

1/18/2017

4.2

First Supplemental Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

8-K

4.2

1/18/2017

4.3

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

10-K

4.3

X

10.1*

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 14, 2010.

Def 14A

Appendix A

11/4/2013

10.2*

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 5, 2016.

S-8

10.1

6/2/2016

10.3

Veeco Amended and Restated 2010 Stock Incentive Plan, effective March 3, 2017.

10-Q

10.1

11/3/2017

10.4

Veeco Instruments Inc. 2019 Stock Incentive Plan.

S-8

10.1

5/7/2019

10.5

Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011).

S-8

10.1

5/26/2017

10.6*

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2015.

10-Q

10.1

8/3/2015

 

 

 

 

 

 

 

 

 

 

Filed or

Exhibit

 

 

 

Incorporated by Reference

 

Furnished

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date

 

Herewith

2.1

 

Agreement and Plan of Merger dated as of February 2, 2017 among Ultratech, Inc., Veeco Instruments Inc. and Ulysses Acquisition Subsidiary Corp.

 

8-K

 

2.1

 

2/3/2017

 

 

2.2

 

Securities Purchase Agreement, dated December 4, 2014, by and among Solid State Equipment Holdings LLC, certain securityholders thereof, Veeco Instruments Inc. and certain other parties thereto.

 

10-K

 

2.1

 

2/24/2015

 

 

2.3

 

Agreement and Plan of Merger, dated September 18, 2013, by and among Veeco, Veeco Wyoming Inc., Synos Technology, Inc., certain stockholders of Synos Technology, Inc., and Shareholder Representative Services LLC.

 

10-K

 

2.1

 

2/28/2014

 

 

3.1

 

Amended and Restated Certificate of Incorporation of Veeco dated December 1, 1994, as amended June 2, 1997 and July 25, 1997.

 

10-Q

 

3.1

 

8/14/1997

 

 

3.2

 

Amendment to Certificate of Incorporation of Veeco dated May 29, 1998.

 

10-K

 

3.2

 

3/14/2001

 

 

3.3

 

Amendment to Certificate of Incorporation of Veeco dated May 5, 2000.

 

10-Q

 

3.1

 

8/14/2000

 

 

3.4

 

Amendment to Certificate of Incorporation of Veeco dated May 16, 2002.

 

10-Q

 

3.1

 

10/26/2009

 

 

3.5

 

Amendment to Certificate of Incorporation of Veeco dated May 18, 2010.

 

10-K

 

3.8

 

2/24/2011

 

 

3.6

 

Fifth Amended and Restated Bylaws of Veeco effective February 5, 2016.

 

8-K

 

3.1

 

2/10/2016

 

 

3.7

 

Certificate of Designation, Preferences, and Rights of Series A Junior Participating Preferred Stock of Veeco.

 

10-Q

 

3.1

 

5/9/2001

 

 

4.1

 

Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

 

8-K

 

4.1

 

1/18/2017

 

 

4.2

 

First Supplemental Indenture, dated as of January 18, 2017, by and between Veeco Instruments Inc. and U.S. Bank National Association, as Trustee (relating to the 2.70% Convertible Notes due 2023).

 

8-K

 

4.2

 

1/18/2017

 

 

10.1

 

Loan Agreement dated as of December 15, 1999 between Applied Epi, Inc. and Jackson National Life Insurance Company.

 

10-Q

 

10.2

 

11/14/2001

 

 

10.2

 

Promissory Note dated as of December 15, 1999 issued by Applied Epi, Inc. to Jackson National Life Insurance Company.

 

10-Q

 

10.3

 

11/14/2001

 

 

43

Table of Contents

 

 

 

 

 

 

 

 

 

 

Filed or

Exhibit

 

 

 

Incorporated by Reference

 

Furnished

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date

 

Herewith

10.3

 

Amendment to Loan Documents effective as of September 17, 2001 between Applied Epi, Inc. and Jackson National Life Insurance Company (executed in June 2002).

 

10-Q

 

10.2

 

8/14/2002

 

 

10.4*

 

Veeco Amended and Restated 2000 Stock Incentive Plan, effective July 20, 2006.

 

10-Q

 

10.4

 

8/4/2006

 

 

10.5*

 

Amendment No. 1 effective April 18, 2007 (ratified by the Board August 7, 2007) to Veeco Amended and Restated 2000 Stock Incentive Plan.

 

10-Q

 

10.1

 

8/7/2007

 

 

10.6*

 

Amendment No. 2 dated January 22, 2009 to Veeco Amended and Restated 2000 Stock Incentive Plan.

 

10-K

 

10.41

 

3/2/2009

 

 

10.7*

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 14, 2010.

 

Def 14A

 

Appendix A

 

11/4/2013

 

 

10.8*

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective May 5, 2016.

 

S-8

 

10.1

 

6/2/2016

 

 

10.9

 

Veeco Amended and Restated 2010 Stock Incentive Plan, effective March 3, 2017.

 

10-Q

 

10.1

 

11/3/2017

 

 

10.10

 

Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan (as Amended and Restated as of May 31, 2011).

 

S-8

 

10.1

 

5/26/2017

 

 

10.11*

 

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2015.

 

10-Q

 

10.1

 

8/3/2015

 

 

10.12*

 

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

 

10-Q

 

10.1

 

11/1/2016

 

 

10.13*

 

Form of Notice of Critical Priorities Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

 

10-Q

 

10.2

 

11/1/2016

 

 

10.14*

 

Veeco 2013 Inducement Stock Incentive Plan, effective September 26, 2013.

 

10-Q

 

10.1

 

11/4/2013

 

 

10.15*

 

Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

 

S-8

 

10.9

 

6/2/2016

 

 

10.16*

 

Form of Support Agreement (issued in connection with the Agreement and Plan of Merger with Ultratech, Inc. dated February 2, 2017).

 

8-K

 

10.1

 

2/3/2017

 

 

10.17

 

Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers (August 2017).

 

10-Q

 

10.2

 

8/3/2017

 

 

10.18*

 

Veeco Amended and Restated Senior Executive Change in Control Policy, effective as of January 1, 2014.

 

10-K

 

10.22

 

2/28/2014

 

 

10.19*

 

Employment Agreement effective as of July 1, 2007 between Veeco and John R. Peeler.

 

10-Q

 

10.3

 

8/7/2007

 

 

10.20*

 

Amendment effective December 31, 2008 to Employment Agreement between Veeco and John R. Peeler.

 

10-K

 

10.38

 

3/2/2009

 

 

10.21*

 

Second Amendment effective June 11, 2010 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.1

 

7/29/2010

 

 

10.22*

 

Third Amendment effective April 25, 2012 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.2

 

5/9/2012

 

 

10.23*

 

Amendment dated June 12, 2014 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.3

 

7/31/2014

 

 

10.24

 

Amendment dated June 12, 2017 to Employment Agreement between Veeco and John R. Peeler.

 

10-Q

 

10.1

 

8/3/2017

 

 

10.25*

 

Letter Agreement dated April 8, 2014 between Veeco and Shubham Maheshwari.

 

10-Q

 

10.1

 

7/31/2014

 

 

10.26*

 

Letter Agreement dated January 30, 2012 between Veeco and Dr. William J. Miller.

 

10-K

 

10.30

 

2/22/2012

 

 

Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

10.7*

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

10-Q

10.1

11/1/2016

10.8*

Form of Notice of Critical Priorities Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective June 2016.

10-Q

10.2

11/1/2016

10.9*

Form of Notice of Performance Share Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2018.

10-Q

10.1

5/7/2018

10.10*

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2018.

10-Q

10.2

5/7/2018

10.11

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019.

10-Q

 

10.1

 

5/7/2019

10.12

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version A)

10-Q

 

10.2

 

5/7/2019

10.13

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2010 Stock Incentive Plan, effective March 2019 (time-based version B)

10-Q

 

10.3

 

5/7/2019

10.14*

Veeco 2013 Inducement Stock Incentive Plan, effective September 26, 2013

10-Q

10.1

11/4/2013

10.15*

Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

S-8

10.9

6/2/2016

10.16

First Amendment to Veeco Instruments Inc. 2016 Employee Stock Purchase Plan.

S-8

10.11

5/7/2019

10.17

Form of Amended and Restated Indemnification Agreement entered into between Veeco and each of its directors and executive officers (August 2017).

10-Q

10.2

8/3/2017

10.18*

Veeco Amended and Restated Senior Executive Change in Control Policy, effective as of January 1, 2014.

10-K

10.22

2/28/2014

10.19*

Letter Agreement dated January 30, 2012 between Veeco and Dr. William J. Miller.

10-K

10.30

2/22/2012

10.20*

Letter Agreement dated August 29, 2018 between Veeco and Dr. William J. Miller.

8-K

10.2

9/4/2018

10.21

Amendment dated March 22, 2019 to the Letter Agreement between Veeco and William J. Miller, Ph.D.

10-Q

10.4

5/7/2019

10.22*

Employment Agreement effective as of July 1, 2007 between Veeco and John R. Peeler.

10-Q

10.3

8/7/2007

10.23*

Amendment effective December 31, 2008 to Employment Agreement between Veeco and John R. Peeler.

10-K

10.38

3/2/2009

10.24*

Second Amendment effective June 11, 2010 to Employment Agreement between Veeco and John R. Peeler.

10-Q

10.1

7/29/2010

44


Filed or

Exhibit

Incorporated by Reference

Furnished

Number

    

Exhibit Description

    

Form

    

Exhibit

    

Filing Date

    

Herewith

10.25*

Third Amendment effective April 25, 2012 to Employment Agreement between Veeco and John R. Peeler.

10-Q

10.2

5/9/2012

10.26*

Amendment dated June 12, 2014 to Employment Agreement between Veeco and John R. Peeler.

10-Q

10.3

7/31/2014

10.27*

Amendment dated June 12, 2017 to Employment Agreement between Veeco and John R. Peeler.

10-Q

10.1

8/3/2017

10.28*

Amendment dated August 29, 2018 to Employment Agreement between Veeco and John R. Peeler.

8-K

10.1

9/4/2018

10.29*

Letter Agreement dated April 8, 2014 between Veeco and Shubham Maheshwari.

10-Q

10.1

7/31/2014

10.30*

Letter Agreement dated August 29, 2018 between Veeco and Shubham Maheshwari.

8-K

10.3

9/4/2018

10.31

Amendment dated March 22, 2019 to the Letter Agreement between Veeco and Shubham Maheshwari.

10-Q

10.5

5/7/2019

10.32*

Letter Agreement dated January 21, 2004 between Veeco and John P. Kiernan.

10-K

10.38

3/12/2004

10.33*

Amendment effective June 9, 2006 to Letter Agreement between Veeco and John P. Kiernan.

10-Q

10.3

8/4/2006

10.34*

Amendment effective December 31, 2008 to Letter Agreement between Veeco and John P. Kiernan.

10-K

10.40

3/2/2009

10.35

Letter dated January 1, 2020 from Veeco to John P. Kiernan.

8-K

99.2

1/2/2020

21.1

Subsidiaries of the Registrant.

X

23.1

Consent of KPMG LLP.

X

31.1

Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

X

31.2

Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

X

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

X

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

X

101.INS

XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

**

101.XSD

XBRL Schema.

**

101.PRE

XBRL Presentation.

**

101.CAL

XBRL Calculation.

**

101.DEF

XBRL Definition.

**

101.LAB

XBRL Label.

**

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

**

*    Indicates a management contract or compensatory plan or arrangement, as required by Item 15(a) (3) of Form 10-K.

**  Filed herewith electronically

45

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 21, 2018.2020.

Veeco Instruments Inc.

By:

/S/ JOHN R. PEELERWILLIAM J. MILLER, Ph.D.

John R. PeelerWilliam J. Miller, Ph.D.

Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated, on February 21, 2018.2020.

Signature

    

Title

/s/ WILLIAM J. MILLER, Ph.D.

Chief Executive Officer and Director

William J. Miller, Ph.D.

(principal executive officer)

/s/ JOHN P. KIERNAN

Senior Vice President and Chief Financial Officer

John P. Kiernan

(principal financial & accounting officer)

/s/ JOHN R. PEELER

Chairman and Chief Executive Officer

John R. Peeler

(principal executive officer)

/s/ SHUBHAM MAHESHWARI

Executive Vice President and Chief Financial Officer

Shubham Maheshwari

(principal financial officer)

/s/ JOHN P. KIERNAN

Senior Vice President, Finance, Chief Accounting Officer, and Treasurer

John P. Kiernan

(principal accounting officer)

/s/ KATHLEEN A. BAYLESS

Director

Kathleen A. Bayless

/s/ RICHARD A. D’AMORE

Director

Richard A. D’Amore

/s/ GORDON HUNTER

Director

Gordon Hunter

/s/ KEITH D. JACKSON

Director

Keith D. Jackson

/s/ MARY JANE RAYMOND

Director

Mary Jane Raymond

/s/ PETER J. SIMONE

Director

Peter J. Simone

/s/ THOMAS ST. DENNIS

Director

Thomas St. Dennis

46

F-1



Report of Independent Registered Public Accounting Firm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TheTo the Stockholders and Board of Directors and Stockholders of

Veeco Instruments Inc.:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Veeco Instruments Inc. and subsidiaries (the “Company”)Company) as of December 31, 20172019 and 2016,2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2017,2019, and the related notes and financial statement Scheduleschedule II — Valuation– valuation and Qualifying Accountsqualifying accounts (collectively, the “consolidatedconsolidated financial statements”)statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20172019 and 2016,2018, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2017,2019, in conformity with U.S. generally accepted accounting principlesprinciples.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the Company’s internal control over financial reporting as of December 31, 2017,2019, based on criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission”,Commission, and our report dated February 21, 20182020 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgment. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Assessment of the value of excess and obsolete inventory

As discussed in Note 1 to the consolidated financial statements, the Company assesses the valuation of all inventories, including materials, work-in-process, and finished goods, each reporting period. Obsolete inventory or inventory in excess of the Company’s estimated usage requirement is written down to its estimated net realizable value if less than

F-2

cost. Estimates of usage include the Company’s analysis of anticipated demand, possible alternative uses of its inventory, as well as other qualitative factors. As of December 31, 2019, the Company’s inventories totaled $133.1 million, representing 16.3% of total assets.

We identified the assessment of the value of excess and obsolete inventory as a critical audit matter. Subjective auditor judgment was required to evaluate the Company’s estimates of anticipated demand and possible alternative uses of its inventory, which are affected by market and economic conditions outside the Company’s control.

The primary procedures we performed to address this critical audit matter included the following. We tested certain internal controls over the Company’s inventory valuation process, including controls related to the development of estimates of anticipated demand and possible alternative uses of inventory. We evaluated current year estimates of anticipated demand used to value excess and obsolete inventory when it significantly differed from historical sales volumes and assessed possible alternative uses of inventory. For certain inventory items, we compared the prior year anticipated demand to actual results to assess the Company’s ability to accurately forecast. We compared possible alternative uses of certain inventory determined in the prior year to actual uses in the current year.

/s/ KPMG LLP

We have served as the Company’s auditor since 2015.

Melville, New York

February 21, 2018

F-2Melville, New York

February 21, 2020

F-3



Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

 

 

December 31,

 

December 31,

 

 

 

2017

 

2016

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

279,736

 

$

277,444

 

Restricted cash

 

847

 

 

Short-term investments

 

47,780

 

66,787

 

Accounts receivable, net

 

98,866

 

58,020

 

Inventories

 

120,266

 

77,063

 

Deferred cost of sales

 

16,060

 

6,160

 

Prepaid expenses and other current assets

 

33,437

 

16,034

 

Total current assets

 

596,992

 

501,508

 

Property, plant, and equipment, net

 

85,058

 

60,646

 

Intangible assets, net

 

369,843

 

58,378

 

Goodwill

 

307,131

 

114,908

 

Deferred income taxes

 

2,953

 

2,045

 

Other assets

 

25,310

 

21,047

 

Total assets

 

$

1,387,287

 

$

758,532

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

50,318

 

$

22,607

 

Accrued expenses and other current liabilities

 

60,339

 

33,201

 

Customer deposits and deferred revenue

 

108,953

 

85,022

 

Income taxes payable

 

3,846

 

2,311

 

Current portion of long-term debt

 

 

368

 

Total current liabilities

 

223,456

 

143,509

 

Deferred income taxes

 

36,845

 

13,199

 

Long-term debt

 

275,630

 

826

 

Other liabilities

 

10,643

 

6,403

 

Total liabilities

 

546,574

 

163,937

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.

 

 

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 48,229,251 and 40,714,790 shares issued at December 31, 2017 and December 31, 2016, respectively; 48,144,416 and 40,588,194 shares outstanding at December 31, 2017 and December 31, 2016, respectively.

 

482

 

407

 

Additional paid-in capital

 

1,053,079

 

763,303

 

Accumulated deficit

 

(213,376

)

(168,583

)

Accumulated other comprehensive income

 

1,812

 

1,777

 

Treasury stock, at cost, 84,835 and 126,596 shares at December 31, 2017 and 2016, respectively.

 

(1,284

)

(2,309

)

Total stockholders’ equity

 

840,713

 

594,595

 

Total liabilities and stockholders’ equity

 

$

1,387,287

 

$

758,532

 

December 31,

December 31,

    

2019

    

2018

Assets

Current assets:

Cash and cash equivalents

$

129,294

$

212,273

Restricted cash

657

809

Short-term investments

 

115,252

 

48,189

Accounts receivable, net

 

45,666

 

66,808

Contract assets

25,351

10,397

Inventories

 

133,067

 

156,311

Deferred cost of sales

 

445

 

3,072

Prepaid expenses and other current assets

14,966

22,221

Assets held for sale

11,180

Total current assets

 

475,878

 

520,080

Property, plant, and equipment, net

 

75,711

 

80,284

Operating lease right-of-use assets

14,453

Intangible assets, net

61,518

85,149

Goodwill

 

181,943

 

184,302

Deferred income taxes

1,549

1,869

Other assets

 

7,036

 

29,132

Total assets

$

818,088

$

900,816

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$

21,281

$

39,611

Accrued expenses and other current liabilities

 

41,243

 

46,450

Customer deposits and deferred revenue

 

54,870

 

72,736

Income taxes payable

 

830

 

1,256

Total current liabilities

 

118,224

 

160,053

Deferred income taxes

 

5,648

 

5,690

Long-term debt

 

300,068

 

287,392

Operating lease long-term liabilities

10,300

Other liabilities

 

9,336

 

9,906

Total liabilities

 

443,576

 

463,041

Stockholders' equity:

Preferred stock, $0.01 par value; 500,000 shares authorized; 0 shares issued and outstanding.

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 48,994,346 and 48,547,417 shares issued at December 31, 2019 and December 31, 2018, respectively; 48,994,346 and 48,024,685 shares outstanding at December 31, 2019 and December 31, 2018, respectively.

 

490

 

485

Additional paid-in capital

 

1,071,058

 

1,061,325

Accumulated deficit

 

(698,930)

 

(619,983)

Accumulated other comprehensive income

 

1,894

 

1,820

Treasury stock, at cost, 522,732 shares at December 31, 2018.

(5,872)

Total stockholders' equity

 

374,512

 

437,775

Total liabilities and stockholders' equity

$

818,088

$

900,816

See accompanying Notes to the Consolidated Financial Statements.

F-3

F-4



Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Net sales

 

$

484,756

 

$

332,451

 

$

477,038

 

Cost of sales

 

300,438

 

199,593

 

299,797

 

Gross profit

 

184,318

 

132,858

 

177,241

 

Operating expenses, net:

 

 

 

 

 

 

 

Research and development

 

81,987

 

81,016

 

78,543

 

Selling, general, and administrative

 

100,250

 

77,642

 

90,188

 

Amortization of intangible assets

 

35,475

 

19,219

 

27,634

 

Restructuring

 

11,851

 

5,640

 

4,679

 

Acquisition costs

 

17,786

 

 

 

Asset impairment

 

1,139

 

69,520

 

126

 

Other, net

 

(392

)

223

 

(697

)

Total operating expenses, net

 

248,096

 

253,260

 

200,473

 

Operating income (loss)

 

(63,778

)

(120,402

)

(23,232

)

Interest income

 

2,335

 

1,180

 

1,050

 

Interest expense

 

(19,457

)

(222

)

(464

)

Income (loss) before income taxes

 

(80,900

)

(119,444

)

(22,646

)

Income tax expense (benefit)

 

(36,107

)

2,766

 

9,332

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

Diluted

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

 

44,174

 

39,340

 

39,742

 

Diluted

 

44,174

 

39,340

 

39,742

 

For the year ended December 31,

    

2019

    

2018

    

2017

Net sales

$

419,349

$

542,082

$

475,686

Cost of sales

 

261,155

 

348,363

 

299,458

Gross profit

 

158,194

 

193,719

 

176,228

Operating expenses, net:

Research and development

 

90,557

 

97,755

 

81,987

Selling, general, and administrative

 

79,749

 

92,060

 

100,250

Amortization of intangible assets

 

17,085

 

32,351

 

35,475

Restructuring

 

6,403

 

8,556

 

11,851

Acquisition costs

2,959

17,786

Asset impairment

 

4,020

 

375,172

 

1,139

Other operating expense (income), net

(42)

368

(392)

Total operating expenses, net

197,772

609,221

248,096

Operating income (loss)

 

(39,578)

 

(415,502)

 

(71,868)

Interest income

 

4,680

 

3,186

 

2,335

Interest expense

 

(22,085)

 

(21,518)

 

(19,457)

Other income (expense), net

(20,973)

Income (loss) before income taxes

 

(77,956)

 

(433,834)

 

(88,990)

Income tax expense (benefit)

 

777

 

(26,746)

 

(37,594)

Net income (loss)

$

(78,733)

$

(407,088)

$

(51,396)

Income (loss) per common share:

Basic

$

(1.66)

$

(8.63)

$

(1.16)

Diluted

$

(1.66)

$

(8.63)

$

(1.16)

Weighted average number of shares:

Basic

 

47,482

 

47,151

 

44,174

Diluted

 

47,482

 

47,151

 

44,174

See accompanying Notes to the Consolidated Financial Statements.

F-4

F-5



Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

Change in net unrealized gains or losses

 

(7

)

(6

)

(49

)

Reclassification adjustments for net (gains) losses included in net loss

 

 

18

 

 

Net unrealized gain (loss) on available-for-sale securities

 

(7

)

12

 

(49

)

Minimum pension liability:

 

 

 

 

 

 

 

Change in minimum pension liability

 

 

 

15

 

Reclassification adjustments for net (gains) losses included in net loss

 

 

866

 

 

Net changes related to minimum pension liability

 

 

866

 

15

 

Currency translation adjustments:

 

 

 

 

 

 

 

Change in currency translation adjustments

 

42

 

(19

)

(87

)

Reclassification adjustments for net (gains) losses included in net loss

 

 

(430

)

 

Net changes related to currency translation adjustments

 

42

 

(449

)

(87

)

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax

 

35

 

429

 

(121

)

 

 

 

 

 

 

 

 

Total comprehensive income (loss)

 

$

(44,758

)

$

(121,781

)

$

(32,099

)

For the year ended December 31,

    

2019

    

2018

    

2017

Net income (loss)

$

(78,733)

$

(407,088)

$

(51,396)

Other comprehensive income (loss), net of tax:

Available-for-sale securities:

Change in net unrealized gains or losses

 

49

 

11

 

(7)

Unrealized gain (loss) on available-for-sale securities

 

49

 

11

(7)

Currency translation adjustments:

Change in currency translation adjustments

 

(19)

 

5

 

42

Reclassification adjustments for net (gains) losses included in net income

 

44

 

(8)

 

Net changes related to currency translation adjustments

 

25

 

(3)

 

42

Other comprehensive income (loss), net of tax

 

74

 

8

 

35

Total comprehensive income (loss)

$

(78,659)

$

(407,080)

$

(51,361)

See accompanying Notes to the Consolidated Financial Statements.

F-5

F-6



Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Stockholders’Stockholders' Equity

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Retained

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

Earnings

 

Other

 

 

 

 

 

Common Stock

 

Treasury Stock

 

Paid-in

 

(Accumulated

 

Comprehensive

 

 

 

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Deficit)

 

Income

 

Total

 

Balance at December 31, 2014

 

40,360

 

$

404

 

 

$

 

$

750,139

 

$

(13,080

)

$

1,469

 

$

738,932

 

Net loss

 

 

 

 

 

 

(31,978

)

 

(31,978

)

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

(121

)

(121

)

Share-based compensation expense

 

 

 

 

 

17,986

 

 

 

17,986

 

Net issuance under employee stock plans

 

636

 

6

 

 

 

(988

)

 

 

(982

)

Purchases of common stock

 

 

 

469

 

(9,222

)

 

 

 

(9,222

)

Balance at December 31, 2015

 

40,996

 

410

 

469

 

(9,222

)

767,137

 

(45,058

)

1,348

 

714,615

 

Cumulative effect of change in accounting principle - adoption of ASU 2016-09

 

 

 

 

 

1,315

 

(1,315

)

 

 

Net loss

 

 

 

 

 

 

(122,210

)

 

(122,210

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

429

 

429

 

Share-based compensation expense

 

 

 

 

 

15,741

 

 

 

15,741

 

Net issuance under employee stock plans

 

(281

)

(3

)

(1,072

)

19,948

 

(20,890

)

 

 

(945

)

Purchases of common stock

 

 

 

730

 

(13,035

)

 

 

 

(13,035

)

Balance at December 31, 2016

 

40,715

 

407

 

127

 

(2,309

)

763,303

 

(168,583

)

1,777

 

594,595

 

Net loss

 

 

 

 

 

 

(44,793

)

 

(44,793

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

35

 

35

 

Share-based compensation expense

 

 

 

 

 

24,396

 

 

 

24,396

 

Net issuance under employee stock plans

 

313

 

3

 

(245

)

4,043

 

(9,795

)

 

 

(5,749

)

Stock issuance for business acquisition

 

7,201

 

72

 

 

 

 

 

228,800

 

 

 

 

 

228,872

 

Convertible Senior Notes, equity component

 

 

 

 

 

46,375

 

 

 

46,375

 

Purchases of common stock

 

 

 

203

 

(3,018

)

 

 

 

(3,018

)

Balance at December 31, 2017

 

48,229

 

$

482

 

85

 

$

(1,284

)

$

1,053,079

 

$

(213,376

)

$

1,812

 

$

840,713

 

    

    

    

    

    

    

Accumulated

    

Additional

Other

Common Stock

Treasury Stock

Paid-in

Accumulated

Comprehensive

Shares

Amount

Shares

    

Amount

Capital

Deficit

Income

Total

Balance at December 31, 2016

 

40,715

407

127

(2,309)

763,303

(161,474)

1,777

$

601,704

Net loss

 

 

 

 

 

 

(51,396)

 

 

(51,396)

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

35

 

35

Share-based compensation expense

 

 

 

 

 

24,396

 

 

 

24,396

Net issuance under employee stock plans

 

313

3

(245)

4,043

(9,795)

(5,749)

Stock issuance for business acquisition

7,201

72

228,800

228,872

Convertible Senior Notes, equity component

45,249

45,249

Purchases of common stock

 

 

203

 

(3,018)

 

 

 

 

(3,018)

Balance at December 31, 2017

 

48,229

482

85

(1,284)

1,051,953

(212,870)

1,812

840,093

Net loss

 

 

 

 

 

 

(407,088)

 

 

(407,088)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

8

 

8

Share-based compensation expense

 

 

 

 

 

16,074

 

 

 

16,074

Net issuance under employee stock plans

318

3

(512)

6,721

(6,702)

(25)

(3)

Purchases of common stock

 

 

 

950

 

(11,309)

 

 

 

 

(11,309)

Balance at December 31, 2018

 

48,547

485

523

(5,872)

1,061,325

(619,983)

1,820

437,775

Net loss

 

(78,733)

 

(78,733)

Other comprehensive income, net of tax

 

74

 

74

Share-based compensation expense

 

15,270

 

15,270

Net issuance under employee stock plans

447

5

(523)

5,872

(5,537)

(214)

126

Balance at December 31, 2019

 

48,994

$

490

$

$

1,071,058

$

(698,930)

$

1,894

$

374,512

See accompanying Notes to the Consolidated Financial Statements.

F-6

F-7



Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

Cash Flows from Operating Activities

 

 

 

 

 

 

 

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

50,095

 

32,650

 

39,850

 

Non-cash interest expense

 

10,446

 

 

 

Deferred income taxes

 

(33,875

)

940

 

2,648

 

Share-based compensation expense

 

24,396

 

15,741

 

17,986

 

Asset impairment

 

1,139

 

69,520

 

126

 

Provision for bad debts

 

99

 

171

 

43

 

Gain on sale of lab tools

 

 

 

(1,261

)

Gain on cumulative translation adjustment

 

 

(430

)

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

4,520

 

(8,667

)

10,715

 

Inventories and deferred cost of sales

 

6,336

 

(5,389

)

(12,312

)

Prepaid expenses and other current assets

 

(10,204

)

6,726

 

(39

)

Accounts payable and accrued expenses

 

12,197

 

(24,202

)

9,470

 

Customer deposits and deferred revenue

 

19,096

 

8,807

 

(20,738

)

Income taxes receivable and payable, net

 

775

 

547

 

759

 

Long-term income tax liability

 

(4,877

)

 

 

Other, net

 

(1,204

)

1,952

 

520

 

Net cash provided by (used in) operating activities

 

34,146

 

(23,844

)

15,789

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

Acquisitions of businesses, net of cash acquired

 

(401,828

)

 

(68

)

Capital expenditures

 

(24,272

)

(11,479

)

(13,887

)

Proceeds from the sale of investments

 

348,927

 

152,301

 

88,647

 

Payments for purchases of investments

 

(282,947

)

(103,394

)

(85,838

)

Proceeds from held for sale assets

 

2,284

 

9,512

 

3,068

 

Other

 

 

(230

)

1,000

 

Net cash provided by (used in) investing activities

 

(357,836

)

46,710

 

(7,078

)

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

2,992

 

1,656

 

2,233

 

Restricted stock tax withholdings

 

(8,741

)

(2,601

)

(3,215

)

Purchases of common stock

 

(2,869

)

(13,349

)

(8,907

)

Proceeds from long-term debt borrowings

 

335,752

 

 

 

Principal payments on long-term debt

 

(1,194

)

(340

)

(314

)

Net cash provided by (used in) financing activities

 

325,940

 

(14,634

)

(10,203

)

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

42

 

(20

)

(87

)

Net increase (decrease) in cash and cash equivalents

 

2,292

 

8,212

 

(1,579

)

Cash and cash equivalents - beginning of period

 

277,444

 

269,232

 

270,811

 

Cash and cash equivalents - end of period

 

$

279,736

 

$

277,444

 

$

269,232

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

 

Interest paid

 

$

4,675

 

$

225

 

$

485

 

Income taxes paid

 

1,939

 

1,669

 

7,091

 

Non-cash operating and financing activities

 

 

 

 

 

 

 

Net transfer of inventory to property, plant and equipment

 

(97

)

1,827

 

 

For the year ended December 31,

    

2019

    

2018

    

2017

Cash Flows from Operating Activities

Net income (loss)

$

(78,733)

$

(407,088)

$

(51,396)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Depreciation and amortization

 

34,399

 

49,998

 

50,095

Non-cash interest expense

12,676

11,762

10,446

Deferred income taxes

 

360

 

(27,620)

 

(35,363)

Share-based compensation expense

 

15,270

 

16,074

 

24,396

Asset impairment

4,020

375,172

1,139

Impairment of equity investments

20,973

Provision for bad debts

392

99

Changes in operating assets and liabilities:

Accounts receivable and contract assets

 

5,796

 

21,821

 

10,240

Inventories and deferred cost of sales

 

14,969

 

(24,678)

 

6,244

Prepaid expenses and other current assets

 

7,520

 

11,216

 

(10,204)

Accounts payable and accrued expenses

 

(26,945)

 

(19,672)

 

11,308

Customer deposits and deferred revenue

 

(17,866)

 

(39,296)

 

22,446

Income taxes receivable and payable, net

 

(655)

 

(4,800)

 

775

Long-term income tax liability

(4,877)

Other, net

 

408

 

(627)

 

(355)

Net cash provided by (used in) operating activities

 

(7,416)

 

(37,738)

 

34,993

Cash Flows from Investing Activities

Acquisitions of businesses, net of cash acquired

(2,662)

(401,828)

Capital expenditures

 

(10,873)

 

(12,654)

 

(24,272)

Proceeds from the sale of investments

 

127,349

 

90,065

 

348,927

Payments for purchases of investments

 

(192,988)

 

(93,046)

 

(282,947)

Proceeds from held for sale assets

 

645

 

 

2,284

Net cash provided by (used in) investing activities

(75,867)

(18,297)

(357,836)

Cash Flows from Financing Activities

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

3,106

 

3,064

 

2,992

Restricted stock tax withholdings

 

(2,980)

 

(3,069)

 

(8,741)

Purchases of common stock

(11,457)

(2,869)

Proceeds from long-term debt borrowings

335,752

Principal payments on long-term debt

(1,194)

Net cash provided by (used in) financing activities

 

126

 

(11,462)

 

325,940

Effect of exchange rate changes on cash and cash equivalents

 

26

 

(4)

 

42

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

(83,131)

 

(67,501)

 

3,139

Cash, cash equivalents, and restricted cash - beginning of period

 

213,082

 

280,583

 

277,444

Cash, cash equivalents, and restricted cash - end of period

$

129,951

$

213,082

$

280,583

Supplemental Disclosure of Cash Flow Information

Interest paid

$

9,408

$

9,708

$

4,675

Income taxes paid

2,931

4,799

1,939

Non-cash operating and financing activities

Net transfer of inventory to property, plant and equipment

4,916

1,479

(97)

Right-of-use assets obtained in exchange for lease obligations

5,576

See accompanying Notes to the Consolidated Financial Statements.

F-7


F-8


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements

Note 1 — Significant Accounting Policies

(a) Description of Business

Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

(b) Basis of Presentation

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 20172019 the interim quarters ended on March 31, June 30, and September 29, and during 2018 the interim quarters ended on April 2,1, July 2, and October 1, and during 2016 the interim quarters ended on April 3, July 3, and October 2.September 30. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements.

(c) Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) the best estimate ofstand-alone selling priceprices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) the fair value, less cost to sell, of assets held for sale; (vii) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (viii)(vii) the recoverability of long-lived assets; (ix)(viii) liabilities for product warranty and legal contingencies; (x)(ix) share-based compensation; (x) lease term and incremental borrowing rates used in determining operating lease assets and liabilities; and (xi) income tax uncertainties. Actual results could differ from those estimates.

(d) Principles of Consolidation

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

(e) Foreign Currencies

Assets and liabilities of the Company’s foreign subsidiaries that operate using local functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

F-8(f) Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable


F-9


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(f) Revenue Recognition

consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists with a customer; delivery of the specified products has occurred or services have been rendered; prices are contractually fixed or determinable; and collectability is reasonably assured. Revenue is recorded including shipping and handling costs and excluding applicable taxes related to sales.

ContractsCompany’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the accounting units of the multiple-element arrangementsperformance obligations within a contract and to determine how the revenue should be allocated among the accounting units.performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single multiple-element arrangementcontract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period.

 

When there are separate units of accounting, the Company allocates revenue to each elementperformance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the followingprices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; or the best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. The Company uses BESP for the elements in its arrangements. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items.prices generally using an expected cost plus margin approach.

 

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majoritymany of thethese arrangements, a customer source inspection of the system is performed in the Company’s facility, or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery.delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below for certain contracts.date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferreddeferred. The Company recognizes such revenue and fully recognizedcosts upon obtaining objective evidence that the receipt of final customer acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

 

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for the right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; it does not require significant changes to the features or capabilities of the equipment or involve constructing elaborate interfaces or connections subsequent to factory acceptance. The Company has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage the Company to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, the Company records the cost of the installation at the earlier of the time of revenue recognition for the system or when installation services are performed.

F-9



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

In certain cases, the Company’s products are soldcontracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. The amountRevenue recognized in advance of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount that has been billed that is not contingent upon acceptance provisions or ii)recorded as a contract asset on the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.Consolidated Balance Sheets.

 

The Company recognizes revenue related to maintenance and service contracts ratably over time based upon the applicablerespective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

 

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred even ifsince the expected performance period is one year or less.

F-10

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in “Cost of sales” in the Consolidated Statements of Operations when the Company recognizes revenue for the related revenue is deferred in accordance withgoods. Taxes assessed by governmental authorities that are collected by the above policy.Company from a customer are excluded from revenue.

(g) Warranty Costs

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts forrecords the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a semiannualquarterly basis when the actual product performance or field expense differs from original estimates.

(h) Shipping and Handling Costs

Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

(i) Research and Development Costs

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

(j) Advertising Expense

The cost of advertising is expensed as incurred and totaled $0.9$0.5 million, $0.8$0.9 million, and $0.9 million for the years ended December 31, 2017, 2016,2019, 2018, and 2015,2017, respectively.

(k) Accounting for Share-BasedShare-based Compensation

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the estimated fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one1 award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards, as well as purchase rights under the Employee Stock Purchase Plan. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information.

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company issuesgrants performance share units and awards (“PSUs” and “PSAs”). that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the probabilityconclusion of athe performance condition being metperiod is recognized in the period of the change in estimate. AtCompensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the performanceservice period the number of shares granted may vary from the original target based onupon the level of achievementattainment of the performance targets.or market conditions.

F-11

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 1(u), “Recently Adopted Accounting Standards,15, “Stock Plans,” for additional information concerning the Company’s early adoption of Accounting Standards Update (“ASU”) 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting.information.

(l) Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which makesmade broad and complex changes to the U.S. tax code. Certain income tax effects ofIn response to the 2017 Tax Act, are reflected in the Company’s financial results in accordance withSEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides SEC staffprovided guidance regardingon accounting for the applicationtax effects of Accounting Standards Codification Topic2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”). See Note 17, “Income Taxes,” for further information on, in the financial statement impact ofreporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act.

Because ofIn January 2018, the complexity ofFASB released guidance on the newaccounting for taxes under the global intangible low-taxed income (“GILTI”) rule, the Company is continuing to evaluate this provisionprovisions of the 2017 Tax Act and the applicationAct. The GILTI provisions impose a tax on foreign income in excess of ASC 740. Under U.S. GAAP, the Company is allowed to make an accounting policy choicea deemed return on tangible assets of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into the Company’s measurement of its deferred taxes (the “deferred method”). The Company’s selection of an accounting policy with respect to the new GILTI tax rules will depend, in part, on analyzing its global income to determine whether it

F-10



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

expects to have future U.S. inclusions in taxable income related to GILTI, and if so, what the impact will be. This assessment depends not only on the Company’s current structure and estimated future results of global operations, but also on its intent and ability to modify its structure and/or business.foreign operations. The Company is not yet able to reasonably estimate the effect of this provision of the 2017 Tax Act; therefore, the Company has not made any adjustments related to potential GILTI tax in its consolidated financial statements and has not made a policy election decision regarding whether to record deferredaccount for income taxes on GILTI.incurred under GILTI as a period cost.

(m) Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. TheHistorically, the Company has not experienced any material credit losses on its investments.

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.6 million and $0.3 million at December 31, 20172019 and 2016.2018, respectively.

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were insignificantimmaterial for the years ended December 31, 2017, 2016,2019, 2018, and 2015.2017.

F-12

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(n) Fair Value of Financial Instruments

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments.

(o) Cash, Cash Equivalents, and Short-TermShort-term Investments

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $12.5$78.5 million and $1.5$69.6 million of cash equivalents at December 31, 20172019 and 2016,2018, respectively.

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 77%56% and 54%32% of cash and cash equivalents were maintained outside the United States at December 31, 20172019 and 2016,2018, respectively.

MarketableShort-term investments consist of marketable debt securities, and are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.”income” on the Consolidated Balance Sheets. These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

F-11



TableNon-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other operating expense (income), net” in the Consolidated Statements of ContentsOperations.

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(p) Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. TheEach quarter the Company assesses the valuation and recoverability of all inventories, including manufacturing rawinventories: materials work-in-process,(raw materials, spare parts, and service inventory); work-in-process; and finished goods, each quarter.goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. EstimatesThe Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of net realizable value include, but are not limited to, management’s forecasts related tomaterials, and other qualitative factors. Unanticipated changes in demand for the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and ultimate realizationproducts may require a write down of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory, write-downs may be required andwhich would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,“Acquisitions and Dispositions,” for additional information.

(q) Business Combinations

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on

F-13

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Business Combinations,“Acquisitions and Dispositions,” for additional information.

(r) Goodwill and Indefinite-Lived IntangiblesIntangible Assets

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated research and development (“R&D&D”) efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise.

TheIn testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill.

The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries.

In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method.

(s) Long-LivedLong-lived Assets and Cost Method Investment

Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, covenants not-to-compete, and backlog and are initially recorded at fair value. Long-lived intangiblesintangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined.

F-12



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

Long-lived assets and cost method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds

F-14

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

(t) Recent Accounting PronouncementsLeases

Upon the adoption of ASC Topic 842, Leases (“ASC 842”) as of January 1, 2019, the Company determines at contract inception if an arrangement is a lease, or contains a lease, of an identified asset for which the Company has the right to obtain substantially all of the economic benefits from its use and the right to direct its use. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, while lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The FASB issued ASU 2014-09, as amended: implicit discount rate in the Company’s leases generally cannot readily be determined, and therefore the Company uses its incremental borrowing rate based on information available at lease commencement date in determining the present value of future payments. The Company has options to renew or terminate certain leases. These options are included in the determination of lease term when it is reasonably certain that the Company will exercise such options. The Company does not separate lease and non-lease components in determining ROU assets or lease liabilities for real estate leases. Additionally, the Company does not recognize ROU assets or lease liabilities for leases with original terms or renewals of one year or less.

(u) Recently Adopted Accounting Standards

The Company adopted ASC Topic 606, Revenue from Contracts with Customers, which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requires, as of January 1, 2018, using the Company’s revenue recognition to depict the transfer of promised goods or services to customersfull retrospective method. All amounts and disclosures set forth in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017.this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 will beare the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance as well asand the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, willis now generally be recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s currentprevious revenue recognition model for certain contracts that arewere subject to the billing retention constraint described above.constraint. The new performance obligation related to installation services under the new standard will generally beis now recognized as the installation services are performed, which is later than under the Company’s currentprevious revenue recognition model. Taken together, the Company does not believe these changes will have a material impact on the consolidated financial statements.

The Company plans to adopt using the full retrospective method.

In January 2016, the FASB issuedadopted ASU 2016-01: 2016-01, Financial Instruments Overall, whichas of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. ForThe Company measures equity investments without readily observable market prices entities have the option to either measure these investments at fair value every quarter, or measure at cost, adjusted for changes in observable prices minus impairment. Changes in measurement under either alternative must be recognizedare included in net income. Publicly-traded companies are required to adopt“Other income (expense), net” in the update for reporting periods beginning after December 15, 2017; early adoption is permitted. The Company doesConsolidated Statements of Operations. This ASU has not expect this ASU will havehad a material impact on the consolidated financial statements upon adoption, and the Company will monitor its cost methodequity investments each reporting period for changes in observable market prices, if any, which may be material in future periods.

In February 2016, the FASB issued ASU 2016-02: The Company adopted ASC Topic 842, Leases (“ASC 842”), whichas of January 1, 2019. ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company has adopted using this transition method, and therefore prior period balances have not been adjusted. In addition, interest onASC 842 provides for a number of optional exemptions in transition. The Company has elected certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs were not reassessed under the new standard. The adoption of the standard impacted the Company’s Consolidated Balance Sheets through the recognition of ROU assets and lease liabilities is to be recognized separately fromof approximately $14.2 million each as of January 1, 2019 but did not have an impact on the amortizationConsolidated Statements of right-of-use assets in the StatementOperations, Statements of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the StatementComprehensive Income, or Statements of Cash Flows. When the standard is adopted, the Company will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early application permitted. The Company is evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.

F-13F-15



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(v) Recent Accounting Pronouncements Not Yet Adopted

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

(u) Recently Adopted Accounting Standards

In January 2017, the FASB issued ASU 2017-04: Simplifying the Test for Goodwill Impairment, which eliminates the requirement to calculate the implied fair value of goodwill when testing goodwill for impairment. Instead, if the carrying value of an entity’s reporting unit(s) exceeds fair value, then an impairment charge should be recorded equal to the difference. The Company has early adopted the ASU effective January 1, 2017, and it did not have a material impact on the consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accounting for share-based payments. The Company early adopted the ASU effective January 1, 2016. Beginning in 2016, excess tax benefits and deficiencies are recognized as income tax expense or benefit in the income statement in the reporting period incurred. The Company also made an accounting policy election to account for forfeitures when they occur. The ASU transition guidance requires that this election be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period in which the ASU is adopted. Accordingly, the Company recorded a $1.3 million charge to the opening accumulated deficit balance as of January 1, 2016, with a corresponding adjustment to additional paid-in capital, resulting in no impact to the opening balance of total stockholders’ equity. In addition, the Company recorded additional deferred tax assets with an equally offsetting valuation allowance of $2.4 million.

Note 2 — Income (Loss) Per Share

The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share.

The dilutive effect of the Convertible Senior Notes on income per share is calculated using the treasury stock method since the Company has both the current intent and ability to settle the principal amount of the Convertible Senior Notes in cash. See Note 12, “Debt,” for additional information on the Convertible Senior Notes.

Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period under the two-class method.period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury

F-14



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved.

The computations of basic and diluted income (loss) per share for the years ended December 31, 2017, 2016,2019, 2018, and 20152017 are as follows:

 

For the year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands, except per share amounts)

 

For the year ended December 31,

    

2019

    

2018

    

2017

(in thousands, except per share amounts)

Net income (loss)

 

$

(44,793

)

$

(122,210

)

$

(31,978

)

$

(78,733)

$

(407,088)

$

(51,396)

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

$

(1.66)

$

(8.63)

$

(1.16)

Diluted

 

$

(1.01

)

$

(3.11

)

$

(0.80

)

$

(1.66)

$

(8.63)

$

(1.16)

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

44,174

 

39,340

 

39,742

 

 

47,482

 

47,151

 

44,174

Effect of potentially dilutive share-based awards

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

44,174

 

39,340

 

39,742

 

 

47,482

 

47,151

 

44,174

 

 

 

 

 

 

 

Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses

 

72

 

312

 

1,017

 

 

 

 

 

 

 

 

Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive

 

239

 

107

 

146

 

 

 

 

 

 

 

 

Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive

 

1,744

 

1,896

 

2,111

 

 

 

 

 

 

 

 

Maximum potential shares to be issued for settlement of Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive

 

8,618

 

 

 

Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive

531

28

239

Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive

1,689

2,474

1,744

Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive

8,618

8,618

8,618

Note 3 — Fair Value Measurements

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

F-16

Table of Contents

·                  Level 1: Quoted prices in active markets that are unadjustedVeeco Instruments Inc. and accessible at the measurement date for identical, unrestricted assets or liabilities;Subsidiaries

Notes to Consolidated Financial Statements (Continued)

·                  Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

·                  Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or

F-15



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 20172019 and 2016:2018:

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

(in thousands)

 

December 31, 2017

 

 

 

 

 

 

 

 

 

    

Level 1

    

Level 2

    

Level 3

    

Total

(in thousands)

December 31, 2019

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

12,490

 

$

 

$

 

$

12,490

 

Total

 

$

12,490

 

$

 

$

 

$

12,490

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

33,895

 

$

 

$

 

$

33,895

 

Corporate debt

 

 

10,886

 

 

10,886

 

Certificate of deposits and time deposits

$

67,009

$

$

$

67,009

Commercial paper

 

 

2,999

 

 

2,999

 

10,484

10,484

Total

 

$

33,895

 

$

13,885

 

$

 

$

47,780

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

 

$

1,501

 

$

 

$

1,501

 

1,000

1,000

Total

 

$

 

$

1,501

 

$

 

$

1,501

 

$

67,009

$

11,484

$

$

78,493

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

40,008

 

$

 

$

 

$

40,008

 

$

105,130

$

$

$

105,130

Government agency securities

 

 

10,012

 

 

10,012

 

1,139

1,139

Corporate debt

 

 

13,773

 

 

13,773

 

6,002

6,002

Commercial paper

 

 

2,994

 

 

2,994

 

2,981

2,981

Total

 

$

40,008

 

$

26,779

 

$

 

$

66,787

 

$

105,130

$

10,122

$

$

115,252

December 31, 2018

Cash equivalents

Certificate of deposits and time deposits

$

65,571

$

$

$

65,571

U.S. treasuries

3,990

3,990

Total

$

69,561

$

$

$

69,561

Short-term investments

U.S. treasuries

$

37,184

$

$

$

37,184

Corporate debt

8,516

8,516

Commercial paper

2,489

2,489

Total

$

37,184

$

11,005

$

$

48,189

The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency.

F-17

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 4 — Investments

At December 31, 20172019 and 20162018 the amortized cost and fair value of marketable securities, which are included in “Short-term investments” on the Consolidated Balance Sheets, were as follows:

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Estimated

 

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

(in thousands)

 

December 31, 2017

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

33,914

 

$

 

$

(19

)

$

33,895

 

Corporate debt

 

10,894

 

 

(8

)

10,886

 

Commercial paper

 

2,999

 

 

 

2,999

 

Total

 

$

47,807

 

$

 

$

(27

)

$

47,780

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Estimated

Cost

Gains

Losses

Fair Value

(in thousands)

December 31, 2019

U.S. treasuries

 

$

40,013

 

$

 

$

(5

)

$

40,008

 

$

105,096

$

38

$

(4)

$

105,130

Government agency securities

 

10,020

 

 

(8

)

10,012

 

1,139

1,139

Corporate debt

 

13,780

 

 

(7

)

13,773

 

6,003

(1)

6,002

Commercial paper

 

2,994

 

 

 

2,994

 

2,981

2,981

Total

 

$

66,807

 

$

 

$

(20

)

$

66,787

 

$

115,219

$

38

$

(5)

$

115,252

December 31, 2018

U.S. treasuries

$

37,191

$

$

(7)

$

37,184

Corporate debt

 

8,525

 

 

(9)

 

8,516

Commercial paper

2,489

2,489

Total

$

48,205

$

$

(16)

$

48,189

F-16



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Available-for-sale securities in a loss position at December 31, 20172019 and 20162018 were as follows:

 

December 31, 2017

 

December 31, 2016

 

 

 

 

Gross

 

 

 

Gross

 

 

Estimated

 

Unrealized

 

Estimated

 

Unrealized

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

 

(in thousands)

 

December 31, 2019

December 31, 2018

    

    

Gross

    

    

Gross

Estimated

Unrealized

Estimated

Unrealized

Fair Value

Losses

Fair Value

Losses

(in thousands)

U.S. treasuries

 

$

33,895

 

$

(19

)

$

20,002

 

$

(5

)

$

22,943

$

(4)

$

37,184

$

(7)

Government agency securities

 

 

 

10,012

 

(8

)

Corporate debt

 

10,886

 

(8

)

13,773

 

(7

)

 

6,002

 

(1)

 

8,516

 

(9)

Total

 

$

44,781

 

$

(27

)

$

43,787

 

$

(20

)

$

28,945

$

(5)

$

45,700

$

(16)

At December 31, 20172019 and 2016,2018, there were no0 short-term investments that had been in a continuous loss position for more than 12 months.

The maturities of securities classified as available-for-sale at December 31, 20172019 were all due in one year or less. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were minimalThe realized gains or losses for the years ended December 31, 2019, 2018, and 2017 2016, and 2015.were immaterial.

Cost Method InvestmentOther Investments

The CompanyVeeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”). The Company, over which Veeco does not exert significant influence over Kateeva and therefore the investment is carried at cost.influence. The carrying value of the investment was $21.0 million at December 31, 20172018. Additionally, during the year ended December 31, 2018, the Company made a separate non-marketable investment of $3.5 million in another entity. The Company does not exert significant influence over this investment and 2016.its ownership interest is also less than 20%. Neither equity investment has a readily observable market price, and therefore the Company has elected to measure these investments at cost, adjusted for changes in observable market prices minus impairment. The investment isinvestments are included in “Other assets” on the Consolidated Balance Sheets. TheThere were no changes in observable market prices for either investment isfor the year ended December 31, 2019. These investments are subject to a periodic impairment review; as there are no open-market valuations, the impairment analysis requiresreviews which require judgment. The analysis includesanalyses include assessments of Kateeva’sthe

F-18

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

companies’ financial condition, the business outlookoutlooks for itstheir products and technology, itstechnologies, their projected results and cash flow,flows, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. Fair value ofDuring the investment is not estimated unless there arequarter ended December 31, 2019, the Company identified events or changes in circumstances that could have a significant adverse effectimpairment indicators on the fair valueCompany’s investment in Kateeva, and as a result of a valuation analysis, concluded that its investment in Kateeva is fully impaired, and recorded a non-cash impairment charge of $21.0 million, included in “Other income (expense), net” in the investment. No such eventsConsolidated Statements of Operations. There were 0 impairment charges recorded for either investment for the years ended December 31, 2018 or circumstances are present.2017.

Note 5 — Business CombinationsAcquisitions and Dispositions

Ultratech acquisition

On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:

    

Acquisition Date

(May 26, 2017)

(in thousands)

Cash consideration, net of cash acquired of $229.4 million

$

404,490

Equity consideration (7.2 million shares issued)

 

228,643

Replacement equity awards attributable to pre-acquisition service

228

Acquisition date fair value

$

633,361

F-17


F-19


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Cash consideration, net of cash acquired of $229.4 million

 

$

404,489

 

Equity consideration (7.2 million shares issued)

 

228,644

 

Replacement equity awards attributable to pre-acquisition service

 

228

 

Acquisition date fair value

 

$

633,361

 

Approximately $2.7 million of the cash merger consideration is included in “Accrued expenses and other current liabilities” on the Consolidated Balance Sheets as of December 31, 2017 related to shareholder appraisal proceedings.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Short-term investments

 

$

47,161

 

Accounts receivable

 

45,465

 

Inventories

 

59,100

 

Deferred cost of sales

 

242

 

Prepaid expense and other current assets

 

7,217

 

Property, plant, and equipment

 

18,152

 

Intangible assets

 

346,940

 

Other assets

 

6,442

 

Total identifiable assets acquired

 

530,719

 

 

 

 

 

Accounts payable

 

24,291

 

Accrued expenses and other current liabilities

 

16,356

 

Customer deposits and deferred revenue

 

4,834

 

Deferred income taxes

 

32,478

 

Other liabilities

 

11,622

 

Total liabilities assumed

 

89,581

 

 

 

 

 

Net identifiable assets acquired

 

441,138

 

Goodwill

 

192,223

 

Net assets acquired

 

$

633,361

 

Acquisition Date

(May 26, 2017)

(in thousands)

Short-term investments

$

47,161

Accounts receivable

45,465

Inventories

 

59,100

Deferred cost of sales

242

Prepaid expense and other current assets

7,217

Property, plant, and equipment

18,152

Intangible assets

346,940

Other assets

6,442

Total identifiable assets acquired

530,719

Accounts payable

24,291

Accrued expenses and other current liabilities

16,356

Customer deposits and deferred revenue

4,834

Deferred income taxes

32,478

Other liabilities

11,622

Total liabilities assumed

89,581

Net identifiable assets acquired

441,138

Goodwill

192,223

Net assets acquired

$

633,361

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

F-18

Acquisition Date

(May 26, 2017)

    

Amount

    

Useful life

(in thousands)

Technology

$

158,390

 

9

years

Customer relationships

 

116,710

 

12

years

Backlog

3,080

6

months

In-process research and development

 

43,340

 

*

Trademark and tradenames

25,420

7

years

Intangible assets acquired

$

346,940



*

In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

158,390

 

9 years

 

Customer relationships

 

116,710

 

12 years

 

Backlog

 

3,080

 

6 months

 

In-process research and development

 

43,340

 

*

 

Trademark and tradenames

 

25,420

 

7 years

 

Intangible assets acquired

 

$

346,940

 

 

 


*In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

F-20

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and meetmet the criteria for recognition as IPR&D as of the date of the acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflectsreflected the present value of the projected cash flows that arewere expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which iswas related to Ultratech’s lithography technologies and one-thirdone-third of which iswas related to Ultratech’s laser annealing technologies.

During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group and determined that the revised projections were significantly lower than projected results at the time of the acquisition and that these revised projections required the Company to assess the Ultratech asset group for impairment. See Note 6, “Goodwill and Intangible Assets,” for additional information.

For the year ended December 31, 2018 and 2017, acquisition related costs were approximately $3.0 million and $17.8 million, respectively, including non-cash charges of $4.2 million related to accelerated share-based compensation for employee terminations.terminations for the year ended December 31, 2017.

The amounts of net sales and income (loss) from operations before income taxes of Ultratech included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2017 are as follows:

 

Year ended 
December 31, 2017

 

 

(in thousands)

 

    

Year ended

December 31, 2017

(in thousands)

Net sales

 

$

65,530

 

$

65,280

Loss before income taxes

 

$

(62,762

)

$

(62,284)

Loss before income taxes of Ultratech for the year ended December 31, 2017 of $62.8$62.3 million includes acquisition costs of $17.8 million, release of inventory fair value step-up related to purchase accounting of $9.6 million, amortization expense on intangible assets of $23.9 million, and restructuring charges of $3.3 million.

The following table presents unaudited pro forma financial information for the year ended December 31, 2017, as if the acquisition of Ultratech had occurred on January 1, 2016:

Year ended December 31, 2017

(in thousands, except per share amounts)

Net sales

$

546,428

Loss before income taxes

(90,000)

Diluted earnings per share

$

(1.38)

F-19



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Net sales

 

$

555,498

 

$

526,501

 

Loss before income taxes

 

(81,910

)

(218,023

)

Diluted earnings per share

 

$

(1.24

)

$

(4.67

)

The pro-forma results were calculated by combining the audited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:

(i)Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(i)                                     Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(ii)Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

(ii)                                  Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

(iii)
(iii)All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from the year ended December 31, 2017 and included in the year ended December 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.

F-21

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(iv)All amortization of inventory step-up has been removed from the year ended December 31, 2017 and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold.

(v)Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016.

(vi)Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

(vii)All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share.

Dispositions

As of December 31, 2019, the Company determined that one of its non-core product lines (the “disposal group”) met the held for sale criteria, and as such, the related assets are presented as “Assets held for sale” on the Consolidated Balance Sheets. Long-lived assets and definite-lived intangible assets are not depreciated or amortized while classified as held for sale. The potential sale of this disposal group does not represent a strategic shift that will have a material effect on the Company’s operations and financial results, nor is it considered a component of the Company, and as such it did not meet the criteria to be reported as discontinued operations.

For the year ended December 31, 2017 and2019, the Company recorded a non-cash impairment charge on these assets held for sale of $4.0 million, included in “Asset impairment” in the year endedConsolidated Statements of Operations, in order to measure the disposal group at the lower of its carrying value or fair value less costs to sell as of December 31, 2016, as such expenses would have been incurred2019, which resulted in a corresponding held for sale valuation allowance on its assets held for sale in the first quarter following the acquisition.

(iv)                              All amortizationConsolidated Balance Sheet. The major classes of inventory step-up has been removed from the year endedassets that were classified as held for sale as of December 31, 20172019 are as follows:

December 31, 2019

(in thousands)

Assets held for sale:

 

Inventories

$

5,985

Property, plant, and equipment, net

310

Intangible assets, net

6,546

Goodwill

2,359

Impairment

(4,020)

Total Assets held for sale

$

11,180

F-22

Table of Contents

Veeco Instruments Inc. and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold.

(v)                                 Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016.

(vi)                              Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

(vii)                           All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share.

Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 6 — Goodwill and Intangible Assets

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances during the years indicated:

 

 

Gross carrying

 

Accumulated

 

 

 

 

 

amount

 

impairment

 

Net amount

 

 

 

(in thousands)

 

Balance at December 31, 2015 and 2016

 

$

238,108

 

$

123,200

 

$

114,908

 

Acquisition

 

192,223

 

 

192,223

 

Balance at December 31, 2017

 

$

430,331

 

$

123,200

 

$

307,131

 

    

Gross carrying

    

Accumulated

    

amount

impairment

Net amount

    

(in thousands)

Balance at December 31, 2017

$

430,331

$

123,200

$

307,131

Impairment

122,829

(122,829)

Balance at December 31, 2018

430,331

246,029

184,302

Allocated to Assets held for sale

2,359

(2,359)

Balance at December 31, 2019

$

430,331

$

248,388

$

181,943

The Company performs its annual goodwill impairment test at the beginning of the fourth quarter each year. As the Company maintains a single goodwill reporting unit, it determines the fair value of its reporting unit based upon the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The annual test performed at the beginning of the fourth quarter of fiscal 20162018 and 20172019 did not result in any potential impairment as the fair value of the reporting unit was determined to exceed the carrying amount of the reporting unit.

F-20



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

As a result of a significant decline in the Company’s stock price during the fourth quarter of 2018, the Company determinedconcluded it was appropriate to perform an interim goodwill impairment test as of the end of the fourth quarter.fiscal 2018. The Company determined the fair value of its reporting unit, as calculated using both the adjusted market capitalization approach, noted above, and a market approach, which was based on a review of comparable companies’ market-derived trailing twelve month revenue multiples. Both approaches indicated the fair value exceededdetermined to be below the carrying amountvalue of the reporting unit, and nothe Company recorded an impairment charge equal to the excess of goodwill existed atcarrying value over fair value, or $122.8 million, for the year ended December 31, 2017. 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statements of Operations. The valuation of goodwill will continue to be subject to changes in the Company’s market capitalization and observable market control premiums. This analysis is sensitive to changes in the Company’s stock price and absent other qualitative factors, the Company may be required to record additional goodwill impairment charges in future periods if the stock price declines and remains depressed for an extended period of time. 

The components of purchased intangible assets were as follows:

 

 

 

December 31, 2017

 

December 31, 2016

 

 

Weighted

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

Average Remaining

 

Gross

 

Amortization

 

 

 

Gross

 

Amortization

 

 

 

 

Amortization

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

Period

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

(in years)

 

(in thousands)

 

December 31, 2019

December 31, 2018

Average

Accumulated

Accumulated

    

Remaining

    

Gross

    

Amortization

    

    

Gross

    

Amortization

    

Amortization

Carrying

and

Net

Carrying

and

Net

Period

Amount

Impairment

Amount

Amount

Impairment

Amount

(in years)

(in thousands)

Technology

 

8.0

 

$

307,588

 

$

133,121

 

$

174,467

 

$

149,198

 

$

113,904

 

$

35,294

 

5.0

$

327,908

$

291,766

$

36,142

$

337,218

$

290,808

$

46,410

Customer relationships

 

11.4

 

164,595

 

39,336

 

125,259

 

47,885

 

28,659

 

19,226

 

9.2

146,465

126,764

19,701

164,595

136,126

28,469

In-process R&D

 

 

43,340

 

 

43,340

 

 

 

 

13,710

10,530

3,180

Trademarks and tradenames

 

6.4

 

30,910

 

4,321

 

26,589

 

2,590

 

1,948

 

642

 

4.4

30,910

25,256

5,654

30,910

23,899

7,011

Indefinite-lived trademark

 

 

 

 

 

2,900

 

 

2,900

 

Other

 

2.0

 

3,686

 

3,498

 

188

 

2,026

 

1,710

 

316

 

1.1

 

3,686

 

3,665

 

21

 

3,686

 

3,607

 

79

Total

 

9.2

 

$

550,119

 

$

180,276

 

$

369,843

 

$

204,599

 

$

146,221

 

$

58,378

 

6.3

$

508,969

$

447,451

$

61,518

$

550,119

$

464,970

$

85,149

Other intangible assets primarily consist of patents, licenses, and backlog.

During 2016,the second quarter of 2018, the Company decidedlowered its projected results for the Ultratech asset group, which were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as fan-out wafer

F-23

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to reduce future investmentsConsolidated Financial Statements (Continued)

level packaging (“FOWLP”), and a delay in certain technologiesthe adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and asreduced revenue projections for the Company’s advanced packaging lithography systems. In addition, there has been a delay in the build out of 28nm facilities by companies in China who were expected to purchase the Company’s Laser Spike Anneal systems. Taken together, the reduced projections identified during the second quarter of 2018 required the Company to assess the Ultratech asset group for impairment. As a result recorded a non-cash impairment charge of $54.3 million for the related intangible purchased technology. The impairment charge was based onanalysis, which included projected cash flows that required the use of unobservable inputs,, the Company recorded non-cash impairment charges of $216.4 million and was recorded$35.9 million related to definite-lived intangible assets and in-process research and development assets, respectively, during the second quarter of 2018. The impairment charge is included in “Asset impairment” in the Consolidated StatementsStatement of Operations. Subsequently, certain in-process research and development projects were completed and moved to the “Technology” line in the above table.

Based on the intangible assets recorded at December 31, 2017,2019, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense, excluding in-process R&D, is expected to be as follows:

 

Amortization

 

 

(in thousands)

 

2018

 

$

54,128

 

2019

 

57,071

 

Amortization

    

(in thousands)

2020

 

54,382

 

$

15,333

2021

 

40,959

 

 

12,280

2022

 

26,009

 

 

10,018

2023

 

8,347

2024

 

6,708

Thereafter

 

93,954

 

8,832

Total

 

$

326,503

 

$

61,518

Note 7 — Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis.basis. Inventories consist of the following:

December 31,

December 31,

    

2019

    

2018

(in thousands)

Materials

$

82,155

$

90,816

Work-in-process

 

42,575

 

42,354

Finished goods

 

8,337

 

23,141

Total

$

133,067

$

156,311

F-21


F-24


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Materials

 

$

59,919

 

$

46,457

 

Work-in-process

 

37,222

 

25,250

 

Finished goods

 

23,125

 

5,356

 

Total

 

$

120,266

 

$

77,063

 

Note 8 — Property, Plant, and Equipment and Assets Held for Sale

Property and equipment, net, consist of the following:

 

December 31,

 

Average

 

 

2017

 

2016

 

Useful Life

 

 

(in thousands)

 

 

 

December 31,

December 31,

    

2019

    

2018

    

Average Useful Life

(in thousands)

Land

 

$

5,669

 

$

5,669

 

N/A

 

$

5,061

$

5,669

N/A

Building and improvements

 

54,449

 

50,814

 

10 – 40 years

 

 

61,884

 

61,124

10 – 40 years

Machinery and equipment(1)

 

126,829

 

99,370

 

3 – 10 years

 

Machinery and equipment (1)

 

137,692

 

128,385

3 – 10 years

Leasehold improvements

 

10,073

 

3,652

 

3 – 7 years

 

 

6,703

 

9,033

3 – 7 years

Gross property, plant, and equipment

 

197,020

 

159,505

 

 

 

 

211,340

 

204,211

Less: accumulated depreciation and amortization

 

111,962

 

98,859

 

 

 

 

135,629

 

123,927

Net property, plant, and equipment

 

$

85,058

 

$

60,646

 

 

 

$

75,711

$

80,284

(1)Machinery and equipment also includes software, furniture, and fixtures


(1) Machinery and equipment also includes software, furniture and fixtures

Depreciation expense was $14.6$17.3 million, $13.4$17.6 million, and $12.2$14.6 million for the years ended December 31, 2017, 2016,2019, 2018, and 2015,2017, respectively. During 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded an impairment charge of $3.3 million of property, plant, and equipment.

As part of the Company’s efforts to reduce costs, enhance efficiency, and streamline operations, the Company removed certain lab equipment that is no longer required and recorded a non-cash impairment charge of $6.2 million for the year ended December 31, 2016. Additionally, as part of that initiative,2019, the Company listed its two facilitiesclassified vacant land in South Korea for sale. When each facility was reclassifiedSt. Paul, Minnesota as held for sale, and subsequently sold the Company determined that theland for approximately $0.6 million, which approximated its carrying values of the buildings exceeded their fair market values, less cost to sell, and recorded net impairment charges of $4.5 million for the year ended December 31, 2016. Both facilities were sold before the end of 2016 at prices that approximated the revised carrying values.value.

Finally, during the year ended December 31, 2016, the Company recorded an impairment charge of approximately $1.2 million related to an owned property in St. Paul, Minnesota. The property was sold during 2017, resulting in an additional impairment charge of $0.7 million for the year ended December 31, 2017. There were no assets held for sale as of December 31, 2017 and 2016. All impairment charges were recorded in “Asset impairment” in the Consolidated Statements of Operations.

Note 9 — Accrued Expenses and Other Liabilities

The components of accrued expenses and other current liabilities were as follows:

December 31,

December 31,

    

2019

    

2018

(in thousands)

Payroll and related benefits

$

15,174

$

20,486

Warranty

7,067

7,852

Operating lease liabilities

4,196

Interest

4,321

4,321

Professional fees

2,443

2,897

Sales, use, and other taxes

 

811

 

2,670

Restructuring liability

 

2,841

 

2,213

Other

 

4,390

 

6,011

Total

$

41,243

$

46,450

F-22



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Payroll and related benefits

 

$

32,996

 

$

18,780

 

Warranty

 

6,532

 

4,217

 

Interest

 

4,430

 

 

Professional fees

 

3,942

 

1,827

 

Merger consideration payable

 

2,662

 

 

Installation

 

2,271

 

1,382

 

Sales, use, and other taxes

 

2,144

 

1,282

 

Restructuring liability

 

1,520

 

1,796

 

Other

 

3,842

 

3,917

 

Total

 

$

60,339

 

$

33,201

 

Customer deposits and deferred revenue

Customer deposits totaled $41.5$26.6 million and $22.2$28.3 million at December 31, 20172019 and 2016,2018, respectively, which are included in “Customer“Customer deposits and deferred revenue” in the Consolidated Balance Sheets. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

(in thousands)

Balance - December 31, 2018

 

$

44,415

Deferral of revenue

 

5,816

Recognition of previously deferred revenue

 

(21,982)

Balance - December 31, 2019

 

$

28,249

F-25

Table of Contents

Other liabilitiesVeeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

As of December 31, 2019, the Company has approximately $38.9 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 87% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company maintainshas elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Other liabilities

As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that was assumed from Ultratech that allowsallowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2017,2019 and 2018, plan assets approximated $3.4$2.7 million and $3.2 million, respectively, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $4.7$3.1 million and $3.5 million, respectively and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities also included asset retirement obligations of $3.3$3.2 million and income tax payables of $1.0 million at both December 31, 2019 and 2018, and medical and dental benefits for former executives of $2.2$2.0 million and acquisition related accruals of $0.4$2.2 million at December 31, 2017. At December 31, 2016, other liabilities primarily consisted of a non-current income tax payable of $4.9 million.2019 and 2018, respectively.

Note 10 — Restructuring Charges

During 2016,the second quarter of 2018, the Company undertookinitiated plans to reduce excess capacity associated with the manufacture and support of the Company’s advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into its San Jose, California facility. As a result of this and other cost saving initiatives, the Company announced headcount reductions of approximately 40 employees. During the year ended December 31, 2019, additional accruals were recognized and payments were made related to these restructuring activitiesinitiatives.

The Company continued to record restructuring charges during the year ended December 31, 2019 as parta result of its initiativeefforts to further streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technologycosts. In the second half of 2019, the Company executed an initiative to reorganize various functions along product lines and created a central research and development which togetherorganization to better allocate its resources to the Company’s highest priority projects. In addition, the Company delayered the organization. Collectively, these actions impacted approximately 75 employees. These activities were substantially completed in 2017. In addition, during 2017, the Company began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs.

During 2015, charges of $4.7 million were recognized related to the closing of facilities in Ft. Collins, Colorado, Camarillo, California, and Hyeongok-ri, South Korea, as well as other cost reduction initiatives, which together impacted approximately 5060 employees.

The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2017, 2016,2019, 2018, and 20152017 and the remaining accrued balance of restructuring costs at December 31, 2017,2019, which is included in Accrued“Accrued expenses and other current liabilities” in the Consolidated Balance Sheets:

    

Personnel

    

Facility

    

Severance and

Related Costs

Related Costs

and Other

Total

(in thousands)

Balance - December 31, 2016

$

1,796

$

$

1,796

Provision

 

4,714

 

5,257

 

9,971

Payments

 

(4,990)

 

(5,257)

 

(10,247)

Balance - December 31, 2017

 

1,520

1,520

Provision

 

4,681

2,714

7,395

Payments

 

(4,058)

(2,644)

(6,702)

Balance - December 31, 2018

2,143

70

2,213

Provision

5,803

203

6,006

Payments

(5,105)

(273)

(5,378)

Balance - December 31, 2019

$

2,841

$

$

2,841

F-23


F-26


Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Personnel

 

 

 

 

 

 

 

Severance and

 

Facility

 

 

 

 

 

Related Costs

 

Closing Costs

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2014

 

$

1,428

 

$

 

$

1,428

 

Provision

 

3,513

 

1,166

 

4,679

 

Payments

 

(4,117

)

(1,166

)

(5,283

)

Balance at December 31, 2015

 

824

 

 

824

 

Provision

 

4,544

 

1,098

 

5,642

 

Changes in estimate

 

(2

)

 

(2

)

Payments

 

(3,570

)

(1,098

)

(4,668

)

Balance at December 31, 2016

 

1,796

 

 

1,796

 

Provision

 

4,714

 

5,257

 

9,971

 

Payments

 

(4,990

)

(5,257

)

(10,247

)

Balance - December 31, 2017

 

$

1,520

 

$

 

$

1,520

 

Included within restructuringRestructuring expense in the Consolidated Statements of Operations for the yearyears ended December 31, 2019, 2018, and 2017 is approximatelyincluded non-cash charges of $0.4 million, $1.2 million, and $1.9 million, of non-cash chargesrespectively, which are excluded from the table above, related to accelerated share-based compensation for employee terminations.

Note 11 — Commitments and Contingencies

Warranty

Warranties are typically valid for one year from the date of system final acceptance, and the Company estimates the costs that may be incurred under the warranty. Estimated warranty costs are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and is affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs.

Changes in the Company’s product warranty reserves were as follows:

 

December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

December 31,

    

2019

    

2018

    

2017

(in thousands)

Balance, beginning of the year

 

$

4,217

 

$

8,159

 

$

5,411

 

$

7,852

$

6,532

$

4,217

Warranties issued

 

5,817

 

3,916

 

7,873

 

 

5,865

 

6,737

 

5,817

Addition from Ultratech acquisition

 

1,889

 

 

 

1,889

Consumption of reserves

 

(6,330

)

(6,433

)

(3,551

)

 

(6,242)

 

(6,573)

 

(6,330)

Changes in estimate

 

939

 

(1,425

)

(1,574

)

 

(408)

 

1,156

 

939

Balance, end of the year

 

$

6,532

 

$

4,217

 

$

8,159

 

$

7,067

$

7,852

$

6,532

Minimum Lease Commitments

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of December 31, 2019 was 3 years, and the weighted average discount rate used in determining the present value of future lease payments was 6.0%.

The following table provides the maturities of lease liabilities at December 31, 2019:

Operating

    

Leases

(in thousands)

Payments due by period:

2020

$

4,932

2021

5,020

2022

4,428

2023

1,133

2024

551

Thereafter

Total future minimum lease payments

16,064

Less: Imputed interest

(1,568)

Total

$

14,496

Reported as of December 31, 2019

Other current liabilities

$

4,196

Operating lease liabilities

10,300

Total

$

14,496

F-27

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Minimum lease commitments at December 31, 20172018 for property and equipment under operating lease agreements (exclusive of renewal options) are payablewere as follows:

Operating

    

Leases

(in thousands)

Payments due by period:

2019

$

5,143

2020

 

5,056

2021

 

2,432

2022

 

1,812

2023

 

1,066

Thereafter

548

Total

$

16,057

F-24



TableOperating lease cost for the year ended December 31, 2019 was $5.5 million. Variable lease cost for the year ended December 31, 2019 was $1.7 million. Additionally, the Company has an immaterial amount of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Operating

 

 

 

Leases

 

 

 

(in thousands)

 

Payments due by period:

 

 

 

2018

 

$

5,655

 

2019

 

5,533

 

2020

 

5,529

 

2021

 

2,307

 

2022

 

2,308

 

Thereafter

 

2,919

 

Total

 

$

24,251

 

short-term leases. Lease expense was $5.3$7.2 million, $2.5$6.3 million, and $2.3$5.3 million for the years ended December 31, 2017, 2016,2019, 2018, and 2015,2017, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance.

Legal Proceedings

On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, 2 purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262. The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim. Discovery1933 for, among other things, alleged false/misleading statements in the matter has commencedregistration statement and a trial on the action is scheduled to begin in December 2018.

On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLC and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization.

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patentprospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in a chemical vapor deposition reactor and seeking injunctive relief and monetary damages against Veeco Shanghai. On December 7, 2017, without providing notice to Veeco and without hearing Veeco’s position on alleged infringement, the Fujian High Court issued a preliminary injunction, applicable in China, that requires Veeco Shanghai to stop importing, making, selling, and offering to sell Veeco EPIK 700 modeladvanced packaging business, increased MOCVD systems and to stop importing, selling, and offering to sell wafer carriers used as supplies for the EPIK 700 MOCVD system.

On February 8, 2018, Veeco, AMEC, and SGL announced that they had mutually agreed to settle the pending litigation among the parties and to amicably resolve all pending disputes, including AMEC’s lawsuit against Veeco before the Fujian High Courtcompetition in China, and Veeco’s lawsuit against SGL beforean intellectual property dispute. Veeco is defending this matter vigorously.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the U.S. DistrictSuperior Court for the Eastern District of New York. As part of the settlement, all legal actions worldwide (in court, patent offices,State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and otherwise), betweenunjust enrichment against current and former Veeco AMEC,directors premised on purported misstatements and SGL, and their affiliates, will be dismissed and/or otherwise withdrawn. As a result, all business processes, including sales, service, and importation, will be continued.omissions in the registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

F-25



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Concentrations of Credit Risk

The Company depends on purchases from its ten10 largest customers, which accounted for 67% and 73%61% of net accounts receivable at December 31, 20172019 and 2016,2018, respectively.

F-28

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Customers who accounted for more than 10% of net accounts receivable or net sales are as follows:

 

 

Accounts Receivable

 

Net Sales

 

 

 

Year ended December 31,

 

For the Year Ended December 31,

 

Customer

 

2017

 

2016

 

2017

 

2016

 

2015

 

Customer A

 

24

%

23

%

21

%

13

%

*

 

Customer B

 

*

 

17

%

*

 

*

 

*

 

Customer C

 

*

 

*

 

*

 

*

 

20

%

Customer D

 

*

 

*

 

*

 

*

 

12

%

Accounts Receivable

Net Sales 

 

December 31,

For the Year Ended December 31,

 

Customer

    

2019

    

2018

    

2019

    

2018

    

2017

 

Customer A

16

%  

22

%  

11

%  

*

*

Customer B

21

%  

*

*

*

*

Customer C

*

*

*

12

%  

*

Customer D

*

*

*

*

21

%


*

*

Less than 10% of aggregate accounts receivable or net sales

The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 18, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 to 90 days from the date of invoice.

Receivable Purchase Agreement

In December 2017, the Company entered into a Receivable Purchase Agreement with a financial institution to sell certain of its tradesome geographies, receivables from customers without recourse,may be payable up to $23.0 million at any point in time for a term of one year. Under150 days from the termsdate of the agreement, the Company may offer to sell certain eligible accounts receivable (the “Receivables”) to the financial institution (the “Purchaser”), which may accept such offer, and purchase the offered Receivables. The Purchaser will assume credit risk of the Receivables purchased; provided, however, the Company will service the Receivables, and as such servicer, collect and otherwise enforce the Receivables on behalf of the Purchaser. Pursuant to this agreement, the Company sold $15.0 million of Receivables during the year ended December 31, 2017 and maintained $8.0 million available under the agreement for additional sales of Receivables as of December 31, 2017. The sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.invoice.

Suppliers

The Company outsources certain functions to third parties, including the manufacture of someseveral of its MOCVD and Ultratech systems. While the Company primarily relies on one supplier for the manufacturing of these systems,its outsourcing partners to perform their contracted functions, the Company maintains a minimumsome level of internal manufacturing capability for these systems. In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The failure of the Company’s present outsourcing partners and suppliers to meet their contractual obligations under their supply arrangements and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows, and relationships with its customers.

In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The Company’s inability to develop alternative sources, if necessary, could result in a prolonged interruption in supply or a significant increase in the price of one or more components, which could adversely affect the Company’s operating results.

F-26



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The Company had deposits with its suppliers of $7.6$5.9 million and $7.8$12.8 million at December 31, 20172019 and 2016,2018, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets.

Purchase Commitments

The Company had purchase commitments of $181.0$63.3 million at December 31, 2017,2019, substantially all of which will come due within one year. Purchase commitments are primarily for inventory used in manufacturing products and are partially offset by existing deposits with suppliers.

Bank Guarantees

The Company has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At December 31, 2017,2019, outstanding bank guarantees and letters of credit totaled $6.5$10.2 million and unused bank guarantees and letters of credit of $66.5 $21.6million were available to be drawn upon.

Note 12 — Debt

Mortgage Payable

At December 31, 2016, the Company had a mortgage note payable associated with its property in St. Paul, Minnesota, which, during the third quarter of 2017 was fully extinguished in connection with the sale of the building. The carrying value of the property exceeded the carrying value of the mortgage note of $1.2 million at December 31, 2016. The annual interest rate on the note was 7.91%.

Convertible Senior Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes (the “Convertible Senior Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The

F-29

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Convertible Senior Notes mature on January 15, 2023 (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted.

The Convertible Senior Notes are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Convertible Senior Notes are convertible into cash, shares of the Company’s common stock, or a combination thereof, at the Company’s election, upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior Notes, representing an initial effective conversion price of $40.03 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee, but will not be adjusted for accrued but unpaid interest.

Holders may convert all or any portion of their notes, in multiples of one1 thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 only under the following circumstances:

(i)During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

F-27



(ii)During the five consecutive business day period after any 5 consecutive trading day period (the “measurement period”) in which the trading price per 1 thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

Table of Contents

(iii)If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv)Upon the occurrence of specified corporate events.

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

(i)                ��        During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii)                      During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii)                   If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv)                  Upon the occurrence of specified corporate events.

On or after October 15, 2022, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances.

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior Notes over the estimated fair value of the liability component of $72.5 million was recognized as a debt discount and recorded as an increase to additional paid-in capital and will be amortized over the expected life of the

F-30

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense.

The transaction costs of $9.2 million incurred in connection with the issuance of the Convertible Senior Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million reduced the value of the equity component recognized in stockholders’stockholders' equity.

The carrying value of the Convertible Senior Notes is as follows:

 

December 31,

 

 

2017

 

 

(in thousands)

 

December 31,

December 31,

    

2019

    

2018

 

(in thousands)

Principal amount

 

$

345,000

 

$

345,000

$

345,000

Unamortized debt discount

 

(63,022

)

 

(40,820)

 

(52,336)

Unamortized transaction costs

 

(6,348

)

 

(4,112)

 

(5,272)

Net carrying value

 

$

275,630

 

$

300,068

$

287,392

Total interest expense related to the Convertible Senior Notes is as follows:

For the year ended December 31,

2019

2018

(in thousands)

Cash Interest Expense

  

  

Coupon interest expense

$

9,315

$

9,315

Non-Cash Interest Expense

 

 

  

Amortization of debt discount

 

11,516

 

10,686

Amortization of transaction costs

 

1,160

 

1,076

Total Interest Expense

$

21,991

$

21,077

F-28



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended
December 31,

 

 

 

2017

 

 

 

(in thousands)

 

Cash Interest Expense

 

 

 

Coupon interest expense

 

$

8,901

 

Non-Cash Interest Expense

 

 

 

Amortization of debt discount

 

9,490

 

Amortization of transaction costs

 

956

 

Total Interest Expense

 

$

19,347

 

The Company determined the Convertible Senior Notes is a Level 2 liability in the fair value hierarchy and estimated its fair value as $300.7$330.3 million at December 31, 2017.2019.

Note 13 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rate changesrates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company entered into monthly forward derivative contracts with the intent of mitigating a portion of this risk. The Company only used derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts were recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executed derivative transactions with highly rated financial institutions to mitigate counterparty risk.

A summary of the foreign exchange derivatives outstanding on December 31, 2017 is as follows:

 

 

Fair Value

 

Maturity Dates

 

Notional Amount

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

 

January 2018

 

$

622

 

The Company did not have any outstanding derivative contracts at December 31, 2016.

2019 and 2018. The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2017, 2016,2018 and 2015,2017, which are included in “Other operating expense (income), net” in the Consolidated Statements of Operations:Operations as well as the weighted average notional amount of derivatives outstanding for each period:

F-31

 

 

Year ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

(6

)

$

219

 

$

 

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Year ended December 31,

2018

2017

Gains (losses)

Weighted average notional amount

Gains (losses)

Weighted average notional amount

(in thousands)

Foreign currency exchange forwards

$

327

$

2,869

$

(6)

$

314

Note 14 — Stockholders’ Equity

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

Unrealized

Gains (Losses)

Foreign

on Available

Currency

for Sale 

    

Translation

    

Securities

    

Total

(in thousands)

Balance - December 31, 2016

$

1,797

$

(20)

$

1,777

Other comprehensive income (loss)

42

(7)

35

Balance - December 31, 2017

1,839

(27)

1,812

Other comprehensive income (loss)

(3)

11

8

Balance - December 31, 2018

1,836

(16)

1,820

Other comprehensive income (loss)

 

25

 

49

 

74

Balance - December 31, 2019

$

1,861

$

33

$

1,894

F-29



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

 

 

 

 

Unrealized

 

 

 

 

 

Foreign Currency

 

Minimum Pension

 

Gains (Losses) on
Available for Sale

 

 

 

 

 

Translation

 

Liability

 

Securities

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2014

 

$

2,333

 

$

(881

)

$

17

 

$

1,469

 

Other comprehensive income (loss)

 

(87

)

15

 

(49

)

(121

)

Balance - December 31, 2015

 

2,246

 

(866

)

(32

)

1,348

 

Other comprehensive income (loss), before reclassifications

 

(19

)

 

(6

)

(25

)

Amounts reclassified from AOCI

 

(430

)

866

 

18

 

454

 

Other comprehensive income (loss)

 

(449

)

866

 

12

 

429

 

Balance - December 31, 2016

 

1,797

 

 

(20

)

1,777

 

Other comprehensive income (loss)

 

42

 

 

(7

)

35

 

Balance - December 31, 2017

 

$

1,839

 

$

 

$

(27

)

$

1,812

 

The Company did not allocate additional tax expense (benefit) to other comprehensive income (loss) for all years presented as the Company is in a full valuation allowance position such that a deferred tax asset related to amounts recognized in other comprehensive income is not regarded as realizable on a more-likely-than-not basis.

During 2016, the Company finalized the process to terminate a defined benefit plan. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” in the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations. Additionally the Company completed its plan to liquidate one of its subsidiaries in Korea. As a result of this liquidation, a cumulative translation gain of $0.4 million was reclassified from “Accumulated other comprehensive income” to “Other, net” in the Consolidated Statements of Operations.

Preferred Stock

The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock, par value $0.01, with voting and economic rights to be determined by the Board of Directors. As of December 31, 2017, no2019, 0 preferred shares have been issued.

Treasury Stock

The share repurchase program authorized by ourthe Company’s Board of Directors in October 2015 expired on October 28, 2017. On December 11, 2017, ourthe Company’s Board of Directors authorized a new program to repurchase up to $100 million of ourthe Company’s common stock to be completed through December 11, 2019. At December 31, 2017, $3.0the end of the program, $14.3 million of the $100 million had been utilized, of which approximately $0.1 million is included in “Accrued expenses and other current liabilities” on the Consolidated Balance Sheets as of December 31, 2017. Repurchases are expected to be made from time to time in the open market or in privately negotiated transactions in accordance with applicable federal securities laws.utilized.

The Company records treasury stock purchases under the cost method using the first-in, first-out (“FIFO”) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and if additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is charged to accumulated deficit.

F-30F-32



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 15 — Stock Plans

Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”), which are administered by the Compensation Committee of the Board of Directors. The 2019 Plan originated as the 2010 Stock Incentive Plan and was originally approved by the Company’s shareholders.shareholders in May 2010. This Plan was subsequently amended, as approved by shareholders, in 2013, 2016, and 2019 (at which time the Plan was renamed the 2019 Stock Incentive Plan (as amended to date, the “2019 Plan”). The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2010 Stock Incentive2019 Plan, (as amended to date, the “2010 Plan”), which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share awards (“PSAs”), performance share units (“PSUs”), share appreciation rights, dividend equivalent rights, or any combination thereof. The Company settles awards under the Plans with newly issued shares or with shares held in treasury.

In 2013, the Board of Directors granted equity awards to certain employees under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”). The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. Stock options under this plan vest over a three year period and have a 10-year term, and RSUs under this plan vest over a two or four year period. At December 31, 2013, the Inducement Plan was merged into the 20102019 Plan and is considered an inactive plan with no0 further shares available for grant. At December 31, 20172019, there are 2,000 option shares and no0 RSUs outstanding under the Inducement Plan.

The Company is authorized to issue up to 10.613.3 million shares under the 2010 Plan, including additional shares authorized under plan amendments approved by shareholders in 2016 and 2013.2019 Plan. Option awards are granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 20102019 Plan. At December 31, 2017,2019, there are 1.41.1 million option shares and 0.60.9 million RSUs and PSUs outstanding under the 20102019 Plan.

During 2016, the Company’s Board of Directors approved the 2016 Employee Stock Purchase Plan (“ESPP”). The Company is authorized to issue up to 750,0001.5 million shares under the ESPP.ESPP, including additional shares authorized under a plan amendment approved by shareholders in 2019. Under the ESPP, substantially all employees in the U.S. may purchase the Company’s common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of the Company’s common stock at the beginning or end of each six-month Offer Period,offer period, as defined in the ESPP, and subject to certain limits. The ESPP was approved by the Company’s shareholders.

During 2017, in connection with the acquisition of Ultratech, the Company assumed certain restricted stock units (the “Assumed RSUs”) available and outstanding under the Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan, as amended (the “Ultratech Plan”). The Assumed RSUs remain subject to the terms set forth in the award agreement governing the award and the Ultratech Plan, except that the Assumed RSUs relate to shares of Company common stock and the number of restricted stock units was adjusted pursuant to the terms of the acquisition to reflect the difference in the value of a share of Company common stock and a share of Ultratech common stock prior to closing the acquisition. The Assumed RSUs were converted into 338,144 restricted stock units of the Company and generally vest over 50 months. After the acquisition and notwithstanding any other provisions of the Ultratech Plan, no0 further grants will be made under the Ultratech Plan, and the Company is solely maintaining the Ultratech Plan with respect to the Assumed RSUs. At December 31, 2017,2019, there are 0.1 million7,483 RSUs outstanding under the assumed Ultratech Plan.

Shares Reserved for Future Issuance

At December 31, 2017,2019, the Company has 5.76.0 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 20102019 Plan.At December 31, 2017,2019, the Company has 0.5 million shares reserved to cover future issuances under the ESPP Plan.

F-31F-33



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Share-Based Compensation

The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated:

 

For the year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

For the year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Cost of sales

 

$

2,505

 

$

1,956

 

$

2,495

 

 

$

1,903

 

$

1,885

 

$

2,505

Research and development

 

2,957

 

3,324

 

4,031

 

3,340

3,611

2,957

Selling, general, and administrative

 

12,851

 

10,433

 

11,474

 

9,630

9,417

12,851

Restructuring

 

1,880

 

 

 

397

1,161

1,880

Acquisition costs

 

4,203

 

 

 

 

 

 

4,203

Total

 

$

24,396

 

$

15,713

 

$

18,000

 

$

15,270

$

16,074

$

24,396

The Company did not realize any tax benefits associated with share-based compensation for the years ended December 31, 2017, 2016,2019, 2018, and 2015,2017 due to the full valuation allowance on its U.S. deferred tax assets. See Note 17, “Income Taxes” for additional information. The Company capitalized an insignificantimmaterial amount of share-based compensation into inventory for the years ended December 31, 2017, 2016,2019, 2018, and 2015.2017.

Unrecognized share-based compensation costs at December 31, 20172019 are summarized below:

 

Unrecognized

 

Weighted

 

 

Share-Based

 

Average Period

 

 

Compensation

 

Expected to be

 

 

Costs

 

Recognized

 

 

(in thousands)

 

(in years)

 

    

Unrecognized

    

Weighted

Share-Based

Average Period

Compensation

Expected to be

Costs

Recognized

(in thousands)

(in years)

Stock option awards

 

$

 12

 

0.3

 

 

$

Restricted stock units

 

6,157

 

2.8

 

1,884

2.4

Restricted stock awards

 

21,656

 

2.6

 

 

15,431

2.5

Performance share units

 

4,685

 

2.1

 

 

5,464

1.8

Total unrecognized share-based compensation cost

 

$

32,510

 

2.7

 

 

$

22,779

2.3

Stock Option Awards

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2017,2019, options outstanding that have vested and are expected to vest are as follows:

 

 

 

 

 

Weighted

 

 

 

 

Number

 

Weighted

 

Average

 

Aggregate

 

 

of

 

Average

 

Remaining

 

Intrinsic

 

 

Shares

 

Exercise Price

 

Contractual Life

 

Value

 

 

(in thousands)

 

 

 

(in years)

 

(in thousands)

 

Weighted

Number

Weighted

Average

Aggregate

of

Average

Remaining

Intrinsic

    

Shares

    

Exercise Price

    

Contractual Life

    

Value

(in thousands)

(in years)

(in thousands)

Vested

 

1,389

 

$34.99

 

3.9

 

 

1,119

$

34.88

2.0

Expected to vest

 

5

 

30.18

 

4.2

 

 

 

Total

 

1,394

 

$34.97

 

3.9

 

 

1,119

34.88

2.0

F-32



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The aggregate intrinsic value represents the difference between the option exercise price and $14.85,$14.69, the closing price of the Company’s common stock on December 29, 2017,31, 2019, the last trading day of the Company’s fiscal year as reported on the NASDAQ StockGlobal Select Market.

F-34

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Additional information with respect to stock option activity:

 

Number of
Shares

 

Weighted
Average
Exercise Price

 

 

(in thousands)

 

 

 

Balance - December 31, 2014

 

2,391

 

$

31.65

 

Granted

 

17

 

30.22

 

Exercised

 

(192

)

12.95

 

Expired or forfeited

 

(152

)

38.15

 

Balance - December 31, 2015

 

2,064

 

32.91

 

Granted

 

 

 

Exercised

 

(194

)

12.18

 

Expired or forfeited

 

(294

)

34.44

 

Weighted 

Number of

Average

    

Shares

    

Exercise Price

(in thousands)

Balance - December 31, 2016

 

1,576

 

35.18

 

1,576

$

35.18

Granted

 

 

 

Exercised

 

(18

)

30.03

 

(18)

 

30.03

Expired or forfeited

 

(164

)

37.47

 

(164)

 

37.47

Balance - December 31, 2017

 

1,394

 

$

34.97

 

1,394

34.97

Expired or forfeited

(172)

 

36.21

Balance - December 31, 2018

1,222

34.80

Expired or forfeited

(103)

33.97

Balance - December 31, 2019

1,119

34.88

The following table summarizes stock option information at December 31, 2017:2019:

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Aggregate

 

Average

 

Weighted

 

 

 

Aggregate

 

Average

 

Weighted

 

Range of

 

 

 

Intrinsic

 

Remaining

 

Average

 

 

 

Intrinsic

 

Remaining

 

Average

 

Exercise Prices

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

$20.00 – $30.00

 

25

 

$

 

5.0

 

$

28.13

 

23

 

$

 

5.0

 

$

28.03

 

$30.01 – $40.00

 

1,197

 

 

4.0

 

32.84

 

1,194

 

 

4.0

 

32.84

 

$40.01 – $50.00

 

39

 

 

1.3

 

48.05

 

39

 

 

1.3

 

48.05

 

$50.01 – $60.00

 

133

 

 

3.3

 

51.70

 

133

 

 

3.3

 

51.70

 

 

 

1,394

 

 

3.9

 

$

34.97

 

1,389

 

$

 

3.9

 

$

34.99

 

Options Outstanding and Exercisable

    

    

    

Weighted

    

Aggregate

Average

Weighted

Intrinsic

Remaining

Average

Range of Exercise Prices

Shares

Value

Contractual Life

Exercise Price

(in thousands)

(in thousands)

(in years)

$20.00 - $30.00

 

20

$

2.6

$

27.83

$30.01 - $40.00

969

2.1

32.81

$40.01 - $50.00

 

10

 

 

0.8

 

46.14

$50.01 - $60.00

 

120

 

1.4

 

51.70

 

1,119

$

2.0

34.88

The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model.

Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards. No options were granted in 2017 or 2016. The weighted average estimated values of employee stock option grants as well as the weighted average assumptions that were used in calculating such values during fiscal year 2015 was based on estimates at the date of grant as follows:

F-33



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Year ended December 31,

 

 

 

2015

 

Weighted average fair value

 

$

10.58

 

Dividend yield

 

0

%

Expected volatility factor(1)

 

44

%

Risk-free interest rate(2)

 

1.18

%

Expected life (in years)(3)

 

3.9

 


(1)         Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded options.

(2)         The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

(3)         The expected life is the number of years the Company estimates that options will be outstanding prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

The following table summarizes information on options exercised for the periods indicated:

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

Year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Cash received from options exercised

 

$

431

 

$

494

 

$

2,233

 

$

$

$

431

Intrinsic value of options exercised

 

$

51

 

$

1,165

 

$

2,089

 

$

$

$

51

RSAs, RSUs, PSAs, PSUs

RSAs are stock awards issued to employees that are subject to specified restrictions and a risk of forfeiture. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest. PSAs and PSUs are awards that result in a payment to a grantee inan issuance of shares of common stock to employees if certain performance goals and vesting criteriaor market conditions are achieved. TheseAll of these awards typically vest over one to five years and vesting is subject to the grantee’semployee's continued service with the Company and, in the case of performance awards, meeting thecertain performance condition.or market conditions. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant.grant, or, in the case of performance awards with market conditions, fair value is determined using a Monte Carlo simulation.

F-35

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The following table summarizes the equity activity of non-vested restricted shares and performance shares:

    

    

Weighted

Average

Number of

Grant Date

Shares

Fair Value

(in thousands)

Balance - December 31, 2016

 

1,949

$

23.85

Granted

 

674

29.22

Performance award adjustments

(25)

20.95

Assumed from Ultratech

338

31.75

Vested

 

(831)

27.67

Forfeited

(225)

26.29

Balance - December 31, 2017

1,880

25.41

Granted

1,257

17.37

Performance award adjustments

(5)

32.67

Vested

(523)

26.39

Forfeited

(391)

24.66

Balance - December 31, 2018

2,218

20.74

Granted

1,107

11.53

Performance award adjustments

(25)

28.91

Vested

(768)

21.77

Forfeited

(275)

18.48

Balance - December 31, 2019

2,257

16.20

F-34



TableThe total fair value of Contents

Veeco Instruments Inc.shares that vested during the years ended December 31, 2019, 2018, and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

Number of
Shares

 

Weighted
Average
Grant Date
Fair Value

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2014

 

1,237

 

$

34.27

 

Granted

 

672

 

30.33

 

Vested

 

(389

)

35.65

 

Forfeited

 

(122

)

34.46

 

Balance - December 31, 2015

 

1,398

 

31.97

 

Granted

 

1,166

 

17.59

 

Vested

 

(349

)

32.73

 

Forfeited

 

(266

)

27.31

 

Balance - December 31, 2016

 

1,949

 

23.85

 

Granted

 

674

 

29.22

 

Performance award adjustments

 

(25

)

20.95

 

Assumed from Ultratech

 

338

 

31.75

 

Vested

 

(831

)

27.67

 

Forfeited

 

(225

)

26.29

 

Balance - December 31, 2017

 

1,880

 

$

25.41

 

2017 was $8.8 million, $9.1 million, and $22.3 million, respectively. For performance awards, the final number of shares earned will vary depending on the achievement of the actual results relative to the performance targets.or market conditions. Each performance award is included in the table above at the grant date target share amount until the end of the performance period (ifif not previously forfeited). forfeited.

The total fair value of shares that vestedperformance awards with market conditions is estimated on the date of grant using a Monte Carlo simulation. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive these awards. The weighted average fair value and the assumptions used in calculating such values during fiscal years 2019 and 2018 for performance awards with market conditions were based on estimates at the years ended December 31, 2017, 2016,date of grant as follows:

Year ended December 31,

2019

    

2018

    

Weighted average fair value

$

16.45

$

15.58

Dividend yield

0

%  

0

%  

Expected volatility factor(1)

53

%  

49

%  

Risk-free interest rate(2)

2.37

%  

2.88

%  

Expected life (in years)(3)

2.8

 

3.0

 

(1)Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.
(2)The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.
(3)The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

F-36

Table of Contents

Veeco Instruments Inc. and 2015 was $22.3 million, $7.5 million, and $9.6 million, respectively.Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Employee Stock Purchase Plan

For the years ended December 31, 20172019, 2018, and 2016,2017 the Company received cash proceeds of $2.6$3.1 million, $3.1 million, and $1.2$2.6 million, and issued shares of 163,000395,941, 332,096, and 83,000,163,000, respectively, under the ESPP Plan. The weighted average estimated values of employee purchase rights as well as the weighted average assumptions that were used in calculating such values during fiscal years 20172019, 2018, and 20162017 were based on estimates at the date of grant as follows:

 

Year ended December 31,

 

 

2017

 

2016

 

Year ended December 31,

 

2019

    

2018

    

2017

 

Weighted average fair value

 

$

7.09

 

$

4.45

 

$

2.96

$

4.94

$

7.09

Dividend yield

 

0

%

0

%

0

%  

0

%  

0

%

Expected volatility factor(1)

 

36

%

43

%

Risk-free interest rate(2)

 

0.99

%

0.35

%

Expected life (in years)(3)

 

0.5

 

0.5

 

Expected volatility factor(1)

60

%  

62

%  

36

%

Risk-free interest rate(2)

2.41

%  

1.81

%  

0.99

%

Expected life (in years)(3)

0.5

 

0.5

 

0.5

(1)Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.
(2)The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.
(3)The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.


(1)         Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded options.

(2)         The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

(3)         The expected life is the number of years the Company estimates that options will be outstanding prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

F-35



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Note 16 — Retirement Plans

The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty50 cents for every dollar employees contribute, up to the lesser of three3 percent of the employee’s eligible compensation or three3 percent of the maximum the employee is permitted to contribute under then current Internal Revenue Code limitations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. In addition, the Company assumed Ultratech’s 401(k) plan as a result of the merger, and Ultratech’s plan was merged into the Company’s existing plan effective January 1, 2018. The Company recognized costsprovided employer contributions associated with these plans of approximately $2.7$2.4 million, $2.6$2.0 million, and $2.5$1.8 million for the years ended December 31, 2019, 2018, and 2017, 2016, and 2015, respectively.

During 2016, the Company finalized the process to terminate a defined benefit plan it had acquired in the year 2000. The plan had been frozen as of September 30, 1991, and no further benefits had been accrued by participants since that date. In connection with the termination, responsibility for the payment of benefits under the plan was transferred to an insurance company. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” in the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations.

Note 17 — Income Taxes

The amounts of income (loss) before income taxes attributable to domestic and foreign operations were as follows:

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

Year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Domestic

 

$

(96,809

)

$

(123,021

)

$

(53,553

)

$

(78,486)

$

(286,561)

$

(101,573)

Foreign

 

15,909

 

3,577

 

30,907

 

 

530

 

(147,273)

 

12,583

Total

 

$

(80,900

)

$

(119,444

)

$

(22,646

)

$

(77,956)

$

(433,834)

$

(88,990)

F-37

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Significant components of the expense (benefit) for income taxes consisted of the following:

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

Year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Current:

 

 

 

 

 

 

 

Federal

 

$

 

$

 

$

139

 

$

$

(1,682)

$

Foreign

 

(2,246

)

1,937

 

6,952

 

 

304

 

2,518

 

(2,246)

State and local

 

15

 

(111

)

(407

)

 

113

 

38

 

15

Total current expense (benefit) for income taxes

 

(2,231

)

1,826

 

6,684

 

 

417

 

874

 

(2,231)

Deferred:

 

 

 

 

 

 

 

Federal

 

(34,786

)

1,459

 

2,104

 

 

162

 

205

 

(35,912)

Foreign

 

1,652

 

(646

)

516

 

 

116

 

(27,932)

 

1,291

State and local

 

(742

)

127

 

28

 

 

82

 

107

 

(742)

Total deferred expense (benefit) for income taxes

 

(33,876

)

940

 

2,648

 

 

360

 

(27,620)

 

(35,363)

Total expense (benefit) for income taxes

 

$

(36,107

)

$

2,766

 

$

9,332

 

$

777

$

(26,746)

$

(37,594)

F-36



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

The income tax expense was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows:

 

Year ended December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

Year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Income tax expense (benefit) at U.S. statutory rates

 

$

(28,315

)

$

(41,806

)

$

(7,926

)

$

(16,396)

$

(91,105)

$

(31,147)

State taxes, net of U.S. federal impact

 

(2,523

)

(1,963

)

(1,607

)

 

(835)

 

(2,848)

 

(2,523)

Effect of international operations

 

9,355

 

8,849

 

(7,659

)

 

785

 

11,847

 

10,158

Research and development tax credit

 

620

 

(801

)

(1,628

)

 

(1,692)

 

(2,230)

 

620

Net change in valuation allowance

 

1,342

 

50,520

 

23,655

 

 

15,098

 

7,747

 

1,883

Change in accrual for unrecognized tax benefits

 

(4,772

)

(1,700

)

4,876

 

 

1,232

 

2,868

 

(4,772)

Subsidiary liquidation

 

 

(12,435

)

 

Share-based compensation

 

99

 

2,133

 

 

1,947

1,848

99

Effect of 2017 Tax Act

 

(11,344

)

 

 

(1,690)

(11,344)

Worthless stock deduction

 

 

 

(2,069

)

Change in entity tax status

 

 

 

904

 

Asset impairment

495

46,872

Other

 

(569

)

(31

)

786

 

 

143

 

(55)

 

(568)

Total expense (benefit) for income taxes

 

$

(36,107

)

$

2,766

 

$

9,332

 

$

777

$

(26,746)

$

(37,594)

The 2017 income tax benefit of $36.1 million includes a $24.2 million income tax benefit related to domestic losses incurred during the year ended December 31, 2017, as the deferred tax liability created by the issuance of the Convertible Senior Notes and recorded as a component of APIC is treated as a source of income in fiscal 2017. Additionally, on December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”). The 2017 Tax Act makes broad and complex changes to the U.S. tax code that affects the Company’s 2017 financial results, including, but not limited to, a one-time transition tax on certain foreign earnings. The 2017 Tax Act also establishes new tax laws that will affect the Company’s financial results after 2017, including a reduction in the U.S. federal corporate income tax rate from 35 percent to 21 percent; current U.S. taxation of global intangible low tax income (“GILTI”) of non-U.S. operations; additional limitations on the deductibility of executive compensation; and limitations on the deductibility of interest.

The Company recognized the income tax effects of the 2017 Tax Act in its 2017 financial statements in accordance with SAB 118, which providesprovided SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. As such, the Company’s 2017 financial results reflect the income tax effects of the 2017 Tax Act, includingincluded provisional amounts for specific income tax effects of the 2017 Tax Act for which the accounting under ASC 740 iswas incomplete but for which a reasonable estimate could be determined. TheDuring the year ended December 31, 2018, the Company will complete its analysisfinalized the accounting for the tax effects of 2017 Tax Act based on legislative updates currently available and finalize the amounts within the measurement period as provided by SAB 118.

The Company is stillrecorded an additional income tax benefit of $1.7 million for alternative minimum tax credits that became refundable in the process of evaluating the impacts ofaccordance with the 2017 Tax Act and considers the amounts recorded to be provisional, except for the impact of the changeAct. The Company also reported an increase in tax rate on its deferred tax assets and liabilitiesof $6.8 million as a result of December 31, 2017,adjustments to tax attributes utilized for one-time transition tax, which the accounting is complete.was offset by a full valuation allowance.

The most significant impacts of the 2017 Tax Act on the Company’s federal income taxes arefor the year ended December 31, 2017 were as follows:

Reduction of the U.S. Corporate Income Tax Rate

The Company measures deferred tax assets and liabilities using enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid. Accordingly, the Company’s deferred tax assets and liabilities were re-measured as of December 22, 2017 to reflect the reduction in the U.S. corporate income tax rate from

F-38

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

35 percent to 21 percent. The Company recorded an income tax benefit of $4.8 million for the year ended December 31, 2017, as the net deferred tax assets were reduced by $25.6 million with a corresponding valuation allowance reduction of $30.4 million.

One-Time Transition Tax on Foreign Earnings

As of December 31, 2017, the Company had $155.8$180.1 million of accumulated undistributedforeign earnings generated by its non-U.S. subsidiaries, of which approximately $140.2 millionthat was subject to the one-time transition tax on foreign earnings.tax. The determinationCompany used its 2017 and carryforward net operating losses to offset the impact of the transition tax requires further analysis regarding the amount and composition of the Company’s historical foreign earnings, which is expected to be completed in the second half of 2018. The Company is expecting to

F-37



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

fully offset the U.S. tax liability with certain current year and carryforward tax attributes.tax. As the Company maintains a full valuation allowance against its U.S. deferred tax assets, the Company did not record an income tax expense related to the transition tax.tax for the year ended December 31, 2017.

Valuation Allowance

The 2017 Tax Act modified the net operating loss (“NOL”Net Operating Loss ("NOL") provisions to provide for an indefinite carryforward of NOLs arising in tax years beginning after December 31, 2017. The 2017 Tax Act also limits the amount of NOL deductions that can be used in any one year to 80 percent of the taxpayer’s taxable income, effective with respect to NOLs arising in tax years beginning after December 31, 2017. The Company recognized an income tax benefit of $6.5 million for the year ended December 31, 2017 related to a reduction in the Company’s valuation allowance as a result of the Company scheduling out the reversals of its net deferred tax assets which resulted in tax amortization on indefinite-lived intangible assets becoming available to offset existing deferred tax assets that are now expected to have an indefinite life.

Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows:

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

December 31,

    

2019

    

2018

(in thousands)

Deferred tax assets:

 

 

 

 

 

Inventory valuation

 

$

8,007

 

$

6,681

 

 

$

11,170

$

8,943

Net operating losses

 

73,458

 

54,527

 

63,342

 

67,787

Credit carry forwards

 

34,966

 

24,598

 

55,103

52,592

Warranty and installation accruals

 

1,690

 

1,757

 

1,391

 

1,695

Share-based compensation

 

7,385

 

12,624

 

6,296

 

6,981

Other

 

1,966

 

6,778

 

9,496

 

2,182

Total deferred tax assets

 

127,472

 

106,965

 

146,798

 

140,180

Valuation allowance

 

(100,684

)

(106,793

)

(130,053)

 

(114,955)

Net deferred tax assets

 

26,788

 

172

 

16,745

 

25,225

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Purchased intangible assets

 

45,807

 

11,071

 

9,345

 

15,401

Undistributed earnings

 

 

186

 

Convertible Senior Notes

 

13,534

 

 

8,831

11,265

Depreciation

 

1,339

 

69

 

2,668

 

2,380

Total deferred tax liabilities

 

60,680

 

11,326

 

20,844

 

29,046

Net deferred taxes

 

$

(33,892

)

$

(11,154

)

 

$

(4,099)

$

(3,821)

The Company is no longer permanently reinvesting future earnings from certain foreign jurisdictions and has recorded an expenseaccrued for foreign tax withholdings of $6.2$0.6 million on its unremitted earnings as of December 31, 2017.2019.

F-39

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

At December 31, 2017,2019, the Company had U.S. federal NOL carryforwards of approximately $301.6$270.9 million, that will expireof which $6.4 million has an indefinite carryforward period, with the remaining expiring in varying amounts between 20242033 and 2037, if not utilized. In connection with the Ultratech acquisition, $119.0the Company has $120.8 million of historical NOL carryforwards were acquired, which are subject to an annual limitation. The Company has $3.5 million of capital loss carryforwards that expire in 2021. At December 31, 2017,2019, the Company had U.S. federal research and development credits of $16.7$29.8 million that will expire between 20182020 and 2037.2039. The Ultratech acquisition resulted in the carryover of $10.9$11.4 million of research and development credit carryforwards, which are subject to an annual limitation. The Company also has $9.4 million of foreign tax credits that expire in 2027. Additionally, the Company has state and local NOL carryforwards of approximately

F-38



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

$127.4 $127.5 million (a net deferred tax asset of $7.6$8.1 million, net of federal tax benefits and before the valuation allowance) that will expire between 20182020 and 2036.2039. Finally, the Company has state credits of $27.1$28.4 million, some of which are indefinite and others that will expire between 20182020 and 2030.2034.

The Company makes assessments to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. As of December 31, 2017,2019, the Company continued to have a cumulative three year loss with respect to its U.S. operations. As such, the Company has recorded a valuation allowance against its U.S. deferred tax assets. During 2017,2019, the Company’s valuation allowance decreasedincreased by approximately $6.1 million, primarily related to re-measurement due to the reduction in the U.S. federal corporate income tax rate from 35 percent to 21 percent, utilization of certain carryforward tax attributes used for the mandatory repatriation tax partially offset by an increase in the valuation allowance related to the Ultratech business combination.$15.1 million.

A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows:

 

December 31,

 

 

2017

 

2016

 

2015

 

 

(in thousands)

 

December 31,

    

2019

    

2018

    

2017

(in thousands)

Balance at beginning of year

 

$

7,452

 

$

9,152

 

$

4,276

 

$

11,137

$

8,269

$

7,452

Additions for tax positions related to current year

 

511

 

1,038

 

5,596

 

 

3,075

 

2,154

 

511

Additions for tax positions related to prior years

 

3

 

233

 

143

 

 

21

 

1,721

 

3

Reductions for tax positions related to prior years

 

(4,877

)

(2,826

)

 

 

(1,814)

 

(934)

 

(4,877)

Reductions due to the lapse of the statute of limitations

 

(122

)

(39

)

(642

)

 

 

(26)

 

(122)

Settlements

 

(287

)

(106

)

(221

)

 

(50)

 

(47)

 

(287)

Additions for business combination

 

5,589

 

 

 

5,589

Balance at end of year

 

$

8,269

 

$

7,452

 

$

9,152

 

$

12,369

$

11,137

$

8,269

If the amount of unrecognized tax benefits at December 31, 20172019 were recognized, the Company’s income tax provision would decrease by $0.6$1.5 million. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.4 million and $0.3 million at both December 31, 20172019 and 2016.2018, respectively.

The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions. All material consolidated federal income tax matters have been concluded for years through 20142016 subject to subsequent utilization of NOLs generated in such years. All material state and local income tax matters have been reviewed through 2012. The majority of the Company’s foreign jurisdictions have been reviewed through 2015. The Company’s major foreign jurisdictions’ statutes of limitation remain open with respect to the tax years 2017 and 2018 for China, 2015 through 20172018 for Germany and Singapore, and 2016 through 20172018 for Taiwan. Income tax matters for Ultratech pre-acquisition periods have been reviewed through 2000 for federal, 1997 for major states and 2003 for foreign jurisdictions. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing tax audits and any resultant settlement.

Note 18 — Segment Reporting and Geographic Information

The Company operates and measures its results in one1 operating segment and therefore has one1 reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make

F-40

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results.

Sales by market is as follows:

For the year ended December 31,

    

2019

    

2018

    

2017

(in thousands)

Sales by end-market

Front-End Semiconductor

$

120,128

$

62,582

$

40,319

Advanced Packaging, MEMS & RF Filters

 

66,909

 

90,775

 

67,406

LED Lighting, Display & Compound Semiconductor

72,791

249,974

248,615

Scientific & Industrial

 

159,521

 

138,751

 

119,346

Total

$

419,349

$

542,082

$

475,686

F-39



Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

 

 

For the year ended December 31,

 

 

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

Sales by end-market

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

253,785

 

$

144,675

 

$

291,133

 

Advanced Packaging, MEMS & RF Filters

 

69,353

 

68,304

 

61,935

 

Scientific & Industrial

 

120,788

 

111,198

 

118,132

 

Front-End Semiconductor

 

40,830

 

8,274

 

5,838

 

Total

 

$

484,756

 

$

332,451

 

$

477,038

 

The Company’s significant operations outside the United States include sales and service offices in China, Europe, and Rest of World. For geographic reporting, sales are attributed to the location in which the customer facility is located.

Sales and long-lived tangible assets by geographic region are as follows:

 

 

Net Sales to Unaffiliated Customers

 

Long-lived Tangible Assets

 

 

 

2017

 

2016

 

2015

 

2017

 

2016

 

2015

 

 

 

(in thousands)

 

United States

 

$

94,936

 

$

85,637

 

$

86,627

 

$

81,046

 

$

60,012

 

$

64,951

 

China

 

107,844

 

85,834

 

242,442

 

64

 

219

 

422

 

EMEA(1)

 

76,636

 

83,410

 

64,019

 

231

 

93

 

96

 

Rest of World

 

205,340

 

77,570

 

83,950

 

3,717

 

322

 

14,121

 

Total

 

$

484,756

 

$

332,451

 

$

477,038

 

$

85,058

 

$

60,646

 

$

79,590

 

Net Sales to Unaffiliated Customers

Long-lived Tangible Assets

    

2019

    

2018

    

2017

    

2019

    

2018

    

2017

(in thousands)

United States

$

126,160

$

125,659

$

93,433

$

75,187

$

78,503

$

81,046

China

 

71,078

 

194,032

 

106,674

 

130

 

81

 

64

EMEA(1)

57,351

89,102

72,979

143

205

231

Rest of World

 

164,760

 

133,289

 

202,600

 

251

 

1,495

 

3,717

Total

$

419,349

$

542,082

$

475,686

$

75,711

$

80,284

$

85,058


(1) 

(1)EMEA consists of Europe, the Middle East, and Africa

Note 19 Selected Quarterly Financial Information (unaudited)

The following table presents selected unaudited financial data for each fiscal quarter of 20172019 and 2016.2018. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations.

 

Fiscal 2017

 

Fiscal 2016

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Q1

 

Q2

 

Q3

 

Q4

 

 

(in thousands, except per share amounts)

 

Fiscal 2019

Fiscal 2018

    

Q1

    

Q2

    

Q3

    

Q4

    

Q1

    

Q2

    

Q3

    

Q4

(in thousands, except per share amounts)

Net sales

 

$

94,386

 

$

115,066

 

$

131,872

 

$

143,432

 

$

78,011

 

$

75,348

 

$

85,482

 

$

93,609

 

$

99,371

$

97,822

$

108,954

$

113,202

$

158,574

$

157,779

$

126,757

$

98,972

Gross profit

 

34,200

 

38,720

 

53,061

 

58,337

 

31,956

 

31,439

 

33,455

 

36,008

 

34,716

36,285

42,223

44,970

56,680

55,395

46,385

35,259

Net income (loss)

 

1,095

 

(18,388

)

(21,884

)

(5,616

)

(15,533

)

(32,082

)

(69,598

)

(4,998

)

(18,530)

(15,565)

(11,767)

(32,871)

(15,827)

(237,634)

(8,953)

(144,674)

Basic income (loss) per common share

 

0.03

 

(0.43

)

(0.47

)

(0.12

)

(0.40

)

(0.82

)

(1.78

)

(0.13

)

(0.40)

(0.33)

(0.25)

(0.69)

(0.34)

(5.02)

(0.19)

(3.11)

Diluted income (loss) per common share

 

0.03

 

(0.43

)

(0.47

)

(0.12

)

(0.40

)

(0.82

)

(1.78

)

(0.13

)

(0.40)

(0.33)

(0.25)

(0.69)

(0.34)

(5.02)

(0.19)

(3.11)

F-41

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Acquisition of UltratechAsset Impairments

During the fourth quarter of 2019, the Company recorded a non-cash impairment charge of $21 million related to its equity investment in Kateeva which is included in “Other income (expense), net” in the Consolidated Statements of Operations, as well as a non-cash impairment charge of $4.0 million related to the classification of a disposal group as held for sale which is included in “Asset impairment” in the Consolidated Statements of Operations. Refer to Note 4, “Investments,” and Note 5, “Acquisitions and Dispositions,” for additional information.

During the second quarter of 2017,2018, the Company acquired Ultratech. The resultsrecorded non-cash impairment charges related to the Ultratech asset group of operations of Ultratech have been included in$216.4 million and $35.9 million for definite-lived intangible assets and in-process research and development assets, respectively. Additionally, during the consolidated financial statements since the date of acquisition. Refer to Note 5, “Business Combinations,” for additional information.

Impairment Charge

During the thirdfourth quarter of 2016,2018, the Company decided to reduce future investments in certain technologies and, as a result, recorded a charge for impairment of $54.3 million for the related intangible purchased technology. Thenon-cash goodwill impairment charge was based on projected cash flows that required the use of unobservable inputs.$122.8 million. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information.

F-40


F-42


Veeco Instruments Inc. and Subsidiaries

Notes to Consolidated Financial Statements (Continued)

Schedule II — Valuation and Qualifying Accounts

 

 

 

Additions

 

 

 

 

 

 

 

 

Charged

 

 

 

 

 

 

 

 

Balance at

 

(Credited)

 

Charged to

 

 

 

Balance at

 

 

Beginning

 

to Costs and

 

Other

 

 

 

End of

 

Additions

Charged

    

Balance at

    

(Credited)

    

Charged to

    

    

Balance at

Beginning

 to Costs and

Other

End of

Deducted from asset accounts:

 

of Period

 

Expenses

 

Accounts

 

Deductions

 

Period

 

of Period

Expenses

Accounts

Deductions

Period

 

(in thousands)

 

(in thousands)

Year ended December 31, 2019

Allowance for doubtful accounts

$

270

$

392

$

$

(60)

$

602

Valuation allowance in net deferred tax assets

 

114,955

 

15,098

 

 

 

130,053

$

115,225

$

15,490

$

$

(60)

$

130,655

Year ended December 31, 2018

Allowance for doubtful accounts

$

270

$

$

$

$

270

Valuation allowance in net deferred tax assets

 

100,456

 

14,499

 

 

 

114,955

$

100,726

$

14,499

$

$

$

115,225

Year ended December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

286

 

$

99

 

$

 

$

(115

)

$

270

 

$

286

$

99

$

$

(115)

$

270

Valuation allowance in net deferred tax assets

 

106,793

 

(51,410

)

45,301

 

 

100,684

 

 

104,744

 

(49,589)

 

45,301

 

 

100,456

 

$

107,079

 

$

(51,311

)

$

45,301

 

$

(115

)

$

100,954

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

206

 

$

171

 

$

 

$

(91

)

$

286

 

Valuation allowance in net deferred tax assets

 

56,273

 

50,520

 

 

 

106,793

 

 

$

56,479

 

$

50,691

 

$

 

$

(91

)

$

107,079

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2015

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

731

 

$

43

 

$

 

$

(568

)

$

206

 

Valuation allowance in net deferred tax assets

 

34,909

 

23,655

 

(2,291

)

 

56,273

 

 

$

35,640

 

$

23,698

 

$

(2,291

)

$

(568

)

$

56,479

 

$

105,030

$

(49,490)

$

45,301

$

(115)

$

100,726

S-1


S-1